0001213900-16-013366.txt : 20160516 0001213900-16-013366.hdr.sgml : 20160516 20160516120511 ACCESSION NUMBER: 0001213900-16-013366 CONFORMED SUBMISSION TYPE: 10-Q PUBLIC DOCUMENT COUNT: 53 CONFORMED PERIOD OF REPORT: 20160331 FILED AS OF DATE: 20160516 DATE AS OF CHANGE: 20160516 FILER: COMPANY DATA: COMPANY CONFORMED NAME: OCEAN BIO CHEM INC CENTRAL INDEX KEY: 0000350737 STANDARD INDUSTRIAL CLASSIFICATION: SPECIALTY CLEANING, POLISHING AND SANITATION PREPARATIONS [2842] IRS NUMBER: 591564329 STATE OF INCORPORATION: FL FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-Q SEC ACT: 1934 Act SEC FILE NUMBER: 000-11102 FILM NUMBER: 161651951 BUSINESS ADDRESS: STREET 1: 4041 SW 47TH AVE CITY: FORT LAUDERDALE STATE: FL ZIP: 33314 BUSINESS PHONE: 9545876280 MAIL ADDRESS: STREET 1: 4041 SW 47TH AVE CITY: FT LAUDERDALE STATE: FL ZIP: 33028 FORMER COMPANY: FORMER CONFORMED NAME: STAR BRITE CORP DATE OF NAME CHANGE: 19841204 10-Q 1 f10q0316_oceanbiochem.htm QUARTERLY REPORT

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 10-Q

 

x        QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the quarterly period ended March 31, 2016

 

¨       TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the transition period from _____ to _____

 

Commission File Number 0-11102

 

OCEAN BIO-CHEM, INC.

(Exact name of registrant as specified in its charter)

 

Florida   59-1564329

(State or other jurisdiction of

incorporation or organization)

  

(I.R.S. Employer

Identification No.)

 

4041 SW 47 AVENUE

FORT LAUDERDALE, FLORIDA  33314

(Address of principal executive offices)

 

954-587-6280

(Registrant’s telephone number, including area code)

 

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.  Yes  x  No  ¨

 

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files).  Yes  x  No  ¨

 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company.  See the definitions of “large accelerated filer,” “accelerated filer” and smaller reporting company” in Rule 12b-2 of the Exchange Act.

 

Large accelerated filer   ☐ Accelerated filer     ☐ 
Non-accelerated filer   ☐  Smaller reporting company ☒ 

 

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Act). Yes  ¨ No  x

 

At May 12, 2016, 9,008,855 shares of the registrant’s Common Stock were outstanding.

 

 

 

 

OCEAN BIO-CHEM, INC. AND SUBSIDIARIES

TABLE OF CONTENTS

 

    Page
PART I Financial Information:  
     
Item 1. Financial Statements 3
     
  Condensed consolidated balance sheets at March 31, 2016 (unaudited) and December 31, 2015 3
     
  Condensed consolidated statements of operations (unaudited) for the three months ended March 31, 2016 and 2015 4
     
  Condensed consolidated statements of comprehensive income (unaudited) for the three months ended March 31, 2016 and 2015 5
     
  Condensed consolidated statements of cash flows (unaudited) for the three months ended March 31, 2016 and 2015 6
     
  Notes to condensed consolidated financial statements 7-13
     
Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations 14-17
     
Item 3. Quantitative and Qualitative Disclosures about Market Risk 17
     
Item 4. Controls and Procedures 17
     
PART II Other Information:  
     
Item 1. Legal Proceedings 17
     
Item 1A. Risk Factors 17
     
Item 6. Exhibits 18
     
  Signatures 19

  

2

 

PART 1 - FINANCIAL INFORMATION

 

Item 1. Financial Statements

 

OCEAN BIO-CHEM, INC. AND SUBSIDIARIES

CONSOLIDATED BALANCE SHEETS

 

   March 31, 2016   December 31, 2015 
   (Unaudited)     
ASSETS        
Current Assets:        
Cash  $2,436,078   $2,468,415 
Trade accounts receivable less allowances of approximately $67,000 and $78,000, respectively   4,090,357    5,092,040 
Receivables due from affiliated companies   1,068,430    1,051,091 
Inventories, net   9,065,836    7,914,950 
Prepaid expenses and other current assets   1,155,669    942,820 
Deferred tax asset   122,831    125,335 
Total Current Assets   17,939,201    17,594,651 
           
Property, plant and equipment, net   5,203,611    5,356,388 
           
Other Assets:          
Intangible assets, net   1,020,398    1,037,968 
Total Other Assets   1,020,398    1,037,968 
Total Assets  $24,163,210   $23,989,007 
           
LIABILITIES AND SHAREHOLDERS' EQUITY          
Current Liabilities:          
Accounts payable – trade  $2,119,425   $1,101,720 
Current portion of long-term debt   453,533    451,148 
Dividends payable   540,531    ---- 
Accrued expenses payable   893,477    1,098,721 
Total Current Liabilities   4,006,966    2,651,589 
           
Deferred tax liability   356,488    365,012 
Long-term debt, less current portion   213,567    328,818 
Total Liabilities   4,577,021    3,345,419 
           
Commitments and contingencies          
Shareholders' Equity:          
Common stock - $.01 par value, 12,000,000 shares authorized; 9,008,855 shares and 8,983,374 shares issued, respectively   90,089    89,834 
Additional paid in capital   9,308,658    9,287,313 
Foreign currency translation adjustment   (282,108)   (284,442)
Retained earnings   10,469,550    11,550,883 
Total Shareholders' Equity   19,586,189    20,643,588 
           
Total Liabilities and Shareholders' Equity  $24,163,210   $23,989,007 

 

The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.

 

3

   

OCEAN BIO-CHEM, INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

(UNAUDITED)

 

   Three Months Ended 
   March 31, 
   2016   2015 
         
Gross sales  $7,072,535   $6,328,343 
Less: discounts, returns, and allowances   322,455    325,914 
           
Net sales   6,750,080    6,002,429 
           
Cost of goods sold   4,368,137    3,965,780 
           
Gross profit   2,381,943    2,036,649 
           
Operating Expenses:          
Advertising and promotion   715,872    615,872 
Selling and administrative   2,485,863    1,421,546 
Total operating expenses   3,201,735    2,037,418 
           
Operating loss   (819,792)   (769)
           
Other (expense)          
Interest, net (expense)   (5,884)   (10,075)
Other (expense)   ---    (12,522)
           
Loss before income taxes   (825,676)   (23,366)
           
Income tax benefit   284,874    7,440 
           
Net loss  $(540,802)  $(15,926)
           
Loss per common share – basic and diluted  $(0.06)  $--- 
           
Dividends declared per common share  $0.06   $--- 

 

The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.

 

4

 

OCEAN BIO-CHEM, INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME

(UNAUDITED)

 

   Three Months Ended 
   March 31, 
   2016   2015 
         
Net loss  $(540,802)  $(15,926)
           
Foreign currency translation adjustment   2,334    (8,115)
           
Comprehensive loss  $(538,468)  $(24,041)

 

The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.

  

5

 

OCEAN BIO-CHEM, INC. AND SUBSIDIARIES
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
(UNAUDITED)

 

   Three Months Ended 
   March 31, 
   2016   2015 
Cash flows from operating activities:        
         
Net loss  $(540,802)  $(15,926)
Adjustments to reconcile net loss to net cash provided by (used in) operating activities:          
           
Depreciation and amortization   246,841    221,559 
Deferred income taxes   (6,020)   (9,012)
Loss on sale of property, plant and equipment   ---    12,522 
Other operating non-cash items   (2,366)   23,874 
           
Changes in assets and liabilities:          
           
Trade accounts receivable   1,012,558    1,374,194 
Inventories   (1,154,606)   (2,001,274)
Prepaid expenses and other current assets   (212,849)   (219,163)
    Receivables due from affiliated companies   (17,339)   (332,708)
Accounts payable and other accrued expenses   812,461    340,462 
           
Net cash provided by (used in) operating activities   137,878    (605,472)
           
Cash flows from investing activities:          
Purchases of property, plant and equipment   (76,494)   (370,795)
            Sale of property, plant, and equipment   ---    55,000 
Net cash used in investing activities   (76,494)   (315,795)
           
Cash flows from financing activities:          
Payments on long-term debt   (112,866)   (105,343)
Proceeds from exercise of stock options   21,600    --- 
Net cash used in financing activities   (91,266)   (105,343)
           
Effect of exchange rates on cash   (2,455)   (24,560)
           
Net decrease in cash   (32,337)   (1,051,170)
           
Cash at beginning of period   2,468,415    3,062,729 
Cash at end of period  $2,436,078   $2,011,559 
           
Supplemental disclosure of cash flow information:          
Cash paid for interest during period  $6,199   $10,379 
Cash paid for income taxes during period  $---   $87,000 

 

The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.

 

6

 

OCEAN BIO-CHEM, INC. AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

 

1. SUMMARY OF ACCOUNTING POLICIES

 

Interim reporting

 

The accompanying unaudited condensed consolidated financial statements include the accounts of Ocean Bio-Chem, Inc. and its wholly-owned subsidiaries. All significant inter-company accounts and transactions have been eliminated in consolidation. Certain prior period data have been reclassified to conform to the current period presentation.  Unless the context indicates otherwise, the term “Company” refers to Ocean Bio-Chem, Inc. and its subsidiaries.

 

The unaudited condensed consolidated financial statements have been prepared in accordance with United States generally accepted accounting principles (“GAAP”) for interim financial information and with the instructions to Form 10-Q and Article 8 of Regulation S-X.  Accordingly, they do not include all of the information and footnotes required by GAAP for complete financial statements.

 

The financial information furnished herein reflects all adjustments, consisting of normal recurring items that, in the opinion of management, are necessary for a fair presentation of the Company’s financial position, results of operations and cash flows for the interim periods.  The results of operations for the three months ended March 31, 2016 are not necessarily indicative of the results to be expected for the year ending December 31, 2016.

 

The information included in this Form 10-Q should be read in conjunction with the Company’s Annual Report on Form 10-K for the year ended December 31, 2015.

 

Use of estimates

 

The preparation of condensed consolidated financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period.  Actual results could differ from those estimates and assumptions.

 

2. RECENT ACCOUNTING PRONOUNCEMENTS

 

There have been no accounting pronouncements or changes in accounting pronouncements during the three months ended March 31, 2016 that are expected to have a material impact on the Company’s financial position, results of operations or cash flows.  Accounting pronouncements that became effective during the three months ended March 31, 2016 did not have a material impact on disclosures or on the Company’s financial position, results of operations or cash flows.

 

7

 

3. INVENTORIES

 

The Company’s inventories at March 31, 2016 and December 31, 2015 consisted of the following:

 

  

March 31,

2016

  

December 31,

2015

 
Raw materials  $3,853,721   $3,749,702 
Finished goods   5,495,717    4,445,130 
Inventories, gross   9,349,438    8,194,832 
           
Inventory reserves   (283,602)   (279,882)
           
Inventories, net  $9,065,836   $7,914,950 

 

The inventory reserves shown in the table above reflect slow moving and obsolete inventory.

 

The Company manages an inventory program for one of its customers to improve the promotion of the Company's products.  The Company manages the inventory levels at the customer’s warehouses and recognizes revenue as the products are sold by the customer.  The inventories managed at the customer’s warehouses amounted to approximately $469,000 and $543,000 at March 31, 2016 and December 31, 2015, respectively, and are included in inventories, net on the condensed consolidated balance sheets.

 

4. PROPERTY, PLANT & EQUIPMENT

 

The Company’s property, plant and equipment at March 31, 2016 and December 31, 2015 consisted of the following:

 

  

Estimate

Useful Life

 

March 31,

2016

  

December 31,

2015

 
Land     $278,325   $278,325 
Building and improvements  30 years   4,652,669    4,652,669 
Manufacturing and warehouse equipment  6-20 years   9,153,057    9,072,162 
Office equipment and furniture  3-5 years   1,268,545    1,293,609 
Construction in process      197,545    215,155 
Leasehold improvements  10-15 years   544,146    544,146 
Vehicles  3 years   42,283    42,283 
Property, plant and equipment, gross      16,136,570    16,098,349 
              
Less accumulated depreciation      (10,932,959)   (10,741,961)
              
Property, plant and equipment, net     $5,203,611   $5,356,388 

 

8

 

5. REVOLVING LINE OF CREDIT

 

On August 4, 2014, the Company and Regions Bank entered into a Business Loan Agreement (the“Business Loan Agreement”), under which the Company was provided a renewed revolving line of credit. Under the renewed revolving line of credit, the Company may borrow up to the lesser of (i) $6 million or (ii) a borrowing base equal to 80% of eligible accounts receivable (as defined in the Business Loan Agreement) plus 50% of eligible inventory (as defined in the Business Loan Agreement). Interest on amounts borrowed under the revolving line of credit is payable monthly at the 30 day LIBOR rate plus 1.65% per annum, unless the Company’s debt service coverage ratio (generally, net operating profit plus depreciation, amortization and lease/rent expense divided by current maturities of long-term debt plus interest and lease/rent expense, calculated on a trailing twelve month basis) falls to or below 2.0 to 1, in which case interest is payable at the 30 day LIBOR rate plus 2.65% per annum.

 

Outstanding amounts under the revolving line of credit are payable on demand. If no demand is made, the Company may repay and reborrow funds from time to time until expiration of the revolving line of credit on July 6, 2016, at which time all outstanding principal and interest will be due and payable. The Company’s obligations under the revolving line of credit are secured by, among other things, the Company’s accounts receivable, inventory, contract rights and general intangibles and, as a result of cross-collateralization of the Company’s obligations under the term loan described in Note 6 and the revolving line of credit, real property and equipment at the Montgomery, Alabama facility of the Company’s subsidiary, Kinpak, Inc. ("Kinpak"). The Business Loan Agreement includes financial covenants requiring a minimum debt service coverage ratio (generally, net operating profit plus depreciation, amortization and lease/rent expense divided by current maturities of long-term debt plus interest and lease/rent expense) of 1.75 to 1.00, calculated on a trailing twelve month basis, and a maximum debt to capitalization ratio (generally, funded debt divided by the sum of total net worth and funded debt) of 0.75 to 1, tested quarterly. The line of credit is subject to several events of default, including a decline in the majority shareholder’s ownership below 50% of all outstanding shares. At March 31, 2016, the Company was not in compliance with the financial covenant relating to its minimum debt service coverage ratio, as its debt service coverage ratio was 1.67. Although the deficiency in the Company’s debt service coverage ratio results in an event of default under the Business Loan Agreement, the Company had no borrowings under the revolving line of credit at March 31, 2016, and Regions Bank waived the default through May 9, 2017. The deficiency in the debt service coverage ratio also may have resulted in an event of default under the term loan described in Note 6 below due to the cross-default provisions of the term loan. However, any resulting default has been waived through May 9, 2017 by Regions Equipment Financing Corporation (“REFCO”), a subsidiary of Regions Bank and the lender under the term loan.

 

6. LONG TERM DEBT

 

On July 6, 2011, REFCO provided to the Company a $2,430,000 term loan with a fixed interest rate of 3.54%, subject to an increase to 4.55% in the event the Company's debt service coverage ratio (net profit plus taxes, interest, depreciation, amortization and rent expense divided by debt service plus interest and lease/rent expense, calculated on a trailing four-quarter basis) falls to or below 2.0 to 1. Principal and interest on the term loan are payable in equal monthly installments through July 6, 2017, the date on which the term loan matures. The proceeds of the term loan were used to pay the Company’s remaining obligations under a lease agreement relating to industrial revenue bonds used to fund the expansion of Kinpak’s facilities and acquisition of related equipment. At March 31, 2016, approximately $585,000 was outstanding under the term loan. The term loan and the revolving line of credit under the Bank Loan Agreement are cross-defaulted (i.e., a default under one instrument is a default under the other). See Note 5 for information regarding REFCO’s waiver of an event of default that may be deemed to have occurred under the cross-default provisions of the term loan as a result of an event of default under the Business Loan Agreement; REFCO has waived the default through May 9, 2017.

 

At March 31, 2016 and December 31, 2015, the Company was obligated under capital lease agreements covering equipment utilized in the Company’s operations.  The capital leases, aggregating approximately $82,000 and $88,000 at March 31, 2016 and December 31, 2015, respectively, mature on July 1, 2020 and carry an interest rate of 2%.

 

The following table provides information regarding the Company’s long term debt at March 31, 2016 and December 31, 2015:

 

   Current Portion   Long Term Portion 
   March 31,
2016		  

December 31,

2015

   March 31,
2016		   December 31,
2015		 
Term loan  $436,441   $432,601   $148,942   $259,503 
Capitalized equipment leases   17,092    18,547    64,625    69,315 
                     
Total long term debt  $453,533   $451,148   $213,567   $328,818 

 

Required principal payments under the Company’s long term obligations are set forth below:

 

12 month period ending March 31,    
2017  $453,533 
2018   167,918 
2019   19,326 
2020   19,682 
2021   6,641 
      
Total  $667,100 

 

9

 

7. RELATED PARTY TRANSACTIONS

 

During the three months ended March 31, 2016 and 2015, the Company sold products to companies affiliated with its Chairman, President and Chief Executive Officer. The affiliated companies distribute the products outside of the United States and Canada. The Company also provides administrative services to these companies. Sales to the affiliated companies aggregated approximately $546,000 and $725,000 during the three months ended March 31, 2016 and 2015, respectively.  Administrative fees aggregated approximately $123,000 and $107,000 during the three months ended March 31, 2016 and 2015, respectively. The Company had accounts receivable from the affiliated companies in connection with the product sales and administrative services aggregating approximately $1,068,000 and $1,051,000 at March 31, 2016 and December 31, 2015, respectively. Transactions with the affiliated companies were made in the ordinary course of business.   While the terms of sale to the affiliated companies differed from the terms applicable to other customers, the affiliated companies bear their own warehousing, distribution, advertising, selling and marketing costs, as well as their own freight charges (the Company pays freight charges in connection with sales to its domestic customers on all but small orders).  Moreover, the Company does not pay sales commissions with respect to products sold to the affiliated companies.  As a result, the Company believes its profit margins with respect to sales of its products to the affiliated companies are similar to the profit margins it realizes with respect to sales of the same products to its larger domestic customers.  Management believes that the sales transactions did not involve more than normal credit risk or present other unfavorable features.

 

A subsidiary of the Company currently uses the services of an entity that is owned by its Chairman, President and Chief Executive Officer to conduct product research and development and to assist in the production of television commercials.  Under this arrangement, the Company paid the entity $10,500 for each of the three month periods ended March 31, 2016 and 2015 for research and development services.

 

The Company leases office and warehouse facilities in Fort Lauderdale, Florida from an entity controlled by its Chairman, President and Chief Executive Officer.  The Company believes that the rental payments are below market rates.  See Note 8 for a description of the lease terms.

 

A director of the Company is Regional Executive Vice President of an entity from which the Company sources most of its insurance needs at an arm’s length competitive basis.  During the three months ended March 31, 2016 and 2015, the Company paid an aggregate of approximately $60,000 and $216,000, respectively in insurance premiums on policies obtained through the entity. The decrease in 2016 is primarily attributable to the Company’s prepayment of the entire annual premium for its general liability policy rather than paying the premium in installments.

 

8. COMMITMENTS AND CONTINGENCIES

 

The Company leases its executive offices and warehouse facilities in Fort Lauderdale, Florida from an entity controlled by its Chairman, President and Chief Executive Officer. The lease, as extended, expires on December 31, 2023. The lease requires an annual minimum base rent of $94,800 and provides for a maximum annual 2% increase in subsequent years, although the entity has not raised the minimum rent since the Company entered into a previous lease agreement in 1998. Additionally, the leasing entity is entitled to reimbursement of all taxes, assessments, and any other expenses that arise from ownership. Each of the parties to the lease has agreed to review the terms of the lease every three years at the request of the other party.  Rent expense under the lease was approximately $24,000 for each of the three months ended March 31, 2016 and 2015. 

 

10

 

On August 13, 2014, Star-Brite Distributing, Inc. (“Star-Brite”), a wholly-owned subsidiary of the Company, filed a complaint for injunctive relief and damages against Gold Eagle Co. (“Gold Eagle”) in the United States District Court for the Southern District of Florida. The complaint alleged that Gold Eagle, in violation of Section 43(a) of the Lanham Act, the Florida Deceptive and Unfair Trade Practices Act, and the Florida False Advertising Statute, made false and/or misleading statements in a comparative marketing campaign against Star Tron® Enzyme Fuel Treatment, an enzyme based fuel additive for the marine market, used to treat ethanol gasoline, commonly referred to as E10 fuel. The complaint also constitutes a claim for common law unfair competition.

 

Gold Eagle filed an answer to complaint and counterclaim, generally denying the allegations in Star-Brite’s complaint and asserting affirmative defenses to Star-Brite’s claims. Gold Eagle’s counterclaim alleged, among other things, that in various advertising and marketing materials for Star Tron, which Star-Brite markets for use in various types of engines, Star-Brite makes false and misleading claims that are causing harm to Gold Eagle, which markets competitive products under the STA-BIL brand, thereby violating the same statutory provisions as Gold Eagle was alleged to have violated in Star-Brite’s complaint, and also constituting common law unfair competition. 

 

Star-Brite filed an answer to the counterclaim, generally denying the allegations, and asserting affirmative defenses.

  

A jury trial was conducted during February 2016. On March 1, 2016, the jury unanimously found that (i) Gold Eagle’s advertising was not literally false; (ii) Gold Eagle did not commit false advertising under the Florida False Advertising Statute; (iii) Star-Brite’s advertising was not literally false and (iv) Star-Brite did not commit false advertising under the Florida False Advertising Statute. As a result of the jury’s verdict, the Court determined that (i) Star-Brite would recover nothing from Gold Eagle, and Star-Brite’s action was dismissed on the merits and (ii) Gold Eagle would recover nothing from Star-Brite, and Gold Eagle’s counterclaim was dismissed on the merits. Neither party has filed an appeal.

 

In post-trial proceedings, Star-Brite is seeking attorneys’ fees and costs under the Florida False Advertising Statute, which provides that a prevailing party in a civil action for violation of the statute will be awarded costs, including attorneys’ fees.  Star-Brite is asserting, among other things, that the issues asserted by Gold Eagle in its counterclaim were the significant issues in the case, that Star-Brite obtained a defense judgment in its favor on the counterclaim, and, therefore, Star-Brite is the prevailing party, entitled to costs and attorney’s fees under the statute.  Star-Brite also asserts that it is entitled to attorney’s fees and costs as a prevailing party on the counterclaim under the Florida Deceptive and Unfair Trade Practices Act.  Gold Eagle has asserted, among other things, that because both parties were denied the relief they sought, neither party should be deemed a prevailing party, or, in the event the Court determines that either party is a prevailing party, Gold Eagle, as defendant in the action, should be deemed the prevailing party. The Court has referred the matter to a Magistrate Judge for appropriate disposition or report and recommendation.

11

 

9. LOSS PER SHARE

 

Basic and diluted loss per share is calculated by dividing net loss by the weighted average number of shares outstanding during the reported period.    The following table sets forth the computation of basic and diluted loss per common share.

 

   Three Months Ended
March 31,		 
   2016   2015 
Loss per common share –Basic and Diluted        
         
Net loss  $(540,802)  $(15,926)
           
Weighted average number of common shares outstanding   8,985,858    8,920,288 
           
Loss per common share – Basic and Diluted  $(0.06)  $0.00 
           

 

For the three months ended March 31, 2016 and 2015, 57,509 and 99,689 shares underlying outstanding stock awards were not included in the computation of loss per common share – diluted because their effect would have been antidilutive.

 

12

 

10.  SECURITIES AUTHORIZED FOR ISSUANCE UNDER EQUITY COMPENSATION PLANS

 

During the three months ended March 31, 2016, stock options to purchase an aggregate of 30,000 shares were exercised. The Company received a total of $21,600, withheld 4,519 shares in connection with the net exercise feature of the stock options and delivered an aggregate of 25,481 shares to the option holders who exercised their options.

 

No stock compensation expense was recognized during the three months ended March 31, 2016 and 2015. At March 31, 2016, there was no unrecognized compensation expense related to stock options. 

No stock awards were issued during the three months ended March 31, 2016 and 2015.

 

The following table provides information at March 31, 2016 regarding outstanding stock options under the Company’s stock option plans. As used in the table below, “2002 NQ” refers to the Company’s 2002 Non-Qualified Stock Option Plan and “2008 NQ” refers to the Company’s 2008 Non-Qualified Stock Option Plan.

 

Plan 

Date

Granted

 

Shares

Underlying

Options Outstanding

  

Shares

Underlying Exercisable

Options

  

Exercise

Price

  

Expiration

Date

 

Weighted

Average

Remaining Term

 
2002NQ  12/17/07   40,000    40,000   $1.32   12/16/17   1.7 
2008NQ  1/11/09   40,000    40,000   $0.69   1/10/19   2.8 
2008NQ  4/26/10   20,000    20,000   $2.07   4/25/20   4.1 
                           
       100,000    100,000   $1.22       2.6 

  

11. SPECIAL CASH DIVIDEND

 

On March 25, 2016, the Company’s Board of Directors  declared a special cash dividend of $0.06 per common share payable on April 26, 2016 to all shareholders of record on April 12, 2016.  On April 12, 2016, there were 9,008,855 shares of common stock outstanding; therefore the Company recorded a $540,531 liability for dividends payable, which is reflected on the March 31, 2016 balance sheet.  In accordance with the action of the Board of Directors, the dividend was paid on April 26, 2016.

 

13

 

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations

 

Forward-looking Statements:

 

Certain statements contained in this Quarterly Report on Form 10-Q, including without limitation, our expectation that legal expenses with respect to the litigation matter described in Note 8 to the condensed consolidated financial statements included in this report will decline during the second quarter of 2016, anticipated higher sales volumes in the second quarter of 2016, our projected income tax rate for the full 2016 year, our ability to provide required capital to support inventory levels, the effect of price increases in raw materials that are petroleum or chemical based or commodity chemicals on our margins, and the sufficiency of funds provided through operations and existing sources of financing to satisfy our cash requirements constitute forward-looking statements. For this purpose, any statements contained in this report that are not statements of historical fact may be deemed to be forward-looking statements. Without limiting the generality of the foregoing, words such as "believe," "may," "will," "expect," "anticipate," "intend," or "could," including the negative or other variations thereof or comparable terminology, are intended to identify forward-looking statements. These statements involve known and unknown risks, uncertainties and other factors which may cause actual results to be materially different from those expressed or implied by such forward-looking statements. Factors that may affect these results include, but are not limited to, the highly competitive nature of our industry; reliance on certain key customers; changes in consumer demand for marine, recreational vehicle and automotive products; advertising and promotional efforts; unanticipated litigation developments; exposure to market risks relating to changes in interest rates, foreign exchange rates, prices for raw materials that are petroleum or chemical based and other factors addressed in Part I, Item 1A (“Risk Factors”) in our annual report on Form 10-K for the year ended December 31, 2015.

 

Overview:

 

We are principally engaged in manufacturing, marketing and distributing a broad line of appearance, performance and maintenance products for the marine, automotive, power sports, recreational vehicle and outdoor power equipment markets, under the Star brite®, StarTron® and other trademarks within the United States of America and Canada. We also manufacture, market and distribute a line of disinfectant, sanitizing and deodorizing products. In addition, we produce private label formulations of many of our products for various customers and provide custom blending and packaging services for these and other products. We sell our products to national retailers and to national and regional distributors who sell our products to specialized retail outlets.

 

Our operating results for the quarter ended March 31, 2016 were adversely affected by professional fees and expenses related to the litigation described in Note 8 to the condensed consolidated financial statements included in this report (the “Advertising Litigation”). Our professional fees and expenses related to the Advertising Litigation were approximately $1,085,000 and $59,000 during the three month periods ended March 31, 2016 and 2015, respectively. As explained in more detail in Note 8 to the condensed consolidated financial statements included in this report, as a result of the jury verdict, neither party to the Advertising Litigation is liable to the other; however, post-trial proceedings regarding costs and legal expenses are continuing. While we anticipate that expenditures related to the Advertising Litigation will decline during the second quarter of 2016, we will continue to incur legal expense with respect to the Advertising Litigation until all post-trial matters are concluded. We are seeking insurance recovery with respect to a portion of our expenditures with respect to the Advertising Litigation; however we cannot provide assurance as to whether, or to what extent, we will obtain such recovery.

  

Critical accounting estimates:

 

See “Management’s Discussion and Analysis of Financial Condition and Results of Operations – Critical Accounting Estimates” in Part II, Item 7 of our Annual Report on Form 10-K for the year ended December 31, 2015 for information regarding our critical accounting estimates.

 

Results of Operations:

 

Three Months Ended March 31, 2016 Compared to the Three Months Ended March 31, 2015

 

The following table provides a summary of our financial results for the three months ended March 31, 2016 and 2015:

 

   For The Three Months Ended March 31, 
           Percent   Percentage of Net Sales 
   2016   2015   Change   2016   2015 
Net sales  $6,750,080   $6,002,429    12.5%   100.0%   100.0%
Cost of goods sold   4,368,137    3,965,780    10.1%   64.7%   66.1%
Gross profit   2,381,943    2,036,649    17.0%   35.3%   33.9%
Advertising and promotion   715,872    615,872    16.2%   10.6%   10.3%
Selling and administrative   2,485,863    1,421,546    74.9%   36.8%   23.7%
Operating loss   (819,792)   (769)   N/A    12.1%   0.0%
Interest (expense), net   (5,884)   (10,075)   (41.6)%   0.1%   0.2%
Other (expense)   ---    (12,522)   N/A    0.0%   0.2%
Income tax benefit   284,874    7,440    3,729.0%   4.2%   0.1%
Net loss  $(540,802)  $(15,926)   3,295.7%   8.0%   0.3%

 

14

 

Net sales increased by approximately $748,000, or 12.5%, to approximately $6,750,000 for the three months ended March 31, 2016 from approximately $6,002,000 during the same period in 2015. The increase is primarily attributable to sales of marine products to some of our largest customers.

 

Cost of goods sold increased by approximately $402,000, or 10.1%, to approximately $4,368,000 for the three months ended March 31, 2016, from approximately $3,966,000 for the same period in 2015.  The increase in cost of goods sold is a result of higher sales volume partially offset by a more favorable mix of products sold during the 2016 period.

 

Gross profit increased by approximately $345,000, or 17.0%, to approximately $2,382,000 for the three months ended March 31, 2016, from approximately $2,037,000 for the same period in 2015. Gross profit increased due to increased sales volume and a more favorable product mix. As a percentage of net sales, gross profit was approximately 35.3% and 33.9% for the three month periods ended March 31, 2016 and 2015, respectively.

 

Advertising and promotion expenses increased by approximately $100,000, or 16.2%, to approximately $716,000 for the three months ended March 31, 2016 from approximately $616,000 for the same period in 2015.  As a percentage of net sales, advertising and promotion expense was approximately 10.6% for the three months ended March 31, 2016 compared to approximately 10.3% for the same period in 2015.  The increase is a result of increased customer cooperative advertising allowances provided to select customers.

 

Selling and administrative expenses increased by approximately $1,064,000, or 74.9%, to approximately $2,486,000 during the three months ended March 31, 2016 from approximately $1,422,000 for the same period in 2015.   Legal fees and expenses related to the Advertising Litigation accounted for approximately $1,026,000 of the increase. As a percentage of net sales, selling and administrative expenses increased to 36.8% for the three months ended March 31, 2016, compared to 23.7% for the same period in 2015. 

 

Operating loss – As a result of the foregoing factors, we incurred an operating loss of approximately $820,000 for the three months ended March 31, 2016, compared to an operating loss of approximately $1,000 for the same period in 2015, an increase in operating loss of approximately $819,000.

 

Interest expense, net decreased by approximately $4,000 to approximately $6,000 for the three months ended March 31, 2016, compared to approximately $10,000 for the same period in 2015. The decrease reflects the declining outstanding principal on our term loan.

 

Income tax benefit – Our income tax benefit for the three months ended March 31, 2016 was approximately $285,000, or 34.5% of our pretax income, compared to an income tax benefit of approximately $7,000, or 31.8% of pretax income, for the same period in 2015. The higher 2016 tax rate reflects our projected rate for the full year of 2016, which is consistent with the year ended December 31, 2015.   

 

Net loss. – As a result of the factors described above, we incurred a net loss of approximately $541,000 for the three months ended March 31, 2016, compared to a net loss of approximately $16,000 for the same period in 2015.

 

15

 

Liquidity and capital resources:

 

Our cash balance was approximately $2,436,000 at March 31, 2016 compared to approximately $2,468,000 at December 31, 2015. At March 31, 2016 and December 31, 2015, we had no borrowings under our revolving line of credit. The cash balance does not reflect a special cash dividend declared by our Board of Directors on March 25, 2016 and paid to our shareholders on April 26, 2016. See Note 11 to the condensed consolidated financial statements included in this report for additional information.

 

Net cash provided by operating activities during the three months ended March 31, 2016 was approximately $138,000 compared to net cash used in operating activities of approximately $605,000 for the three months ended March 31, 2015.  During the 2016 period, we increased gross inventories by approximately $1,155,000 compared to $2,001,000 in the 2015 period. We also had an approximately $472,000 larger increase in accounts payable and other accrued expenses and an approximately $315,000 smaller increase in receivables due from affiliated companies during the three months ended March 31, 2016, as compared to the 2015 period. These increases were partially offset by our higher net loss and an approximately $362,000 lower decrease in our trade accounts receivable balance during the three months ended March 31, 2016, as compared to the 2015 period.

 

Net trade accounts receivable aggregated approximately $4,090,000 at March 31, 2016, a decrease of approximately $1,002,000, or 19.7%, compared to net trade accounts receivable of $5,092,000 at December 31, 2015. The lower trade accounts receivable balance at March 31, 2016 principally reflects lower sales in the first quarter of 2016 as compared to the fourth quarter of 2015.

 

Inventories, net increased by approximately $1,151,000 or 14.5% to approximately $9,066,000 at March 31, 2016 from approximately $7,915,000 at December 31, 2015. We increased inventories in anticipation of higher sales volumes in the second quarter of 2016.

 

Net cash used in investing activities was approximately $76,000 for the three months ended March 31, 2016 compared to approximately $316,000 for the three months ended March 31, 2015.  During the 2016 period, the Company used approximately $76,000 for purchases of property, plant and equipment as compared to $371,000 of such expenditures in the 2015 period. The 2015 period also included cash proceeds of $55,000 from the sale of a recreational vehicle we used for advertising and exhibiting our products at trade shows and other events.

 

Net cash used in financing activities was approximately $91,000 for the three months ended March 31, 2016 compared to approximately $105,000 for the three months ended March 31, 2015. While cash used in both periods reflect repayments under our term loan, the 2016 period reflects a $21,600 offset resulting from the exercise of stock options.

 

See Notes 5 and 6 to the condensed consolidated financial statements included in this report for information concerning our principal credit facilities, consisting of a revolving line of credit and a term loan. At March 31, 2016 and December 31, 2015, we had no borrowings under our revolving line of credit and outstanding balances of approximately $585,000 and $692,000, respectively, under our term loan. The loan agreement related to our revolving line of credit contains various covenants, including financial covenants requiring a minimum debt coverage ratio (generally, net operating profit plus depreciation, amortization and lease/rent expense divided by current maturities of long-term debt plus interest and lease/rent expense) of 1.75 to 1.00, calculated on a trailing twelve month basis, and a maximum debt to capitalization ratio (generally, funded debt divided by the sum of total net worth and funded debt) of 0.75 to 1, tested quarterly. At March 31, 2016, our debt coverage ratio was approximately 1.67 to 1, and our debt to capitalization ratio was approximately 0.03 to 1. At March 31, 2016, we were not in compliance with the financial covenant related to the debt service coverage ratio. Although the deficiency in this ratio constitutes an event of default under the agreement related to our revolving line of credit, no amounts were outstanding under the revolving line of credit, and the lender has waived the default through May 9, 2017. Moreover, while the deficiency also may have constituted an event of default under the term loan due to its cross-default provisions, the lender has waived the default through May 9, 2017. See Note 5 to the condensed consolidated financial statements included in this report for additional information.

 

 

16

 

In addition to the revolving line of credit and term loan, we have obtained financing through capital leases for office equipment, totaling approximately $82,000 and $88,000 at March 31, 2016 and December 31, 2015, respectively.

 

Some of our assets and liabilities are in the Canadian dollars and are subject to currency fluctuations relating to the Canadian dollar. We do not engage in currency hedging and address currency risk as a pricing issue. In the three months ended March 31, 2016, we recorded approximately $2,000 in foreign currency translation adjustments (increasing shareholders’ equity by $2,000).

 

During the past few years, we have introduced a number of new products.  At times, new product introductions have required us to increase our overall inventory and have resulted in lower inventory turnover rates.  The effects of reduced inventory turnover have not been material to our overall operations.  We believe that all required capital to maintain such increases will continue to be provided by operations and, if necessary, our current revolving line of credit or a renewal or replacement of the facility.  However, we cannot assure that we will be able to secure such a renewal or replacement of our revolving line of credit.

 

Many of the raw materials that we use in the manufacturing process are petroleum or chemical based and commodity chemicals that are subject to fluctuating prices. The nature of our business does not enable us to pass through the price increases to our national retailer customers and to our distributors as promptly as we experience increases in raw material costs. This may, at times, adversely affect our margins.

 

At March 31, 2016 and through the date of this report, we did not and do not have any material commitments for capital expenditures.

 

We believe that funds provided through operations and our existing sources of financing will be sufficient to satisfy our cash requirements over at least the next twelve months.

 

Item 3. Quantitative and Qualitative Disclosures about Market Risk

 

Not applicable

 

Item 4. Controls and Procedures

 

Evaluation of Disclosure Controls and Procedures:

 

The Company’s management, with the participation of the Company’s Chief Executive Officer and Chief Financial Officer, evaluated the effectiveness of the Company’s disclosure controls and procedures, as defined in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934, as amended (the "Exchange Act") at the end of the period covered by this report. Based on that evaluation, the Chief Executive Officer and Chief Financial Officer concluded that the Company’s disclosure controls and procedures as of the end of the period covered by this report are effective to provide reasonable assurance that the information required to be disclosed by the Company in reports filed under the Exchange Act are (i) recorded, processed, summarized and reported within the time periods specified in the Securities and Exchange Commission's rules and forms, and (ii) accumulated and communicated to the Company’s management, including the Chief Executive Officer and Chief Financial Officer, as appropriate to allow timely decisions regarding the disclosure.

 

Change in Internal Controls over Financial Reporting:

 

No change in internal control over financial reporting (as defined in Rules 13a-15(f) and 15d-15(f) under the Exchange Act) occurred during the Company’s most recent fiscal quarter that has materially affected, or is reasonably likely to materially affect, the Company’s internal control over financial reporting.

 

PART II - OTHER INFORMATION

 

Item 1. Legal Proceedings

 

See the description of a legal proceeding included in Note 8 to the condensed consolidated financial statements included in this report, which is incorporated herein by reference.

 

Item 1A. Risk Factors

 

In addition to the information set forth in this report, you should carefully consider the factors discussed in Part I -Item 1A, "Risk Factors" in the Company's Annual Report on Form 10-K for the year ended December 31, 2015, which could materially affect the Company’s business, financial condition or future results. 

 

17

 

Item 6. Exhibits

 

Exhibit No.   Description
     
31.1   Certification of Chief Executive Officer pursuant to Rule 13a-14(a) under the Securities Exchange Act.
     
31.2   Certification of Chief Financial Officer pursuant to Rule 13a-14(a) under the Securities Exchange Act.
     
32.1   Certification of Chief Executive Officer pursuant to Rule 13a-14(b) under the Exchange Act and 18 U.S.C. Section 1350.
     
32.2   Certification of Chief Financial Officer pursuant to Rule 13a-14(b) under the Exchange Act and 18 U.S.C. Section 1350.
     
101   The following materials from Ocean Bio-Chem, Inc.’s Quarterly Report on Form 10-Q for the quarter ended March 31, 2016, formatted in XBRL (eXtensible Business Reporting Language): (i) Condensed Consolidated Balance Sheets as of March 31, 2016 and December 31, 2015, (ii) Condensed Consolidated Statements of Operations for the three months ended March 31, 2016 and 2015, (iii) Condensed Consolidated Statements of Comprehensive Income for the three months ended March 31, 2016 and 2015; (iv) Condensed Consolidated Statements of Cash Flows for the three months ended March 31, 2016 and 2015 and (v) Notes  to Condensed Consolidated Financial Statements.

 

18

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the Undersigned thereunto duly authorized.

 

  OCEAN BIO-CHEM, INC.
   
Dated: May 13, 2016 /s/ Peter G. Dornau
  Peter G. Dornau
  Chairman of the Board, President and
  Chief Executive Officer
   
Dated: May 13, 2016 /s/ Jeffrey S. Barocas
  Jeffrey S. Barocas
  Vice President and
  Chief Financial Officer

  

 

19

 

 

 EX-31.1 2 f10q0316ex31i_oceanbio.htm CERTIFICATION

EXHIBIT 31.1

 

CERTIFICATION

 

I, Peter G. Dornau certify that:

 

1. I have reviewed this quarterly report on Form 10-Q of Ocean Bio-Chem, Inc.;

 

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

 

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

 

4. The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

 

a)  Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

 

b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

 

c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

 

d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

 

5. The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of registrant’s board of directors (or persons performing the equivalent functions):

 

a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

 

b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

 

Dated:  May 13, 2016 By: /s/ Peter G. Dornau
    Peter G. Dornau
    Chairman of the Board, President and
    Chief Executive Officer

 EX-31.2 3 f10q0316ex31ii_oceanbio.htm CERTIFICATION

EXHIBIT 31.2

 

CERTIFICATION

 

I, Jeffrey S. Barocas certify that:

 

1. I have reviewed this quarterly report on Form 10-Q of Ocean Bio-Chem, Inc;

 

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

 

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

 

4. The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

 

a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

 

b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

 

c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

 

d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

 

5. The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of registrant’s board of directors (or persons performing the equivalent functions):

 

a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

 

b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

 

Dated:  May 13, 2016 By: /s/ Jeffrey S. Barocas
    Jeffrey S. Barocas
    Vice President
    Chief Financial Officer

 

 EX-32.1 4 f10q0316ex32i_oceanbio.htm CERTIFICATION

EXHIBIT 32.1

 

CERTIFICATION PURSUANT TO RULE 13a-14(b)

UNDER THE SECURITIES EXCHANGE ACT AND 18 U.S.C. 1350

 

I, Peter G. Dornau, Chief Executive Officer of Ocean Bio-Chem, Inc. (the "Company"), hereby certify that, based on my knowledge:

 

  1.

The Company's Quarterly Report on Form 10-Q for the quarter ended March 31, 2016 (the "Report") fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

     

 2. The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

 

Dated:  May 13, 2016 By: /s/ Peter G. Dornau
    Peter G. Dornau
    Chairman of the Board, President and
   

Chief Executive Officer

 

 EX-32.2 5 f10q0316ex32ii_oceanbio.htm CERTIFICATION

EXHIBIT 32.2

 

CERTIFICATION PURSUANT TO RULE 13a-14(b)

UNDER THE SECURITIES EXCHANGE ACT AND 18 U.S.C. 1350

 

I, Jeffrey S. Barocas, Chief Financial Officer of Ocean Bio-Chem, Inc. (the "Company"), hereby certify that, based on my knowledge:

 

  1.

The Company's Quarterly Report on Form 10-Q for the quarter ended March 31, 2016 (the "Report") fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

     
  2. The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

 

Dated:  May 13, 2016 By: /s/ Jeffrey S. Barocas
    Jeffrey S. Barocas
    Vice President
   

Chief Financial Officer

 EX-101.INS 6 obci-20160331.xml XBRL INSTANCE FILE 0000350737 obci:RegionsEquipmentFinanceCorporationMember 2011-07-06 0000350737 obci:RegionsEquipmentFinanceCorporationMember 2011-07-01 2011-07-06 0000350737 2014-08-04 0000350737 2014-08-01 2014-08-04 0000350737 2014-12-31 0000350737 2015-01-01 2015-03-31 0000350737 obci:FortLauderdaleFloridaFacilityMember 2015-01-01 2015-03-31 0000350737 2015-03-31 0000350737 2015-12-31 0000350737 obci:TermLoanMember 2015-12-31 0000350737 obci:CapitalizedEquipmentLeasesMember 2015-12-31 0000350737 2016-01-01 2016-03-31 0000350737 obci:FortLauderdaleFloridaFacilityMember 2016-01-01 2016-03-31 0000350737 us-gaap:BuildingImprovementsMember 2016-01-01 2016-03-31 0000350737 obci:ManufacturingAndWarehouseEquipmentMember us-gaap:MinimumMember 2016-01-01 2016-03-31 0000350737 obci:ManufacturingAndWarehouseEquipmentMember us-gaap:MaximumMember 2016-01-01 2016-03-31 0000350737 obci:OfficeEquipmentAndFurnitureMember us-gaap:MinimumMember 2016-01-01 2016-03-31 0000350737 us-gaap:MaximumMember obci:OfficeEquipmentAndFurnitureMember 2016-01-01 2016-03-31 0000350737 us-gaap:LeaseholdImprovementsMember us-gaap:MinimumMember 2016-01-01 2016-03-31 0000350737 us-gaap:LeaseholdImprovementsMember us-gaap:MaximumMember 2016-01-01 2016-03-31 0000350737 us-gaap:VehiclesMember 2016-01-01 2016-03-31 0000350737 obci:StockOptionPlanOneMember 2016-01-01 2016-03-31 0000350737 obci:StockOptionPlanTwoMember 2016-01-01 2016-03-31 0000350737 obci:StockOptionPlanThreeMember 2016-01-01 2016-03-31 0000350737 us-gaap:MinimumMember 2016-01-01 2016-03-31 0000350737 us-gaap:MaximumMember 2016-01-01 2016-03-31 0000350737 2016-03-31 0000350737 obci:TermLoanMember 2016-03-31 0000350737 obci:CapitalizedEquipmentLeasesMember 2016-03-31 0000350737 obci:StockOptionPlanOneMember 2016-03-31 0000350737 obci:StockOptionPlanTwoMember 2016-03-31 0000350737 obci:StockOptionPlanThreeMember 2016-03-31 0000350737 2016-05-12 xbrli:shares iso4217:USD iso4217:USDxbrli:shares xbrli:pure OCEAN BIO CHEM INC 0000350737 false --12-31 10-Q 2016-03-31 2016 Q1 Smaller Reporting Company 9008855 3062729 2011559 2468415 2436078 5092040 4090357 1051091 1068430 7914950 9065836 942820 1155669 125335 122831 17594651 17939201 5356388 5203611 1037968 1020398 1037968 1020398 23989007 24163210 1101720 2119425 451148 453533 540531 1098721 893477 2651589 4006966 365012 356488 328818 213567 3345419 4577021 89834 90089 9287313 9308658 -284442 -282108 11550883 10469550 20643588 19586189 23989007 24163210 78000 67000 0.01 0.01 12000000 12000000 8983374 9008855 6328343 7072535 325914 322455 6002429 6750080 3965780 4368137 2036649 2381943 615872 715872 1421546 2485863 2037418 3201735 -769 -819792 10075 5884 12522 -23366 -825676 -7440 -284874 -15926 -540802 -0.06 0.06 -8115 2334 -24041 -538468 221559 246841 -9012 -6020 -12522 -23874 2366 -1374194 -1012558 2001274 1154606 219163 212849 332708 17339 340462 812461 -605472 137878 370795 76494 55000 -315795 -76494 105343 112866 21600 -105343 -91266 -24560 -2455 -1051170 -32337 10379 6199 87000 <div><table style="width: 1567px; text-transform: none; text-indent: 0px; letter-spacing: normal; font-family: 'times new roman', times, serif; font-size: 10pt; word-spacing: 0px; border-collapse: collapse; widows: 1; -webkit-text-stroke-width: 0px;" cellspacing="0" cellpadding="0"><tr style="vertical-align: top;"><td style="width: 48px; text-align: justify; line-height: 15.33px;"><font style="font-family: 'times new roman', times, serif; font-size: 10pt;"><b>1.</b></font></td><td style="width: 1519px; text-align: justify; line-height: 15.33px;"><font style="font-family: 'times new roman', times, serif; font-size: 10pt;"><b>SUMMARY OF ACCOUNTING POLICIES</b></font></td></tr></table><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0.5in; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;">&#160;</p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"><b>Interim reporting</b></p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0.5in; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;">&#160;</p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;">The accompanying unaudited condensed consolidated financial statements include the accounts of Ocean Bio-Chem, Inc. and its wholly-owned subsidiaries. All significant inter-company accounts and transactions have been eliminated in consolidation. Certain prior-period data have been reclassified to conform to the current period presentation.&#160;&#160;Unless the context indicates otherwise, the term &#8220;Company&#8221; refers to Ocean&#160;Bio-Chem, Inc. and its subsidiaries.</p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0.5in; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;">&#160;</p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;">The unaudited condensed consolidated financial statements have been prepared in accordance with United States generally accepted accounting principles (&#8220;GAAP&#8221;) for interim financial information and with the instructions to Form 10-Q and Article 8 of Regulation S-X.&#160;&#160;Accordingly, they do not include all of the information and footnotes required by GAAP for complete financial statements.</p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0.5in; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;">&#160;</p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;">The financial information furnished herein reflects all adjustments, consisting of normal recurring items that, in the opinion of management, are necessary for a fair presentation of the Company&#8217;s financial position, results of operations and cash flows for the interim periods.&#160;&#160;The results of operations for the three months ended March 31, 2016 are not necessarily indicative of the results to be expected for the year ending December 31, 2016.</p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0.5in; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;">&#160;</p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;">The information included in this Form 10-Q should be read in conjunction with the Company&#8217;s Annual Report on Form 10-K for the year ended December 31, 2015.</p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;">&#160;</p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"><b>Use of estimates</b></p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; color: #000000; text-transform: none; text-indent: 0.5in; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;">&#160;</p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;">The preparation of condensed consolidated financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period.&#160;&#160;Actual results could differ from those estimates and assumptions.</p></div> <div><table style="width: 1567px; text-transform: none; text-indent: 0px; letter-spacing: normal; font-family: 'times new roman', times, serif; font-size: 10pt; word-spacing: 0px; border-collapse: collapse; widows: 1; -webkit-text-stroke-width: 0px;" cellspacing="0" cellpadding="0"><tr style="vertical-align: top;"><td style="width: 48px; text-align: justify; line-height: 15.33px;"><font style="font-family: 'times new roman', times, serif; font-size: 10pt;"><b>2.</b></font></td><td style="width: 1519px; text-align: justify; line-height: 15.33px;"><font style="font-family: 'times new roman', times, serif; font-size: 10pt;"><b>RECENT ACCOUNTING PRONOUNCEMENTS</b></font></td></tr></table><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; color: #000000; text-transform: none; text-indent: 0.5in; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;">&#160;</p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;">There have been no accounting pronouncements or changes in accounting pronouncements during the three months ended March 31, 2016 that are expected to have a material impact on the Company&#8217;s financial position, results of operations or cash flows.&#160;&#160;Accounting pronouncements that became effective during the three months ended March 31, 2016 did not have a material impact on disclosures or on the Company&#8217;s financial position, results of operations or cash flows.</p></div> <div><table style="width: 1567px; text-transform: none; text-indent: 0px; letter-spacing: normal; font-family: 'times new roman', times, serif; font-size: 10pt; word-spacing: 0px; border-collapse: collapse; widows: 1; -webkit-text-stroke-width: 0px;" cellspacing="0" cellpadding="0"><tr style="vertical-align: top;"><td style="width: 48px; text-align: justify; line-height: 15.33px;"><font style="font-family: 'times new roman', times, serif; font-size: 10pt;"><b>3.</b></font></td><td style="width: 1519px; text-align: justify; line-height: 15.33px;"><font style="font-family: 'times new roman', times, serif; font-size: 10pt;"><b>INVENTORIES</b></font></td></tr></table><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; color: #000000; text-transform: none; text-indent: 0.5in; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;">&#160;</p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;">The Company&#8217;s inventories at March 31, 2016 and December 31, 2015 consisted of the following:</p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; color: #000000; text-transform: none; text-indent: 0.5in; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;">&#160;</p><table style="width: 1567px; text-transform: none; text-indent: 0px; letter-spacing: normal; font-family: 'times new roman', times, serif; word-spacing: 0px; border-collapse: collapse; widows: 1; -webkit-text-stroke-width: 0px;" cellspacing="0" cellpadding="0"><tr style="vertical-align: bottom;"><td style="font-size: 10pt;">&#160;</td><td style="font: 10pt/normal 'times new roman', times, serif; padding-bottom: 1.5pt; font-stretch: normal;">&#160;</td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: center; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid; font-stretch: normal;" colspan="2"><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: center; font-stretch: normal;"><b>March&#160;31,</b></p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: center; font-stretch: normal;"><b>2016</b></p></td><td style="font: 10pt/normal 'times new roman', times, serif; padding-bottom: 1.5pt; font-stretch: normal;">&#160;</td><td style="font: 10pt/normal 'times new roman', times, serif; padding-bottom: 1.5pt; font-stretch: normal;">&#160;</td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: center; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid; font-stretch: normal;" colspan="2"><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: center; font-stretch: normal;"><b>December&#160;31,</b></p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: center; font-stretch: normal;"><b>2015</b></p></td><td style="font: 10pt/normal 'times new roman', times, serif; padding-bottom: 1.5pt; font-stretch: normal;">&#160;</td></tr><tr style="vertical-align: bottom; background-color: #cceeff;"><td style="font: 10pt/normal 'times new roman', times, serif; width: 1191px; text-align: left; font-stretch: normal;">Raw materials</td><td style="font: 10pt/normal 'times new roman', times, serif; width: 16px; font-stretch: normal;">&#160;</td><td style="font: 10pt/normal 'times new roman', times, serif; width: 16px; text-align: left; font-stretch: normal;">$</td><td style="font: 10pt/normal 'times new roman', times, serif; width: 142px; text-align: right; font-stretch: normal;">3,853,721</td><td style="font: 10pt/normal 'times new roman', times, serif; width: 16px; text-align: left; font-stretch: normal;">&#160;</td><td style="font: 10pt/normal 'times new roman', times, serif; width: 15px; font-stretch: normal;">&#160;</td><td style="font: 10pt/normal 'times new roman', times, serif; width: 15px; text-align: left; font-stretch: normal;">$</td><td style="font: 10pt/normal 'times new roman', times, serif; width: 141px; text-align: right; font-stretch: normal;">3,749,702</td><td style="font: 10pt/normal 'times new roman', times, serif; width: 15px; text-align: left; font-stretch: normal;">&#160;</td></tr><tr style="vertical-align: bottom; background-color: white;"><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; text-indent: -29.7pt; padding-bottom: 1.5pt; padding-left: 29.7pt; font-stretch: normal;">Finished goods</td><td style="font: 10pt/normal 'times new roman', times, serif; padding-bottom: 1.5pt; font-stretch: normal;">&#160;</td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid; font-stretch: normal;">&#160;</td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: right; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid; font-stretch: normal;">5,495,717</td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; padding-bottom: 1.5pt; font-stretch: normal;">&#160;</td><td style="font: 10pt/normal 'times new roman', times, serif; padding-bottom: 1.5pt; font-stretch: normal;">&#160;</td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid; font-stretch: normal;">&#160;</td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: right; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid; font-stretch: normal;">4,445,130</td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; padding-bottom: 1.5pt; font-stretch: normal;">&#160;</td></tr><tr style="vertical-align: bottom; background-color: #cceeff;"><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; text-indent: -29.7pt; padding-left: 29.7pt; font-stretch: normal;">Inventories, gross</td><td style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; font-stretch: normal;">&#160;</td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: right; font-stretch: normal;">9,349,438</td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; font-stretch: normal;">&#160;</td><td style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; font-stretch: normal;">&#160;</td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: right; font-stretch: normal;">8,194,832</td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; font-stretch: normal;">&#160;</td></tr><tr style="vertical-align: bottom; background-color: white;"><td style="font-size: 10pt;">&#160;</td><td style="font-size: 10pt;">&#160;</td><td style="text-align: left; font-size: 10pt;">&#160;</td><td style="text-align: right; font-size: 10pt;">&#160;</td><td style="text-align: left; font-size: 10pt;">&#160;</td><td style="font-size: 10pt;">&#160;</td><td style="text-align: left; font-size: 10pt;">&#160;</td><td style="text-align: right; font-size: 10pt;">&#160;</td><td style="text-align: left; font-size: 10pt;">&#160;</td></tr><tr style="vertical-align: bottom; background-color: #cceeff;"><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; text-indent: -29.7pt; padding-bottom: 1.5pt; padding-left: 29.7pt; font-stretch: normal;">Inventory reserves</td><td style="font: 10pt/normal 'times new roman', times, serif; padding-bottom: 1.5pt; font-stretch: normal;">&#160;</td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid; font-stretch: normal;">&#160;</td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: right; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid; font-stretch: normal;">(283,602</td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; padding-bottom: 1.5pt; font-stretch: normal;">)</td><td style="font: 10pt/normal 'times new roman', times, serif; padding-bottom: 1.5pt; font-stretch: normal;">&#160;</td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid; font-stretch: normal;">&#160;</td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: right; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid; font-stretch: normal;">(279,882</td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; padding-bottom: 1.5pt; font-stretch: normal;">)</td></tr><tr style="vertical-align: bottom; background-color: white;"><td style="font-size: 10pt;">&#160;</td><td style="font-size: 10pt;">&#160;</td><td style="text-align: left; font-size: 10pt;">&#160;</td><td style="text-align: right; font-size: 10pt;">&#160;</td><td style="text-align: left; font-size: 10pt;">&#160;</td><td style="font-size: 10pt;">&#160;</td><td style="text-align: left; font-size: 10pt;">&#160;</td><td style="text-align: right; font-size: 10pt;">&#160;</td><td style="text-align: left; font-size: 10pt;">&#160;</td></tr><tr style="vertical-align: bottom; background-color: #cceeff;"><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; text-indent: -29.7pt; padding-bottom: 4pt; padding-left: 29.7pt; font-stretch: normal;">Inventories, net</td><td style="font: 10pt/normal 'times new roman', times, serif; padding-bottom: 4pt; font-stretch: normal;">&#160;</td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double; font-stretch: normal;">$</td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: right; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double; font-stretch: normal;">9,065,836</td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; padding-bottom: 4pt; font-stretch: normal;">&#160;</td><td style="font: 10pt/normal 'times new roman', times, serif; padding-bottom: 4pt; font-stretch: normal;">&#160;</td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double; font-stretch: normal;">$</td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: right; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double; font-stretch: normal;">7,914,950</td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; padding-bottom: 4pt; font-stretch: normal;">&#160;</td></tr></table><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0.5in; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;">&#160;</p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;">The inventory reserves shown in the table above reflect slow moving and obsolete inventory.</p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0.5in; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;">&#160;</p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;">The Company manages an inventory program for one of its customers to improve the promotion of the Company's products.&#160;&#160;The Company manages the inventory levels at the customer&#8217;s warehouses and recognizes revenue as the products are sold by the customer.&#160;&#160;The inventories managed at the customer&#8217;s warehouses amounted to approximately $469,000 and $543,000 at March 31, 2016 and December 31, 2015, respectively, and are included in inventories, net on the condensed consolidated balance sheets.</p></div> <div><table style="width: 1567px; text-transform: none; text-indent: 0px; letter-spacing: normal; font-family: 'times new roman', times, serif; font-size: 10pt; word-spacing: 0px; border-collapse: collapse; widows: 1; -webkit-text-stroke-width: 0px;" cellspacing="0" cellpadding="0"><tr style="vertical-align: top;"><td style="width: 48px; text-align: justify; line-height: 15.33px;"><font style="font-family: 'times new roman', times, serif; font-size: 10pt;"><b>4.</b></font></td><td style="width: 1519px; text-align: justify; line-height: 15.33px;"><font style="font-family: 'times new roman', times, serif; font-size: 10pt;"><b>PROPERTY, PLANT &amp; EQUIPMENT</b></font></td></tr></table><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; color: #000000; text-transform: none; text-indent: 0.5in; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;">&#160;</p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;">The Company&#8217;s property, plant and equipment at March 31, 2016 and December 31, 2015 consisted of the following:</p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; color: #000000; text-transform: none; text-indent: 0.5in; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;">&#160;</p><table style="width: 1567px; text-transform: none; text-indent: 0px; letter-spacing: normal; font-family: 'times new roman', times, serif; word-spacing: 0px; border-collapse: collapse; widows: 1; -webkit-text-stroke-width: 0px;" cellspacing="0" cellpadding="0"><tr style="vertical-align: bottom;"><td style="font-size: 10pt;">&#160;</td><td style="font: 10pt/normal 'times new roman', times, serif; padding-bottom: 1.5pt; font-stretch: normal;">&#160;</td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: center; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid; font-stretch: normal;"><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: center; font-stretch: normal;"><b>Estimate</b></p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: center; font-stretch: normal;"><b>Useful Life</b></p></td><td style="font: 10pt/normal 'times new roman', times, serif; padding-bottom: 1.5pt; font-stretch: normal;">&#160;</td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: center; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid; font-stretch: normal;" colspan="2"><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: center; font-stretch: normal;"><b>March&#160;31,</b></p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: center; font-stretch: normal;"><b>2016</b></p></td><td style="font: 10pt/normal 'times new roman', times, serif; padding-bottom: 1.5pt; font-stretch: normal;">&#160;</td><td style="font: 10pt/normal 'times new roman', times, serif; padding-bottom: 1.5pt; font-stretch: normal;">&#160;</td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: center; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid; font-stretch: normal;" colspan="2"><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: center; font-stretch: normal;"><b>December&#160;31,</b></p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: center; font-stretch: normal;"><b>2015</b></p></td><td style="font: 10pt/normal 'times new roman', times, serif; padding-bottom: 1.5pt; font-stretch: normal;">&#160;</td></tr><tr style="vertical-align: bottom; background-color: #cceeff;"><td style="font: 10pt/normal 'times new roman', times, serif; width: 1003px; font-stretch: normal;">Land</td><td style="width: 16px; font-size: 10pt;">&#160;</td><td style="width: 173px; font-size: 10pt;">&#160;</td><td style="font: 10pt/normal 'times new roman', times, serif; width: 16px; font-stretch: normal;">&#160;</td><td style="font: 10pt/normal 'times new roman', times, serif; width: 16px; text-align: left; font-stretch: normal;">$</td><td style="font: 10pt/normal 'times new roman', times, serif; width: 142px; text-align: right; font-stretch: normal;">278,325</td><td style="font: 10pt/normal 'times new roman', times, serif; width: 15px; text-align: left; font-stretch: normal;">&#160;</td><td style="font: 10pt/normal 'times new roman', times, serif; width: 15px; font-stretch: normal;">&#160;</td><td style="font: 10pt/normal 'times new roman', times, serif; width: 15px; text-align: left; font-stretch: normal;">$</td><td style="font: 10pt/normal 'times new roman', times, serif; width: 141px; text-align: right; font-stretch: normal;">278,325</td><td style="font: 10pt/normal 'times new roman', times, serif; width: 15px; text-align: left; font-stretch: normal;">&#160;</td></tr><tr style="vertical-align: bottom; background-color: white;"><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; font-stretch: normal;">Building and improvements</td><td style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: center; font-stretch: normal;">30 years</td><td style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; font-stretch: normal;">&#160;</td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: right; font-stretch: normal;">4,652,669</td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; font-stretch: normal;">&#160;</td><td style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; font-stretch: normal;">&#160;</td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: right; font-stretch: normal;">4,652,669</td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; font-stretch: normal;">&#160;</td></tr><tr style="vertical-align: bottom; background-color: #cceeff;"><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; font-stretch: normal;">Manufacturing and warehouse equipment</td><td style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: center; font-stretch: normal;">6-20 years</td><td style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; font-stretch: normal;">&#160;</td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: right; font-stretch: normal;">9,153,057</td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; font-stretch: normal;">&#160;</td><td style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; font-stretch: normal;">&#160;</td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: right; font-stretch: normal;">9,072,162</td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; font-stretch: normal;">&#160;</td></tr><tr style="vertical-align: bottom; background-color: white;"><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; font-stretch: normal;">Office equipment and furniture</td><td style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: center; font-stretch: normal;">3-5 years</td><td style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; font-stretch: normal;">&#160;</td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: right; font-stretch: normal;">1,268,545</td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; font-stretch: normal;">&#160;</td><td style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; font-stretch: normal;">&#160;</td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: right; font-stretch: normal;">1,293,609</td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; font-stretch: normal;">&#160;</td></tr><tr style="vertical-align: bottom; background-color: #cceeff;"><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; font-stretch: normal;">Construction in process</td><td style="font-size: 10pt;">&#160;</td><td style="text-align: center; font-size: 10pt;">&#160;</td><td style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; font-stretch: normal;">&#160;</td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: right; font-stretch: normal;">197,545</td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; font-stretch: normal;">&#160;</td><td style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; font-stretch: normal;">&#160;</td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: right; font-stretch: normal;">215,155</td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; font-stretch: normal;">&#160;</td></tr><tr style="vertical-align: bottom; background-color: white;"><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; font-stretch: normal;">Leasehold improvements</td><td style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: center; font-stretch: normal;">10-15 years</td><td style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; font-stretch: normal;">&#160;</td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: right; font-stretch: normal;">544,146</td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; font-stretch: normal;">&#160;</td><td style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; font-stretch: normal;">&#160;</td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: right; font-stretch: normal;">544,146</td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; font-stretch: normal;">&#160;</td></tr><tr style="vertical-align: bottom; background-color: #cceeff;"><td style="font: 10pt/normal 'times new roman', times, serif; padding-bottom: 1.5pt; font-stretch: normal;">Vehicles</td><td style="font: 10pt/normal 'times new roman', times, serif; padding-bottom: 1.5pt; font-stretch: normal;">&#160;</td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: center; padding-bottom: 1.5pt; font-stretch: normal;">3 years</td><td style="font: 10pt/normal 'times new roman', times, serif; padding-bottom: 1.5pt; font-stretch: normal;">&#160;</td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid; font-stretch: normal;">&#160;</td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: right; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid; font-stretch: normal;">42,283</td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; padding-bottom: 1.5pt; font-stretch: normal;">&#160;</td><td style="font: 10pt/normal 'times new roman', times, serif; padding-bottom: 1.5pt; font-stretch: normal;">&#160;</td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid; font-stretch: normal;">&#160;</td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: right; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid; font-stretch: normal;">42,283</td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; padding-bottom: 1.5pt; font-stretch: normal;">&#160;</td></tr><tr style="vertical-align: bottom; background-color: white;"><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; font-stretch: normal;">Property, plant and equipment, gross</td><td style="font-size: 10pt;">&#160;</td><td style="font-size: 10pt;">&#160;</td><td style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; font-stretch: normal;">&#160;</td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: right; font-stretch: normal;">16,136,570</td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; font-stretch: normal;">&#160;</td><td style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; font-stretch: normal;">&#160;</td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: right; font-stretch: normal;">16,098,349</td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; font-stretch: normal;">&#160;</td></tr><tr style="vertical-align: bottom; background-color: #cceeff;"><td style="font-size: 10pt;">&#160;</td><td style="font-size: 10pt;">&#160;</td><td style="font-size: 10pt;">&#160;</td><td style="font-size: 10pt;">&#160;</td><td style="text-align: left; font-size: 10pt;">&#160;</td><td style="text-align: right; font-size: 10pt;">&#160;</td><td style="text-align: left; font-size: 10pt;">&#160;</td><td style="font-size: 10pt;">&#160;</td><td style="text-align: left; font-size: 10pt;">&#160;</td><td style="text-align: right; font-size: 10pt;">&#160;</td><td style="text-align: left; font-size: 10pt;">&#160;</td></tr><tr style="vertical-align: bottom; background-color: white;"><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; padding-bottom: 1.5pt; font-stretch: normal;">Less accumulated depreciation</td><td style="padding-bottom: 1.5pt; font-size: 10pt;">&#160;</td><td style="padding-bottom: 1.5pt; font-size: 10pt;">&#160;</td><td style="font: 10pt/normal 'times new roman', times, serif; padding-bottom: 1.5pt; font-stretch: normal;">&#160;</td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid; font-stretch: normal;">&#160;</td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: right; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid; font-stretch: normal;">(10,932,959</td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; padding-bottom: 1.5pt; font-stretch: normal;">)</td><td style="font: 10pt/normal 'times new roman', times, serif; padding-bottom: 1.5pt; font-stretch: normal;">&#160;</td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid; font-stretch: normal;">&#160;</td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: right; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid; font-stretch: normal;">(10,741,961</td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; padding-bottom: 1.5pt; font-stretch: normal;">)</td></tr><tr style="vertical-align: bottom; background-color: #cceeff;"><td style="font-size: 10pt;">&#160;</td><td style="font-size: 10pt;">&#160;</td><td style="font-size: 10pt;">&#160;</td><td style="font-size: 10pt;">&#160;</td><td style="text-align: left; font-size: 10pt;">&#160;</td><td style="text-align: right; font-size: 10pt;">&#160;</td><td style="text-align: left; font-size: 10pt;">&#160;</td><td style="font-size: 10pt;">&#160;</td><td style="text-align: left; font-size: 10pt;">&#160;</td><td style="text-align: right; font-size: 10pt;">&#160;</td><td style="text-align: left; font-size: 10pt;">&#160;</td></tr><tr style="vertical-align: bottom; background-color: white;"><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; padding-bottom: 4pt; font-stretch: normal;">Property, plant and equipment, net</td><td style="padding-bottom: 4pt; font-size: 10pt;">&#160;</td><td style="padding-bottom: 4pt; font-size: 10pt;">&#160;</td><td style="font: 10pt/normal 'times new roman', times, serif; padding-bottom: 4pt; font-stretch: normal;">&#160;</td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double; font-stretch: normal;">$</td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: right; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double; font-stretch: normal;">5,203,611</td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; padding-bottom: 4pt; font-stretch: normal;">&#160;</td><td style="font: 10pt/normal 'times new roman', times, serif; padding-bottom: 4pt; font-stretch: normal;">&#160;</td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double; font-stretch: normal;">$</td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: right; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double; font-stretch: normal;">5,356,388</td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; padding-bottom: 4pt; font-stretch: normal;">&#160;</td></tr></table></div> <table style="width: 1567px; text-transform: none; text-indent: 0px; letter-spacing: normal; font-family: 'times new roman', times, serif; font-size: 10pt; word-spacing: 0px; border-collapse: collapse; widows: 1; -webkit-text-stroke-width: 0px;" cellspacing="0" cellpadding="0"><tr style="vertical-align: top;"><td style="width: 48px; text-align: justify; line-height: 15.3333px;"><font style="font-family: 'times new roman', times, serif; font-size: 10pt;"><b>5.</b></font></td><td style="width: 1519px; text-align: justify; line-height: 15.3333px;"><font style="font-family: 'times new roman', times, serif; font-size: 10pt;"><b>REVOLVING LINE OF CREDIT</b></font></td></tr></table><p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-align: start; text-transform: none; white-space: normal; widows: 1; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; margin: 0px; text-indent: 0.5in;">&#160;</p><p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-indent: 0px; text-transform: none; white-space: normal; widows: 1; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; margin: 0px; text-align: justify;">On August 4, 2014, the Company and Regions Bank entered into a Business Loan Agreement (the&#8220;Business Loan Agreement&#8221;), under which the Company was provided a renewed revolving line of credit. Under the renewed revolving line of credit, the Company may borrow up to the lesser of (i) $6 million or (ii) a borrowing base equal to 80% of eligible accounts receivable (as defined in the Business Loan Agreement) plus 50% of eligible inventory (as defined in the Business Loan Agreement). Interest on amounts borrowed under the revolving line of credit is payable monthly at the 30 day LIBOR rate plus 1.65% per annum, unless the Company&#8217;s debt service coverage ratio (generally, net operating profit plus depreciation, amortization and lease/rent expense divided by current maturities of long-term debt plus interest and lease/rent expense, calculated on a trailing twelve month basis) falls to or below 2.0 to 1, in which case interest is payable at the 30 day LIBOR rate plus 2.65% per annum.</p><p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-transform: none; white-space: normal; widows: 1; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; margin: 0px; text-align: justify; text-indent: 0.5in;">&#160;</p><p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-indent: 0px; text-transform: none; white-space: normal; widows: 1; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; margin: 0px; text-align: justify;"></p><p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-indent: 0px; text-transform: none; white-space: normal; widows: 1; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; margin: 0px; text-align: justify;">Outstanding amounts under the revolving line of credit are payable on demand. If no demand is made, the Company may repay and reborrow funds from time to time until expiration of the revolving line of credit on July 6, 2016, at which time all outstanding principal and interest will be due and payable. The Company&#8217;s obligations under the revolving line of credit are secured by, among other things, the Company&#8217;s accounts receivable, inventory, contract rights and general intangibles and, as a result of cross-collateralization of the Company&#8217;s obligations under the term loan described in Note 6 and the revolving line of credit, real property and equipment at the Montgomery, Alabama facility of the Company&#8217;s subsidiary, Kinpak, Inc. ("Kinpak"). The Business Loan Agreement includes financial covenants requiring a minimum debt service coverage ratio (generally, net operating profit plus depreciation, amortization and lease/rent expense divided by current maturities of long-term debt plus interest and lease/rent expense) of 1.75 to 1.00, calculated on a trailing twelve month basis, and a maximum debt to capitalization ratio (generally, funded debt divided by the sum of total net worth and funded debt) of 0.75 to 1, tested quarterly. The line of credit is subject to several events of default, including a decline in the majority shareholder&#8217;s ownership below 50% of all outstanding shares. At March 31, 2016, the Company was not in compliance with the financial covenant relating to its minimum debt service coverage ratio, as its debt service coverage ratio was 1.67. Although the deficiency in the Company&#8217;s debt service coverage ratio results in an event of default under the Business Loan Agreement, the Company had no borrowings under the revolving line of credit at March 31, 2016, and Regions Bank waived the default through May 9, 2017. The deficiency in the debt service coverage ratio also may have resulted in an event of default under the term loan described in Note 6 below due to the cross-default provisions of the term loan. However, any resulting default has been waived through May 9, 2017 by Regions Equipment Financing Corporation (&#8220;REFCO&#8221;), a subsidiary of Regions Bank and the lender under the term loan.</p> <table style="width: 1567px; text-transform: none; text-indent: 0px; letter-spacing: normal; font-family: 'times new roman', times, serif; font-size: 10pt; word-spacing: 0px; border-collapse: collapse; widows: 1; -webkit-text-stroke-width: 0px;" cellspacing="0" cellpadding="0"><tr style="vertical-align: top;"><td style="width: 48px; text-align: justify; line-height: 15.3333px;"><font style="font-family: 'times new roman', times, serif; font-size: 10pt;"><b>6.</b></font></td><td style="width: 1519px; text-align: justify; line-height: 15.3333px;"><font style="font-family: 'times new roman', times, serif; font-size: 10pt;"><b>LONG TERM DEBT</b></font></td></tr></table><p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-align: start; text-transform: none; white-space: normal; widows: 1; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; margin: 0px; text-indent: 0.5in;">&#160;</p><p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-indent: 0px; text-transform: none; white-space: normal; widows: 1; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; margin: 0px; text-align: justify;"></p><p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-indent: 0px; text-transform: none; white-space: normal; widows: 1; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; margin: 0px; text-align: justify;">On July 6, 2011, REFCO provided to the Company a $2,430,000 term loan with a fixed interest rate of 3.54%, subject to an increase to 4.55% in the event the Company's debt service coverage ratio (net profit plus taxes, interest, depreciation, amortization and rent expense divided by debt service plus interest and lease/rent expense, calculated on a trailing four-quarter basis) falls to or below 2.0 to 1. Principal and interest on the term loan are payable in equal monthly installments through July 6, 2017, the date on which the term loan matures. The proceeds of the term loan were used to pay the Company&#8217;s remaining obligations under a lease agreement relating to industrial revenue bonds used to fund the expansion of Kinpak&#8217;s facilities and acquisition of related equipment. At March 31, 2016, approximately $585,000 was outstanding under the term loan. The term loan and the revolving line of credit under the Bank Loan Agreement are cross-defaulted (i.e., a default under one instrument is a default under the other). See Note 5 for information regarding REFCO&#8217;s waiver of an event of default that may be deemed to have occurred under the cross-default provisions of the term loan as a result of an event of default under the Business Loan Agreement; REFCO has waived the default through May 9, 2017.</p><p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-indent: 0px; text-transform: none; white-space: normal; widows: 1; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; margin: 0px; text-align: justify;"></p><p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-align: start; text-transform: none; white-space: normal; widows: 1; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; margin: 0px; text-indent: 0.5in;">&#160;</p><p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-indent: 0px; text-transform: none; white-space: normal; widows: 1; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; margin: 0px; text-align: justify;">At March 31, 2016 and December 31, 2015, the Company was obligated under capital lease agreements covering equipment utilized in the Company&#8217;s operations.&#160;&#160;The capital leases, aggregating approximately $82,000 and $88,000 at March 31, 2016 and December 31, 2015, respectively, mature on July 1, 2020 and carry an interest rate of 2%.</p><p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-align: start; text-transform: none; white-space: normal; widows: 1; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; margin: 0px; text-indent: 0.5in;">&#160;</p><p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-indent: 0px; text-transform: none; white-space: normal; widows: 1; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; margin: 0px; text-align: justify;">The following table provides information regarding the Company&#8217;s long term debt at March 31, 2016 and December 31, 2015:</p><p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-align: start; text-transform: none; white-space: normal; widows: 1; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; margin: 0px; text-indent: 0.5in;">&#160;</p><table style="width: 1567px; text-transform: none; text-indent: 0px; letter-spacing: normal; font-family: 'times new roman', times, serif; word-spacing: 0px; border-collapse: collapse; widows: 1; -webkit-text-stroke-width: 0px;" cellspacing="0" cellpadding="0"><tr style="vertical-align: bottom;"><td style="font-size: 10pt;">&#160;</td><td style="font-style: normal; font-variant: normal; font-weight: bold; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; padding-bottom: 1.5pt;">&#160;</td><td style="font-style: normal; font-variant: normal; font-weight: bold; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; text-align: center; border-bottom-width: 1.5pt; border-bottom-style: solid; border-bottom-color: black;" colspan="6">Current Portion</td><td style="padding-bottom: 1.5pt; font-style: normal; font-variant: normal; font-weight: bold; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif;">&#160;</td><td style="font-style: normal; font-variant: normal; font-weight: bold; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; padding-bottom: 1.5pt;">&#160;</td><td style="font-style: normal; font-variant: normal; font-weight: bold; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; text-align: center; border-bottom-width: 1.5pt; border-bottom-style: solid; border-bottom-color: black;" colspan="6">Long Term Portion</td><td style="padding-bottom: 1.5pt; font-style: normal; font-variant: normal; font-weight: bold; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif;">&#160;</td></tr><tr style="vertical-align: bottom;"><td style="font-size: 10pt;">&#160;</td><td style="font-style: normal; font-variant: normal; font-weight: bold; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; padding-bottom: 1.5pt;">&#160;</td><td style="font-style: normal; font-variant: normal; font-weight: bold; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; text-align: center; border-bottom-width: 1.5pt; border-bottom-style: solid; border-bottom-color: black;" colspan="2">March 31,&#160;<br />2016</td><td style="padding-bottom: 1.5pt; font-style: normal; font-variant: normal; font-weight: bold; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif;">&#160;</td><td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; padding-bottom: 1.5pt;">&#160;</td><td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; text-align: center; border-bottom-width: 1.5pt; border-bottom-style: solid; border-bottom-color: black;" colspan="2"><p style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; margin: 0px; text-align: center;"><b>December&#160;31,</b></p><p style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; margin: 0px; text-align: center;"><b>2015</b></p></td><td style="padding-bottom: 1.5pt; font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif;">&#160;</td><td style="font-style: normal; font-variant: normal; font-weight: bold; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; padding-bottom: 1.5pt;">&#160;</td><td style="font-style: normal; font-variant: normal; font-weight: bold; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; text-align: center; border-bottom-width: 1.5pt; border-bottom-style: solid; border-bottom-color: black;" colspan="2">March 31,&#160;<br />2016</td><td style="padding-bottom: 1.5pt; font-style: normal; font-variant: normal; font-weight: bold; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif;">&#160;</td><td style="font-style: normal; font-variant: normal; font-weight: bold; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; padding-bottom: 1.5pt;">&#160;</td><td style="font-style: normal; font-variant: normal; font-weight: bold; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; text-align: center; border-bottom-width: 1.5pt; border-bottom-style: solid; border-bottom-color: black;" colspan="2">December&#160;31,<br />2015</td><td style="padding-bottom: 1.5pt; font-style: normal; font-variant: normal; font-weight: bold; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif;">&#160;</td></tr><tr style="vertical-align: bottom; background-color: #cceeff;"><td style="width: 815px; font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; text-align: left;">Term loan</td><td style="width: 16px; font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif;">&#160;</td><td style="width: 16px; font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; text-align: left;">$</td><td style="width: 142px; font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; text-align: right;">436,441</td><td style="width: 16px; font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; text-align: left;">&#160;</td><td style="width: 16px; font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif;">&#160;</td><td style="width: 16px; font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; text-align: left;">$</td><td style="width: 142px; font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; text-align: right;">432,601</td><td style="width: 16px; font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; text-align: left;">&#160;</td><td style="width: 15px; font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif;">&#160;</td><td style="width: 15px; font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; text-align: left;">$</td><td style="width: 141px; font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; text-align: right;">148,942</td><td style="width: 15px; font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; text-align: left;">&#160;</td><td style="width: 15px; font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif;">&#160;</td><td style="width: 15px; font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; text-align: left;">$</td><td style="width: 141px; font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; text-align: right;">259,503</td><td style="width: 15px; font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; text-align: left;">&#160;</td></tr><tr style="vertical-align: bottom; background-color: white;"><td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; text-align: left; padding-bottom: 1.5pt;">Capitalized equipment leases</td><td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; padding-bottom: 1.5pt;">&#160;</td><td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; text-align: left; border-bottom-width: 1.5pt; border-bottom-style: solid; border-bottom-color: black;">&#160;</td><td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; text-align: right; border-bottom-width: 1.5pt; border-bottom-style: solid; border-bottom-color: black;">17,092</td><td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; text-align: left; padding-bottom: 1.5pt;">&#160;</td><td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; padding-bottom: 1.5pt;">&#160;</td><td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; text-align: left; border-bottom-width: 1.5pt; border-bottom-style: solid; border-bottom-color: black;">&#160;</td><td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; text-align: right; border-bottom-width: 1.5pt; border-bottom-style: solid; border-bottom-color: black;">18,547</td><td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; text-align: left; padding-bottom: 1.5pt;">&#160;</td><td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; padding-bottom: 1.5pt;">&#160;</td><td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; text-align: left; border-bottom-width: 1.5pt; border-bottom-style: solid; border-bottom-color: black;">&#160;</td><td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; text-align: right; border-bottom-width: 1.5pt; border-bottom-style: solid; border-bottom-color: black;">64,625</td><td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; text-align: left; padding-bottom: 1.5pt;">&#160;</td><td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; padding-bottom: 1.5pt;">&#160;</td><td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; text-align: left; border-bottom-width: 1.5pt; border-bottom-style: solid; border-bottom-color: black;">&#160;</td><td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; text-align: right; border-bottom-width: 1.5pt; border-bottom-style: solid; border-bottom-color: black;">69,315</td><td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; text-align: left; padding-bottom: 1.5pt;">&#160;</td></tr><tr style="vertical-align: bottom; background-color: #cceeff;"><td style="font-size: 10pt;">&#160;</td><td style="font-size: 10pt;">&#160;</td><td style="font-size: 10pt; text-align: left;">&#160;</td><td style="font-size: 10pt; text-align: right;">&#160;</td><td style="font-size: 10pt; text-align: left;">&#160;</td><td style="font-size: 10pt;">&#160;</td><td style="font-size: 10pt; text-align: left;">&#160;</td><td style="font-size: 10pt; text-align: right;">&#160;</td><td style="font-size: 10pt; text-align: left;">&#160;</td><td style="font-size: 10pt;">&#160;</td><td style="font-size: 10pt; text-align: left;">&#160;</td><td style="font-size: 10pt; text-align: right;">&#160;</td><td style="font-size: 10pt; text-align: left;">&#160;</td><td style="font-size: 10pt;">&#160;</td><td style="font-size: 10pt; text-align: left;">&#160;</td><td style="font-size: 10pt; text-align: right;">&#160;</td><td style="font-size: 10pt; text-align: left;">&#160;</td></tr><tr style="vertical-align: bottom; background-color: white;"><td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; text-align: left; padding-bottom: 4pt;">Total long term debt</td><td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; padding-bottom: 4pt;">&#160;</td><td style="border-bottom-width: 4pt; border-bottom-style: double; border-bottom-color: black; font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; text-align: left;">$</td><td style="border-bottom-width: 4pt; border-bottom-style: double; border-bottom-color: black; font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; text-align: right;">453,533</td><td style="padding-bottom: 4pt; font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; text-align: left;">&#160;</td><td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; padding-bottom: 4pt;">&#160;</td><td style="border-bottom-width: 4pt; border-bottom-style: double; border-bottom-color: black; font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; text-align: left;">$</td><td style="border-bottom-width: 4pt; border-bottom-style: double; border-bottom-color: black; font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; text-align: right;">451,148</td><td style="padding-bottom: 4pt; font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; text-align: left;">&#160;</td><td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; padding-bottom: 4pt;">&#160;</td><td style="border-bottom-width: 4pt; border-bottom-style: double; border-bottom-color: black; font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; text-align: left;">$</td><td style="border-bottom-width: 4pt; border-bottom-style: double; border-bottom-color: black; font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; text-align: right;">213,567</td><td style="padding-bottom: 4pt; font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; text-align: left;">&#160;</td><td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; padding-bottom: 4pt;">&#160;</td><td style="border-bottom-width: 4pt; border-bottom-style: double; border-bottom-color: black; font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; text-align: left;">$</td><td style="border-bottom-width: 4pt; border-bottom-style: double; border-bottom-color: black; font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; text-align: right;">328,818</td><td style="padding-bottom: 4pt; font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; text-align: left;">&#160;</td></tr></table><p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-align: start; text-transform: none; white-space: normal; widows: 1; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; margin: 0px; text-indent: 0.5in;">&#160;</p><p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-align: start; text-indent: 0px; text-transform: none; white-space: normal; widows: 1; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; margin: 0px;">Required principal payments under the Company&#8217;s long term obligations are set forth below:</p><p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-align: start; text-transform: none; white-space: normal; widows: 1; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; margin: 0px; text-indent: 0.5in;">&#160;</p><table style="width: 1567px; text-transform: none; text-indent: 0px; letter-spacing: normal; font-family: 'times new roman', times, serif; word-spacing: 0px; border-collapse: collapse; widows: 1; -webkit-text-stroke-width: 0px;" cellspacing="0" cellpadding="0"><tr style="vertical-align: bottom;"><td style="font-style: normal; font-variant: normal; font-weight: bold; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; text-align: center; border-bottom-width: 1.5pt; border-bottom-style: solid; border-bottom-color: black;">12 month period ending March 31,</td><td style="font-size: 10pt; padding-bottom: 1.5pt;">&#160;</td><td style="font-size: 10pt;" colspan="2">&#160;</td><td style="padding-bottom: 1.5pt; font-size: 10pt;">&#160;</td></tr><tr style="vertical-align: bottom; background-color: #cceeff;"><td style="width: 1379px; font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; text-align: left;">2017</td><td style="width: 16px; font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif;">&#160;</td><td style="width: 16px; font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; text-align: left;">$</td><td style="width: 141px; font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; text-align: right;">453,533</td><td style="width: 15px; font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; text-align: left;">&#160;</td></tr><tr style="vertical-align: bottom; background-color: white;"><td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; text-align: left;">2018</td><td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif;">&#160;</td><td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; text-align: left;">&#160;</td><td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; text-align: right;">167,918</td><td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; text-align: left;">&#160;</td></tr><tr style="vertical-align: bottom; background-color: #cceeff;"><td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; text-align: left;">2019</td><td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif;">&#160;</td><td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; text-align: left;">&#160;</td><td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; text-align: right;">19,326</td><td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; text-align: left;">&#160;</td></tr><tr style="vertical-align: bottom; background-color: white;"><td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; text-align: left;">2020</td><td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif;">&#160;</td><td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; text-align: left;">&#160;</td><td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; text-align: right;">19,682</td><td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; text-align: left;">&#160;</td></tr><tr style="vertical-align: bottom; background-color: #cceeff;"><td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; text-align: left; padding-bottom: 1.5pt;">2021</td><td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; padding-bottom: 1.5pt;">&#160;</td><td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; text-align: left; border-bottom-width: 1.5pt; border-bottom-style: solid; border-bottom-color: black;">&#160;</td><td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; text-align: right; border-bottom-width: 1.5pt; border-bottom-style: solid; border-bottom-color: black;">6,641</td><td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; text-align: left; padding-bottom: 1.5pt;">&#160;</td></tr><tr style="vertical-align: bottom; background-color: white;"><td style="font-size: 10pt; text-align: left;">&#160;</td><td style="font-size: 10pt;">&#160;</td><td style="font-size: 10pt; text-align: left;">&#160;</td><td style="font-size: 10pt; text-align: right;">&#160;</td><td style="font-size: 10pt; text-align: left;">&#160;</td></tr><tr style="vertical-align: bottom; background-color: #cceeff;"><td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; padding-bottom: 4pt; text-align: left;">Total</td><td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; padding-bottom: 4pt;">&#160;</td><td style="border-bottom-width: 4pt; border-bottom-style: double; border-bottom-color: black; font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; text-align: left;">$</td><td style="border-bottom-width: 4pt; border-bottom-style: double; border-bottom-color: black; font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; text-align: right;">667,100</td><td style="padding-bottom: 4pt; font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; text-align: left;">&#160;</td></tr></table><div>&#160;</div> <div><table style="width: 1567px; text-transform: none; text-indent: 0px; letter-spacing: normal; font-family: 'times new roman', times, serif; font-size: 10pt; word-spacing: 0px; border-collapse: collapse; widows: 1; -webkit-text-stroke-width: 0px;" cellspacing="0" cellpadding="0"><tr style="vertical-align: top;"><td style="width: 48px; text-align: justify; line-height: 15.33px;"><font style="font-family: 'times new roman', times, serif; font-size: 10pt;"><b>7.</b></font></td><td style="width: 1519px; text-align: justify; line-height: 15.33px;"><font style="font-family: 'times new roman', times, serif; font-size: 10pt;"><b>RELATED PARTY TRANSACTIONS</b></font></td></tr></table><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; color: #000000; text-transform: none; text-indent: 0.5in; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;">&#160;</p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;">During the three months ended March 31, 2016 and 2015, the Company sold products to companies affiliated with its Chairman, President and Chief Executive Officer. The affiliated companies distribute the products outside of the United States and Canada. The Company also provides administrative services to these companies. Sales to the affiliated companies aggregated approximately $546,000 and $725,000 during the three months ended March 31, 2016 and 2015, respectively.&#160;&#160;Administrative fees aggregated approximately $123,000 and $107,000&#160;during the three months ended March 31, 2016 and 2015, respectively.&#160;The Company had accounts receivable from the affiliated companies in connection with the product sales and administrative services aggregating approximately $1,068,000 and $1,051,000 at March 31, 2016 and December 31, 2015, respectively. Transactions with the affiliated companies were made in the ordinary course of business.&#160;&#160;&#160;While the terms of sale to the affiliated companies differed from the terms applicable to other customers, the affiliated companies bear their own warehousing, distribution, advertising, selling and marketing costs, as well as their own freight charges (the Company pays freight charges in connection with sales to its domestic customers on all but small orders).&#160;&#160;Moreover, the Company does not pay sales commissions with respect to products sold to the affiliated companies.&#160; As a result, the Company believes its profit margins with respect to sales of its products to the affiliated companies are similar to the profit margins it realizes with respect to sales of the same products to its larger domestic customers.&#160; Management believes that the sales transactions did not involve more than normal credit risk or present other unfavorable features.</p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0.5in; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;">&#160;</p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;">A subsidiary of the Company currently uses the services of an entity that is owned by its Chairman, President and Chief Executive Officer to conduct product research and development and to assist in the production of television commercials.&#160;&#160;Under this arrangement, the Company paid the entity $10,500 for each of the three month periods ended March 31, 2016 and 2015 for research and development services.</p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0.5in; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;">&#160;</p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;">The Company leases office and warehouse facilities in Fort Lauderdale, Florida from an entity controlled by its Chairman, President and Chief Executive Officer.&#160;&#160;The Company believes that the rental payments are below market rates.&#160;&#160;See Note 8 for a description of the lease terms.</p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0.5in; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;">&#160;</p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;">A director of the Company is Regional Executive Vice President of an entity from which the Company sources most of its insurance needs at an arm&#8217;s length competitive basis.&#160;&#160;During the three months ended March 31, 2016 and 2015, the Company paid an aggregate of approximately $60,000 and $216,000, respectively in insurance premiums on policies obtained through the entity. The decrease in 2016 is primarily attributable to the Company&#8217;s prepayment of the entire annual premium for its general liability policy rather than paying the premium in installments.</p></div> <table style="width: 100%; font-size: 10pt; border-collapse: collapse;" cellspacing="0" cellpadding="0"> <tr style="vertical-align: top;"> <td style="width: 3%; line-height: 115%;"><font style="font-size: 10pt; font-family: times new roman, times, serif;"><b>8.</b></font></td> <td style="width: 97%; line-height: 115%;"><font style="font-size: 10pt; font-family: times new roman, times, serif;"><b>COMMITMENTS AND CONTINGENCIES</b></font></td> </tr> </table> <p style="font: 10pt times new roman, times, serif; margin: 0px; text-indent: 0.5in;">&#160;</p> <p style="text-align: justify; font: 10pt times new roman, times, serif; margin: 0px;">The Company leases its executive offices and warehouse facilities in Fort Lauderdale, Florida from an entity controlled by its Chairman, President and Chief Executive Officer. The lease, as extended, expires on December 31, 2023. The lease requires an annual minimum base rent of $94,800 and provides for a maximum annual 2% increase in subsequent years, although the entity has not raised the minimum rent since the Company entered into a previous lease agreement in 1998. Additionally, the leasing entity is entitled to reimbursement of all taxes, assessments, and any other expenses that arise from ownership. Each of the parties to the lease has agreed to review the terms of the lease every three years at the request of the other party.&#160;&#160;Rent expense under the lease was approximately $24,000 for each of the three months ended March 31, 2016 and 2015.&#160;</p> <p style="text-align: justify; font: 10pt times new roman, times, serif; margin: 0px;">&#160;</p> <p style="text-align: justify; font: 10pt times new roman, times, serif; margin: 0px;">On August 13, 2014, Star-Brite Distributing, Inc. (&#8220;Star-Brite&#8221;), a wholly-owned subsidiary of the Company, filed a complaint for injunctive relief and damages against Gold Eagle Co. (&#8220;Gold Eagle&#8221;) in the United States District Court for the Southern District of Florida. The complaint alleged that Gold Eagle, in violation of Section 43(a) of the Lanham Act, the Florida Deceptive and Unfair Trade Practices Act, and the Florida False Advertising Statute, made false and/or misleading statements in a comparative marketing campaign against Star Tron&#174; Enzyme Fuel Treatment, an enzyme based fuel additive for the marine market, used to treat ethanol gasoline, commonly referred to as E10 fuel. The complaint also constitutes a claim for common law unfair competition.</p> <p style="text-align: justify; font: 10pt times new roman, times, serif; margin: 0px; text-indent: 0.5in;"></p> <p style="text-align: justify; font: 10pt times new roman, times, serif; margin: 0px; text-indent: 0.5in;">&#160;</p> <p style="text-align: justify; font: 10pt times new roman, times, serif; margin: 0px;">Gold Eagle filed an answer to complaint and counterclaim, generally denying the allegations in Star-Brite&#8217;s complaint and asserting affirmative defenses to Star-Brite&#8217;s claims. Gold Eagle&#8217;s counterclaim alleged, among other things, that in various advertising and marketing materials for Star Tron, which Star-Brite markets for use in various types of engines, Star-Brite makes false and misleading claims that are causing harm to Gold Eagle, which markets competitive products under the STA-BIL brand, thereby violating the same statutory provisions as Gold Eagle was alleged to have violated in Star-Brite&#8217;s complaint, and also constituting common law unfair competition.&#160;</p> <p style="text-align: justify; font: 10pt times new roman, times, serif; margin: 0px; text-indent: 0.5in;">&#160;</p> <p style="text-align: justify; font: 10pt times new roman, times, serif; margin: 0px;">Star-Brite filed an answer to the counterclaim, generally denying the allegations, and asserting affirmative defenses.</p> <p style="text-align: justify; font: 10pt times new roman, times, serif; margin: 0px;">&#160;&#160;</p> <p style="text-align: justify; font: 10pt times new roman, times, serif; margin: 0px;">A jury trial was conducted during February 2016. On March 1, 2016, the jury unanimously found that (i) Gold Eagle&#8217;s advertising was not literally false; (ii) Gold Eagle did not commit false advertising under the Florida False Advertising Statute; (iii) Star-Brite&#8217;s advertising was not literally false and (iv) Star-Brite did not commit false advertising under the Florida False Advertising Statute. As a result of the jury&#8217;s verdict, the Court determined that (i) Star-Brite would recover nothing from Gold Eagle, and Star-Brite&#8217;s action was dismissed on the merits and (ii) Gold Eagle would recover nothing from Star-Brite, and Gold Eagle&#8217;s counterclaim was dismissed on the merits. Neither party has filed an appeal.</p> <p style="text-align: justify; font: 10pt times new roman, times, serif; margin: 0px; text-indent: 0.5in;"></p> <p style="text-align: justify; font: 10pt times new roman, times, serif; margin: 0px;">&#160;</p> <p style="text-align: justify; font: 10pt times new roman, times, serif; margin: 0px;"></p> <p style="text-align: justify; font: 10pt times new roman, times, serif; margin: 0px;">In post-trial proceedings, Star-Brite is seeking attorneys&#8217; fees and costs under the Florida False Advertising Statute, which provides that a prevailing party in a civil action for violation of the statute will be awarded costs, including attorneys&#8217; fees. &#160;Star-Brite is asserting, among other things, that the issues asserted by Gold Eagle in its counterclaim were the significant issues in the case, that Star-Brite obtained a defense judgment in its favor on the counterclaim, and, therefore, Star-Brite is the prevailing party, entitled to costs and attorney&#8217;s fees under the statute.&#160; Star-Brite also asserts that it is entitled to attorney&#8217;s fees and costs as a prevailing party on the counterclaim under the Florida Deceptive and Unfair Trade Practices Act. &#160;Gold Eagle has asserted, among other things, that because both parties were denied the relief they sought, neither party should be deemed a prevailing party, or, in the event the Court determines that either party is a prevailing party, Gold Eagle, as defendant in the action, should be deemed the prevailing party. The Court has referred the matter to a Magistrate Judge for appropriate disposition or report and recommendation.</p> <table style="font: 10pt/normal 'times new roman', times, serif; width: 1567px; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; border-collapse: collapse; widows: 1; font-size-adjust: none; font-stretch: normal; -webkit-text-stroke-width: 0px;" cellspacing="0" cellpadding="0"><tr style="vertical-align: top;"><td style="width: 48px; line-height: 15.3333px; font-size: 10pt;"><font style="font-family: 'times new roman', times, serif; font-size: 10pt;"><b>9.</b></font></td><td style="width: 1519px; line-height: 15.3333px; font-size: 10pt;"><font style="font-family: 'times new roman', times, serif; font-size: 10pt;"><b>LOSS PER SHARE</b></font></td></tr></table><p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-transform: none; white-space: normal; widows: 1; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; margin: 0px; text-align: justify; text-indent: 0.5in;"></p><p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-transform: none; white-space: normal; widows: 1; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; margin: 0px; text-align: justify; text-indent: 0.5in;">&#160;</p><p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-transform: none; white-space: normal; widows: 1; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; margin: 0px; text-align: justify; text-indent: 0.5in;"></p><p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-indent: 0px; text-transform: none; white-space: normal; widows: 1; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; margin: 0px; text-align: justify;">Basic and diluted loss per share is calculated by dividing net loss by the weighted average number of shares outstanding during the reported period.&#160;&#160;&#160;&#160;The following table sets forth the computation of basic and diluted loss per common share.</p><p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-indent: 0px; text-transform: none; white-space: normal; widows: 1; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; margin: 0px; text-align: justify;">&#160;</p><table style="font: 10pt/normal 'times new roman', times, serif; width: 1567px; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; border-collapse: collapse; widows: 1; font-size-adjust: none; font-stretch: normal; -webkit-text-stroke-width: 0px;" cellspacing="0" cellpadding="0"><tr style="vertical-align: bottom;"><td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt;">&#160;</td><td style="font-weight: bold; text-align: center; border-bottom-width: 1.5pt; border-bottom-style: solid; border-bottom-color: black;" colspan="6">Three Months Ended&#160;<br />March 31,</td><td style="padding-bottom: 1.5pt; font-weight: bold;">&#160;</td></tr><tr style="vertical-align: bottom;"><td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt;">&#160;</td><td style="font-weight: bold; text-align: center; border-bottom-width: 1.5pt; border-bottom-style: solid; border-bottom-color: black;" colspan="2">2016</td><td style="padding-bottom: 1.5pt; font-weight: bold;">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt;">&#160;</td><td style="font-weight: bold; text-align: center; border-bottom-width: 1.5pt; border-bottom-style: solid; border-bottom-color: black;" colspan="2">2015</td><td style="padding-bottom: 1.5pt; font-weight: bold;">&#160;</td></tr><tr style="vertical-align: bottom;"><td style="font-weight: bold;">Loss per common share &#8211;Basic and Diluted</td><td>&#160;</td><td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td><td colspan="2">&#160;</td><td>&#160;</td></tr><tr style="vertical-align: bottom;"><td>&#160;</td><td>&#160;</td><td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td><td colspan="2">&#160;</td><td>&#160;</td></tr><tr style="vertical-align: bottom; background-color: #cceeff;"><td style="width: 1191px; text-align: left;">Net loss</td><td style="width: 16px;">&#160;</td><td style="width: 16px; text-align: left;">$</td><td style="width: 142px; text-align: right;">(540,802</td><td style="width: 16px; text-align: left;">)</td><td style="width: 15px;">&#160;</td><td style="width: 15px; text-align: left;">$</td><td style="width: 141px; text-align: right;">(15,926</td><td style="width: 15px; text-align: left;">)</td></tr><tr style="vertical-align: bottom; background-color: white;"><td>&#160;</td><td>&#160;</td><td style="text-align: left;">&#160;</td><td style="text-align: right;">&#160;</td><td style="text-align: left;">&#160;</td><td>&#160;</td><td style="text-align: left;">&#160;</td><td style="text-align: right;">&#160;</td><td style="text-align: left;">&#160;</td></tr><tr style="vertical-align: bottom; background-color: #cceeff;"><td>Weighted average number of common shares outstanding</td><td>&#160;</td><td style="text-align: left;">&#160;</td><td style="text-align: right;">8,985,858</td><td style="text-align: left;">&#160;</td><td>&#160;</td><td style="text-align: left;">&#160;</td><td style="text-align: right;">8,920,288</td><td style="text-align: left;">&#160;</td></tr><tr style="vertical-align: bottom; background-color: white;"><td>&#160;</td><td>&#160;</td><td style="text-align: left;">&#160;</td><td style="text-align: right;">&#160;</td><td style="text-align: left;">&#160;</td><td>&#160;</td><td style="text-align: left;">&#160;</td><td style="text-align: right;">&#160;</td><td style="text-align: left;">&#160;</td></tr><tr style="vertical-align: bottom; background-color: #cceeff;"><td style="text-align: left;">Loss per common share &#8211; Basic and Diluted</td><td>&#160;</td><td style="text-align: left;">$</td><td style="text-align: right;">(0.06</td><td style="text-align: left;">)</td><td>&#160;</td><td style="text-align: left;">$</td><td style="text-align: right;">0.00</td><td style="text-align: left;">&#160;</td></tr><tr style="vertical-align: bottom; background-color: white;"><td>&#160;</td><td>&#160;</td><td style="text-align: left;">&#160;</td><td style="text-align: right;">&#160;</td><td style="text-align: left;">&#160;</td><td>&#160;</td><td style="text-align: left;">&#160;</td><td style="text-align: right;">&#160;</td><td style="text-align: left;">&#160;</td></tr></table><p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-align: start; text-transform: none; white-space: normal; widows: 1; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; margin: 0px; text-indent: 0.5in;">&#160;</p><p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-indent: 0pt; text-transform: none; white-space: normal; widows: 1; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; margin-top: 0px; margin-bottom: 6pt; margin-left: 0pt; text-align: justify;">For the three months ended March 31, 2016 and 2015, 57,509 and 99,689 shares underlying outstanding stock awards were not included in the computation of loss per common share &#8211; diluted because their effect would have been antidilutive.</p> <table style="width: 1567px; text-transform: none; text-indent: 0px; letter-spacing: normal; font-family: 'times new roman', times, serif; font-size: 10pt; word-spacing: 0px; border-collapse: collapse; widows: 1; -webkit-text-stroke-width: 0px;" cellspacing="0" cellpadding="0"><tr style="vertical-align: top;"><td style="width: 48px; line-height: 15.3333px;"><font style="font-family: 'times new roman', times, serif; font-size: 10pt;"><b>10.&#160;</b></font></td><td style="width: 1519px; line-height: 15.3333px;"><font style="font-family: 'times new roman', times, serif; font-size: 10pt;"><b>SECURITIES AUTHORIZED FOR ISSUANCE UNDER EQUITY COMPENSATION PLANS</b></font></td></tr></table><p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-align: start; text-transform: none; white-space: normal; widows: 1; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; margin: 0px; text-indent: 0.5in;">&#160;</p><p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-indent: 0px; text-transform: none; white-space: normal; widows: 1; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; margin: 0px; text-align: justify;"></p><p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-indent: 0px; text-transform: none; white-space: normal; widows: 1; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; margin: 0px; text-align: justify;">During the three months ended March 31, 2016, stock options to purchase an aggregate of 30,000 shares were exercised. The Company received a total of $21,600, withheld 4,519 shares in connection with the net exercise feature of the stock options and delivered an aggregate of 25,481 shares to the option holders who exercised their options.</p><p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-indent: 0px; text-transform: none; white-space: normal; widows: 1; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; margin: 0px; text-align: justify;">&#160;</p><p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-indent: 0pt; text-transform: none; white-space: normal; widows: 1; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; margin-top: 0px; margin-bottom: 6pt; margin-left: 0pt; text-align: justify;">No stock compensation expense was recognized during the three months ended March 31, 2016 and 2015. At March 31, 2016, there was no unrecognized compensation expense related to stock<b>&#160;</b>options.&#160;</p><p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-indent: 0px; text-transform: none; white-space: normal; widows: 1; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; margin: 0px; text-align: justify;">No stock awards were issued during the three months ended March 31, 2016 and 2015.</p><p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-indent: 0px; text-transform: none; white-space: normal; widows: 1; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; margin: 0px; text-align: justify;">&#160;</p><p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-indent: 0px; text-transform: none; white-space: normal; widows: 1; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; margin: 0px; text-align: justify;"></p><p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-indent: 0px; text-transform: none; white-space: normal; widows: 1; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; margin: 0px; text-align: justify;">The following table provides information at March 31, 2016 regarding outstanding<b>&#160;</b>stock options under the Company&#8217;s stock option plans. As used in the table below, &#8220;2002 NQ&#8221; refers to the Company&#8217;s 2002 Non-Qualified Stock Option Plan and &#8220;2008 NQ&#8221; refers to the Company&#8217;s 2008 Non-Qualified Stock Option Plan.</p><p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-align: start; text-transform: none; white-space: normal; widows: 1; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; margin: 0px; text-indent: 0.5in;">&#160;</p><table style="width: 1567px; text-transform: none; text-indent: 0px; letter-spacing: normal; font-family: 'times new roman', times, serif; word-spacing: 0px; border-collapse: collapse; widows: 1; -webkit-text-stroke-width: 0px;" cellspacing="0" cellpadding="0"><tr style="vertical-align: bottom;"><td style="font-style: normal; font-variant: normal; font-weight: bold; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; border-bottom-width: 1.5pt; border-bottom-style: solid; border-bottom-color: black; text-align: left;">Plan</td><td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; padding-bottom: 1.5pt;">&#160;</td><td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; text-align: center; border-bottom-width: 1.5pt; border-bottom-style: solid; border-bottom-color: black;"><p style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; margin: 0px; text-align: center;"><b>Date</b></p><p style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; margin: 0px; text-align: center;"><b>Granted</b></p></td><td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; padding-bottom: 1.5pt;">&#160;</td><td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; text-align: center; border-bottom-width: 1.5pt; border-bottom-style: solid; border-bottom-color: black;" colspan="2"><p style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; margin: 0px; text-align: center;"><b>Shares</b></p><p style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; margin: 0px; text-align: center;"><b>Underlying</b></p><p style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; margin: 0px; text-align: center;"><b>Options Outstanding</b></p></td><td style="padding-bottom: 1.5pt; font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif;">&#160;</td><td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; padding-bottom: 1.5pt;">&#160;</td><td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; text-align: center; border-bottom-width: 1.5pt; border-bottom-style: solid; border-bottom-color: black;" colspan="2"><p style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; margin: 0px; text-align: center;"><b>Shares</b></p><p style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; margin: 0px; text-align: center;"><b>Underlying Exercisable</b></p><p style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; margin: 0px; text-align: center;"><b>Options</b></p></td><td style="padding-bottom: 1.5pt; font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif;">&#160;</td><td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; padding-bottom: 1.5pt;">&#160;</td><td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; text-align: center; border-bottom-width: 1.5pt; border-bottom-style: solid; border-bottom-color: black;" colspan="2"><p style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; margin: 0px; text-align: center;"><b>Exercise</b></p><p style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; margin: 0px; text-align: center;"><b>Price</b></p></td><td style="padding-bottom: 1.5pt; font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif;">&#160;</td><td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; padding-bottom: 1.5pt;">&#160;</td><td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; text-align: center; border-bottom-width: 1.5pt; border-bottom-style: solid; border-bottom-color: black;"><p style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; margin: 0px; text-align: center;"><b>Expiration</b></p><p style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; margin: 0px; text-align: center;"><b>Date</b></p></td><td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; padding-bottom: 1.5pt;">&#160;</td><td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; text-align: center; border-bottom-width: 1.5pt; border-bottom-style: solid; border-bottom-color: black;" colspan="2"><p style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; margin: 0px; text-align: center;"><b>Weighted</b></p><p style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; margin: 0px; text-align: center;"><b>Average</b></p><p style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; margin: 0px; text-align: center;"><b>Remaining Term</b></p></td><td style="padding-bottom: 1.5pt; font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif;">&#160;</td></tr><tr style="vertical-align: bottom; background-color: #cceeff;"><td style="width: 220px; font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; text-align: left;">2002NQ</td><td style="width: 16px; font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif;">&#160;</td><td style="width: 220px; font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; text-align: center;">12/17/07</td><td style="width: 16px; font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif;">&#160;</td><td style="width: 16px; font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; text-align: left;">&#160;</td><td style="width: 189px; font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; text-align: right;">40,000</td><td style="width: 16px; font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; text-align: left;">&#160;</td><td style="width: 16px; font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif;">&#160;</td><td style="width: 16px; font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; text-align: left;">&#160;</td><td style="width: 173px; font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; text-align: right;">40,000</td><td style="width: 16px; font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; text-align: left;">&#160;</td><td style="width: 16px; font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif;">&#160;</td><td style="width: 15px; font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; text-align: left;">$</td><td style="width: 172px; font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; text-align: right;">1.32</td><td style="width: 15px; font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; text-align: left;">&#160;</td><td style="width: 15px; font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif;">&#160;</td><td style="width: 203px; font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; text-align: center;">12/16/17</td><td style="width: 15px; font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif;">&#160;</td><td style="width: 15px; font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; text-align: left;">&#160;</td><td style="width: 172px; font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; text-align: right;">1.7</td><td style="width: 15px; font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; text-align: left;">&#160;</td></tr><tr style="vertical-align: bottom; background-color: white;"><td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; text-align: left;">2008NQ</td><td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif;">&#160;</td><td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; text-align: center;">1/11/09</td><td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif;">&#160;</td><td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; text-align: left;">&#160;</td><td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; text-align: right;">40,000</td><td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; text-align: left;">&#160;</td><td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif;">&#160;</td><td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; text-align: left;">&#160;</td><td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; text-align: right;">40,000</td><td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; text-align: left;">&#160;</td><td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif;">&#160;</td><td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; text-align: left;">$</td><td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; text-align: right;">0.69</td><td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; text-align: left;">&#160;</td><td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif;">&#160;</td><td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; text-align: center;">1/10/19</td><td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif;">&#160;</td><td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; text-align: left;">&#160;</td><td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; text-align: right;">2.8</td><td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; text-align: left;">&#160;</td></tr><tr style="vertical-align: bottom; background-color: #cceeff;"><td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; text-align: left;">2008NQ</td><td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif;">&#160;</td><td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; text-align: center;">4/26/10</td><td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif;">&#160;</td><td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; text-align: left;">&#160;</td><td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; text-align: right;">20,000</td><td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; text-align: left;">&#160;</td><td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif;">&#160;</td><td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; text-align: left;">&#160;</td><td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; text-align: right;">20,000</td><td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; text-align: left;">&#160;</td><td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif;">&#160;</td><td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; text-align: left;">$</td><td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; text-align: right;">2.07</td><td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; text-align: left;">&#160;</td><td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif;">&#160;</td><td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; text-align: center;">4/25/20</td><td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif;">&#160;</td><td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; text-align: left;">&#160;</td><td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; text-align: right;">4.1</td><td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; text-align: left;">&#160;</td></tr><tr style="vertical-align: bottom; background-color: white;"><td style="font-size: 10pt; padding-bottom: 1.5pt; text-align: left;">&#160;</td><td style="font-size: 10pt; padding-bottom: 1.5pt;">&#160;</td><td style="font-size: 10pt; text-align: center; padding-bottom: 1.5pt;">&#160;</td><td style="font-size: 10pt; padding-bottom: 1.5pt;">&#160;</td><td style="border-bottom-width: 1.5pt; border-bottom-style: solid; border-bottom-color: black; font-size: 10pt; text-align: left;">&#160;</td><td style="border-bottom-width: 1.5pt; border-bottom-style: solid; border-bottom-color: black; font-size: 10pt; text-align: right;">&#160;</td><td style="padding-bottom: 1.5pt; font-size: 10pt; text-align: left;">&#160;</td><td style="font-size: 10pt; padding-bottom: 1.5pt;">&#160;</td><td style="border-bottom-width: 1.5pt; border-bottom-style: solid; border-bottom-color: black; font-size: 10pt; text-align: left;">&#160;</td><td style="border-bottom-width: 1.5pt; border-bottom-style: solid; border-bottom-color: black; font-size: 10pt; text-align: right;">&#160;</td><td style="padding-bottom: 1.5pt; font-size: 10pt; text-align: left;">&#160;</td><td style="font-size: 10pt; padding-bottom: 1.5pt;">&#160;</td><td style="font-size: 10pt; text-align: left;">&#160;</td><td style="font-size: 10pt; text-align: right;">&#160;</td><td style="padding-bottom: 1.5pt; font-size: 10pt; text-align: left;">&#160;</td><td style="font-size: 10pt; padding-bottom: 1.5pt;">&#160;</td><td style="font-size: 10pt; text-align: center; padding-bottom: 1.5pt;">&#160;</td><td style="font-size: 10pt; padding-bottom: 1.5pt;">&#160;</td><td style="padding-bottom: 1.5pt; font-size: 10pt; text-align: left;">&#160;</td><td style="padding-bottom: 1.5pt; font-size: 10pt; text-align: right;">&#160;</td><td style="padding-bottom: 1.5pt; font-size: 10pt; text-align: left;">&#160;</td></tr><tr style="vertical-align: bottom; background-color: #cceeff;"><td style="font-size: 10pt; padding-bottom: 4pt; text-align: left;">&#160;</td><td style="font-size: 10pt; padding-bottom: 4pt;">&#160;</td><td style="font-size: 10pt; text-align: center; padding-bottom: 4pt;">&#160;</td><td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; padding-bottom: 4pt;">&#160;</td><td style="border-bottom-width: 4pt; border-bottom-style: double; border-bottom-color: black; font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; text-align: left;">&#160;</td><td style="border-bottom-width: 4pt; border-bottom-style: double; border-bottom-color: black; font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; text-align: right;">100,000</td><td style="padding-bottom: 4pt; font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; text-align: left;">&#160;</td><td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; padding-bottom: 4pt;">&#160;</td><td style="border-bottom-width: 4pt; border-bottom-style: double; border-bottom-color: black; font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; text-align: left;">&#160;</td><td style="border-bottom-width: 4pt; border-bottom-style: double; border-bottom-color: black; font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; text-align: right;">100,000</td><td style="padding-bottom: 4pt; font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; text-align: left;">&#160;</td><td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; padding-bottom: 4pt;">&#160;</td><td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; text-align: left;">$</td><td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; text-align: right;">1.22</td><td style="padding-bottom: 4pt; font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; text-align: left;">&#160;</td><td style="font-size: 10pt; padding-bottom: 4pt;">&#160;</td><td style="font-size: 10pt; text-align: center; padding-bottom: 4pt;">&#160;</td><td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; padding-bottom: 4pt;">&#160;</td><td style="padding-bottom: 4pt; font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; text-align: left;">&#160;</td><td style="padding-bottom: 4pt; font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; text-align: right;">2.6</td><td style="padding-bottom: 4pt; font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; text-align: left;">&#160;</td></tr></table><div>&#160;</div> <table style="width: 1567px; text-transform: none; text-indent: 0px; letter-spacing: normal; font-family: 'times new roman', times, serif; font-size: 10pt; word-spacing: 0px; border-collapse: collapse; widows: 1; -webkit-text-stroke-width: 0px;" cellspacing="0" cellpadding="0"><tr style="vertical-align: top;"><td style="width: 48px; line-height: 15.3333px;"><font style="font-family: 'times new roman', times, serif; font-size: 10pt;"><b>11.</b></font></td><td style="line-height: 15.3333px; width: 1519px;"><font style="font-family: 'times new roman', times, serif; font-size: 10pt;"><b>SPECIAL CASH DIVIDEND</b></font></td></tr></table><p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-indent: 0px; text-transform: none; white-space: normal; widows: 1; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; margin: 0px; text-align: justify;">&#160;</p><p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-indent: 0px; text-transform: none; white-space: normal; widows: 1; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; margin: 0px; text-align: justify;"></p><p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-indent: 0px; text-transform: none; white-space: normal; widows: 1; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; margin: 0px; text-align: justify;">On March 25, 2016, the Company&#8217;s Board of Directors&#160;&#160;declared a special cash dividend of $0.06 per common share payable on April 26, 2016 to all shareholders of record on April 12, 2016.&#160;&#160;On April 12, 2016, there were 9,008,855 shares of common stock outstanding; therefore the Company recorded a $540,531 liability for dividends payable, which is reflected on the March 31, 2016 balance sheet.&#160;&#160;In accordance with the action of the Board of Directors, the dividend was&#160;paid on April 26, 2016.</p> <div><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"><b>Interim reporting</b></p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0.5in; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;">&#160;</p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;">The accompanying unaudited condensed consolidated financial statements include the accounts of Ocean Bio-Chem, Inc. and its wholly-owned subsidiaries. All significant inter-company accounts and transactions have been eliminated in consolidation. Certain prior-period data have been reclassified to conform to the current period presentation.&#160;&#160;Unless the context indicates otherwise, the term &#8220;Company&#8221; refers to Ocean&#160;Bio-Chem, Inc. and its subsidiaries.</p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0.5in; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;">&#160;</p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;">The unaudited condensed consolidated financial statements have been prepared in accordance with United States generally accepted accounting principles (&#8220;GAAP&#8221;) for interim financial information and with the instructions to Form 10-Q and Article 8 of Regulation S-X.&#160;&#160;Accordingly, they do not include all of the information and footnotes required by GAAP for complete financial statements.</p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0.5in; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;">&#160;</p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;">The financial information furnished herein reflects all adjustments, consisting of normal recurring items that, in the opinion of management, are necessary for a fair presentation of the Company&#8217;s financial position, results of operations and cash flows for the interim periods.&#160;&#160;The results of operations for the three months ended March 31, 2016 are not necessarily indicative of the results to be expected for the year ending December 31, 2016.</p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0.5in; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;">&#160;</p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;">The information included in this Form 10-Q should be read in conjunction with the Company&#8217;s Annual Report on Form 10-K for the year ended December 31, 2015.</p></div> <div><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"><b>Use of estimates</b></p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; color: #000000; text-transform: none; text-indent: 0.5in; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;">&#160;</p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;">The preparation of condensed consolidated financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period.&#160;&#160;Actual results could differ from those estimates and assumptions.</p></div> <div><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;">&#160;</p><table style="width: 1567px; text-transform: none; text-indent: 0px; letter-spacing: normal; font-family: 'times new roman', times, serif; word-spacing: 0px; border-collapse: collapse; widows: 1; -webkit-text-stroke-width: 0px;" cellspacing="0" cellpadding="0"><tr style="vertical-align: bottom;"><td style="font-size: 10pt;">&#160;</td><td style="font: 10pt/normal 'times new roman', times, serif; padding-bottom: 1.5pt; font-stretch: normal;">&#160;</td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: center; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid; font-stretch: normal;" colspan="2"><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: center; font-stretch: normal;"><b>March&#160;31,</b></p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: center; font-stretch: normal;"><b>2016</b></p></td><td style="font: 10pt/normal 'times new roman', times, serif; padding-bottom: 1.5pt; font-stretch: normal;">&#160;</td><td style="font: 10pt/normal 'times new roman', times, serif; padding-bottom: 1.5pt; font-stretch: normal;">&#160;</td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: center; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid; font-stretch: normal;" colspan="2"><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: center; font-stretch: normal;"><b>December&#160;31,</b></p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: center; font-stretch: normal;"><b>2015</b></p></td><td style="font: 10pt/normal 'times new roman', times, serif; padding-bottom: 1.5pt; font-stretch: normal;">&#160;</td></tr><tr style="vertical-align: bottom; background-color: #cceeff;"><td style="font: 10pt/normal 'times new roman', times, serif; width: 1191px; text-align: left; font-stretch: normal;">Raw materials</td><td style="font: 10pt/normal 'times new roman', times, serif; width: 16px; font-stretch: normal;">&#160;</td><td style="font: 10pt/normal 'times new roman', times, serif; width: 16px; text-align: left; font-stretch: normal;">$</td><td style="font: 10pt/normal 'times new roman', times, serif; width: 142px; text-align: right; font-stretch: normal;">3,853,721</td><td style="font: 10pt/normal 'times new roman', times, serif; width: 16px; text-align: left; font-stretch: normal;">&#160;</td><td style="font: 10pt/normal 'times new roman', times, serif; width: 15px; font-stretch: normal;">&#160;</td><td style="font: 10pt/normal 'times new roman', times, serif; width: 15px; text-align: left; font-stretch: normal;">$</td><td style="font: 10pt/normal 'times new roman', times, serif; width: 141px; text-align: right; font-stretch: normal;">3,749,702</td><td style="font: 10pt/normal 'times new roman', times, serif; width: 15px; text-align: left; font-stretch: normal;">&#160;</td></tr><tr style="vertical-align: bottom; background-color: white;"><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; text-indent: -29.7pt; padding-bottom: 1.5pt; padding-left: 29.7pt; font-stretch: normal;">Finished goods</td><td style="font: 10pt/normal 'times new roman', times, serif; padding-bottom: 1.5pt; font-stretch: normal;">&#160;</td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid; font-stretch: normal;">&#160;</td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: right; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid; font-stretch: normal;">5,495,717</td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; padding-bottom: 1.5pt; font-stretch: normal;">&#160;</td><td style="font: 10pt/normal 'times new roman', times, serif; padding-bottom: 1.5pt; font-stretch: normal;">&#160;</td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid; font-stretch: normal;">&#160;</td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: right; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid; font-stretch: normal;">4,445,130</td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; padding-bottom: 1.5pt; font-stretch: normal;">&#160;</td></tr><tr style="vertical-align: bottom; background-color: #cceeff;"><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; text-indent: -29.7pt; padding-left: 29.7pt; font-stretch: normal;">Inventories, gross</td><td style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; font-stretch: normal;">&#160;</td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: right; font-stretch: normal;">9,349,438</td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; font-stretch: normal;">&#160;</td><td style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; font-stretch: normal;">&#160;</td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: right; font-stretch: normal;">8,194,832</td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; font-stretch: normal;">&#160;</td></tr><tr style="vertical-align: bottom; background-color: white;"><td style="font-size: 10pt;">&#160;</td><td style="font-size: 10pt;">&#160;</td><td style="text-align: left; font-size: 10pt;">&#160;</td><td style="text-align: right; font-size: 10pt;">&#160;</td><td style="text-align: left; font-size: 10pt;">&#160;</td><td style="font-size: 10pt;">&#160;</td><td style="text-align: left; font-size: 10pt;">&#160;</td><td style="text-align: right; font-size: 10pt;">&#160;</td><td style="text-align: left; font-size: 10pt;">&#160;</td></tr><tr style="vertical-align: bottom; background-color: #cceeff;"><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; text-indent: -29.7pt; padding-bottom: 1.5pt; padding-left: 29.7pt; font-stretch: normal;">Inventory reserves</td><td style="font: 10pt/normal 'times new roman', times, serif; padding-bottom: 1.5pt; font-stretch: normal;">&#160;</td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid; font-stretch: normal;">&#160;</td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: right; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid; font-stretch: normal;">(283,602</td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; padding-bottom: 1.5pt; font-stretch: normal;">)</td><td style="font: 10pt/normal 'times new roman', times, serif; padding-bottom: 1.5pt; font-stretch: normal;">&#160;</td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid; font-stretch: normal;">&#160;</td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: right; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid; font-stretch: normal;">(279,882</td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; padding-bottom: 1.5pt; font-stretch: normal;">)</td></tr><tr style="vertical-align: bottom; background-color: white;"><td style="font-size: 10pt;">&#160;</td><td style="font-size: 10pt;">&#160;</td><td style="text-align: left; font-size: 10pt;">&#160;</td><td style="text-align: right; font-size: 10pt;">&#160;</td><td style="text-align: left; font-size: 10pt;">&#160;</td><td style="font-size: 10pt;">&#160;</td><td style="text-align: left; font-size: 10pt;">&#160;</td><td style="text-align: right; font-size: 10pt;">&#160;</td><td style="text-align: left; font-size: 10pt;">&#160;</td></tr><tr style="vertical-align: bottom; background-color: #cceeff;"><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; text-indent: -29.7pt; padding-bottom: 4pt; padding-left: 29.7pt; font-stretch: normal;">Inventories, net</td><td style="font: 10pt/normal 'times new roman', times, serif; padding-bottom: 4pt; font-stretch: normal;">&#160;</td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double; font-stretch: normal;">$</td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: right; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double; font-stretch: normal;">9,065,836</td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; padding-bottom: 4pt; font-stretch: normal;">&#160;</td><td style="font: 10pt/normal 'times new roman', times, serif; padding-bottom: 4pt; font-stretch: normal;">&#160;</td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double; font-stretch: normal;">$</td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: right; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double; font-stretch: normal;">7,914,950</td></tr></table></div> <div><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;">&#160;</p><table style="width: 1567px; text-transform: none; text-indent: 0px; letter-spacing: normal; font-family: 'times new roman', times, serif; word-spacing: 0px; border-collapse: collapse; widows: 1; -webkit-text-stroke-width: 0px;" cellspacing="0" cellpadding="0"><tr style="vertical-align: bottom;"><td style="font-size: 10pt;">&#160;</td><td style="font: 10pt/normal 'times new roman', times, serif; padding-bottom: 1.5pt; font-stretch: normal;">&#160;</td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: center; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid; font-stretch: normal;"><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: center; font-stretch: normal;"><b>Estimate</b></p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: center; font-stretch: normal;"><b>Useful Life</b></p></td><td style="font: 10pt/normal 'times new roman', times, serif; padding-bottom: 1.5pt; font-stretch: normal;">&#160;</td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: center; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid; font-stretch: normal;" colspan="2"><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: center; font-stretch: normal;"><b>March&#160;31,</b></p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: center; font-stretch: normal;"><b>2016</b></p></td><td style="font: 10pt/normal 'times new roman', times, serif; padding-bottom: 1.5pt; font-stretch: normal;">&#160;</td><td style="font: 10pt/normal 'times new roman', times, serif; padding-bottom: 1.5pt; font-stretch: normal;">&#160;</td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: center; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid; font-stretch: normal;" colspan="2"><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: center; font-stretch: normal;"><b>December&#160;31,</b></p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: center; font-stretch: normal;"><b>2015</b></p></td><td style="font: 10pt/normal 'times new roman', times, serif; padding-bottom: 1.5pt; font-stretch: normal;">&#160;</td></tr><tr style="vertical-align: bottom; background-color: #cceeff;"><td style="font: 10pt/normal 'times new roman', times, serif; width: 1003px; font-stretch: normal;">Land</td><td style="width: 16px; font-size: 10pt;">&#160;</td><td style="width: 173px; font-size: 10pt;">&#160;</td><td style="font: 10pt/normal 'times new roman', times, serif; width: 16px; font-stretch: normal;">&#160;</td><td style="font: 10pt/normal 'times new roman', times, serif; width: 16px; text-align: left; font-stretch: normal;">$</td><td style="font: 10pt/normal 'times new roman', times, serif; width: 142px; text-align: right; font-stretch: normal;">278,325</td><td style="font: 10pt/normal 'times new roman', times, serif; width: 15px; text-align: left; font-stretch: normal;">&#160;</td><td style="font: 10pt/normal 'times new roman', times, serif; width: 15px; font-stretch: normal;">&#160;</td><td style="font: 10pt/normal 'times new roman', times, serif; width: 15px; text-align: left; font-stretch: normal;">$</td><td style="font: 10pt/normal 'times new roman', times, serif; width: 141px; text-align: right; font-stretch: normal;">278,325</td><td style="font: 10pt/normal 'times new roman', times, serif; width: 15px; text-align: left; font-stretch: normal;">&#160;</td></tr><tr style="vertical-align: bottom; background-color: white;"><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; font-stretch: normal;">Building and improvements</td><td style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: center; font-stretch: normal;">30 years</td><td style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; font-stretch: normal;">&#160;</td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: right; font-stretch: normal;">4,652,669</td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; font-stretch: normal;">&#160;</td><td style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; font-stretch: normal;">&#160;</td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: right; font-stretch: normal;">4,652,669</td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; font-stretch: normal;">&#160;</td></tr><tr style="vertical-align: bottom; background-color: #cceeff;"><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; font-stretch: normal;">Manufacturing and warehouse equipment</td><td style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: center; font-stretch: normal;">6-20 years</td><td style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; font-stretch: normal;">&#160;</td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: right; font-stretch: normal;">9,153,057</td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; font-stretch: normal;">&#160;</td><td style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; font-stretch: normal;">&#160;</td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: right; font-stretch: normal;">9,072,162</td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; font-stretch: normal;">&#160;</td></tr><tr style="vertical-align: bottom; background-color: white;"><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; font-stretch: normal;">Office equipment and furniture</td><td style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: center; font-stretch: normal;">3-5 years</td><td style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; font-stretch: normal;">&#160;</td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: right; font-stretch: normal;">1,268,545</td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; font-stretch: normal;">&#160;</td><td style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; font-stretch: normal;">&#160;</td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: right; font-stretch: normal;">1,293,609</td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; font-stretch: normal;">&#160;</td></tr><tr style="vertical-align: bottom; background-color: #cceeff;"><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; font-stretch: normal;">Construction in process</td><td style="font-size: 10pt;">&#160;</td><td style="text-align: center; font-size: 10pt;">&#160;</td><td style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; font-stretch: normal;">&#160;</td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: right; font-stretch: normal;">197,545</td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; font-stretch: normal;">&#160;</td><td style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; font-stretch: normal;">&#160;</td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: right; font-stretch: normal;">215,155</td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; font-stretch: normal;">&#160;</td></tr><tr style="vertical-align: bottom; background-color: white;"><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; font-stretch: normal;">Leasehold improvements</td><td style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: center; font-stretch: normal;">10-15 years</td><td style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; font-stretch: normal;">&#160;</td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: right; font-stretch: normal;">544,146</td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; font-stretch: normal;">&#160;</td><td style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; font-stretch: normal;">&#160;</td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: right; font-stretch: normal;">544,146</td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; font-stretch: normal;">&#160;</td></tr><tr style="vertical-align: bottom; background-color: #cceeff;"><td style="font: 10pt/normal 'times new roman', times, serif; padding-bottom: 1.5pt; font-stretch: normal;">Vehicles</td><td style="font: 10pt/normal 'times new roman', times, serif; padding-bottom: 1.5pt; font-stretch: normal;">&#160;</td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: center; padding-bottom: 1.5pt; font-stretch: normal;">3 years</td><td style="font: 10pt/normal 'times new roman', times, serif; padding-bottom: 1.5pt; font-stretch: normal;">&#160;</td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid; font-stretch: normal;">&#160;</td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: right; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid; font-stretch: normal;">42,283</td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; padding-bottom: 1.5pt; font-stretch: normal;">&#160;</td><td style="font: 10pt/normal 'times new roman', times, serif; padding-bottom: 1.5pt; font-stretch: normal;">&#160;</td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid; font-stretch: normal;">&#160;</td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: right; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid; font-stretch: normal;">42,283</td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; padding-bottom: 1.5pt; font-stretch: normal;">&#160;</td></tr><tr style="vertical-align: bottom; background-color: white;"><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; font-stretch: normal;">Property, plant and equipment, gross</td><td style="font-size: 10pt;">&#160;</td><td style="font-size: 10pt;">&#160;</td><td style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; font-stretch: normal;">&#160;</td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: right; font-stretch: normal;">16,136,570</td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; font-stretch: normal;">&#160;</td><td style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; font-stretch: normal;">&#160;</td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: right; font-stretch: normal;">16,098,349</td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; font-stretch: normal;">&#160;</td></tr><tr style="vertical-align: bottom; background-color: #cceeff;"><td style="font-size: 10pt;">&#160;</td><td style="font-size: 10pt;">&#160;</td><td style="font-size: 10pt;">&#160;</td><td style="font-size: 10pt;">&#160;</td><td style="text-align: left; font-size: 10pt;">&#160;</td><td style="text-align: right; font-size: 10pt;">&#160;</td><td style="text-align: left; font-size: 10pt;">&#160;</td><td style="font-size: 10pt;">&#160;</td><td style="text-align: left; font-size: 10pt;">&#160;</td><td style="text-align: right; font-size: 10pt;">&#160;</td><td style="text-align: left; font-size: 10pt;">&#160;</td></tr><tr style="vertical-align: bottom; background-color: white;"><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; padding-bottom: 1.5pt; font-stretch: normal;">Less accumulated depreciation</td><td style="padding-bottom: 1.5pt; font-size: 10pt;">&#160;</td><td style="padding-bottom: 1.5pt; font-size: 10pt;">&#160;</td><td style="font: 10pt/normal 'times new roman', times, serif; padding-bottom: 1.5pt; font-stretch: normal;">&#160;</td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid; font-stretch: normal;">&#160;</td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: right; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid; font-stretch: normal;">(10,932,959</td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; padding-bottom: 1.5pt; font-stretch: normal;">)</td><td style="font: 10pt/normal 'times new roman', times, serif; padding-bottom: 1.5pt; font-stretch: normal;">&#160;</td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid; font-stretch: normal;">&#160;</td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: right; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid; font-stretch: normal;">(10,741,961</td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; padding-bottom: 1.5pt; font-stretch: normal;">)</td></tr><tr style="vertical-align: bottom; background-color: #cceeff;"><td style="font-size: 10pt;">&#160;</td><td style="font-size: 10pt;">&#160;</td><td style="font-size: 10pt;">&#160;</td><td style="font-size: 10pt;">&#160;</td><td style="text-align: left; font-size: 10pt;">&#160;</td><td style="text-align: right; font-size: 10pt;">&#160;</td><td style="text-align: left; font-size: 10pt;">&#160;</td><td style="font-size: 10pt;">&#160;</td><td style="text-align: left; font-size: 10pt;">&#160;</td><td style="text-align: right; font-size: 10pt;">&#160;</td><td style="text-align: left; font-size: 10pt;">&#160;</td></tr><tr style="vertical-align: bottom; background-color: white;"><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; padding-bottom: 4pt; font-stretch: normal;">Property, plant and equipment, net</td><td style="padding-bottom: 4pt; font-size: 10pt;">&#160;</td><td style="padding-bottom: 4pt; font-size: 10pt;">&#160;</td><td style="font: 10pt/normal 'times new roman', times, serif; padding-bottom: 4pt; font-stretch: normal;">&#160;</td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double; font-stretch: normal;">$</td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: right; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double; font-stretch: normal;">5,203,611</td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; padding-bottom: 4pt; font-stretch: normal;">&#160;</td><td style="font: 10pt/normal 'times new roman', times, serif; padding-bottom: 4pt; font-stretch: normal;">&#160;</td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double; font-stretch: normal;">$</td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: right; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double; font-stretch: normal;">5,356,388</td></tr></table></div> <div><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: justify; font-stretch: normal;">&#160;</p><br class="apple-interchange-newline" /><table style="width: 1567px; border-collapse: collapse;" cellspacing="0" cellpadding="0"><tr style="vertical-align: bottom;"><td style="font-size: 10pt;">&#160;</td><td style="font: bold 10pt/normal 'times new roman', times, serif; padding-bottom: 1.5pt; font-stretch: normal;">&#160;</td><td style="font: bold 10pt/normal 'times new roman', times, serif; text-align: center; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid; font-stretch: normal;" colspan="6">Current Portion</td><td style="font: bold 10pt/normal 'times new roman', times, serif; padding-bottom: 1.5pt; font-stretch: normal;">&#160;</td><td style="font: bold 10pt/normal 'times new roman', times, serif; padding-bottom: 1.5pt; font-stretch: normal;">&#160;</td><td style="font: bold 10pt/normal 'times new roman', times, serif; text-align: center; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid; font-stretch: normal;" colspan="6">Long Term Portion</td><td style="font: bold 10pt/normal 'times new roman', times, serif; padding-bottom: 1.5pt; font-stretch: normal;">&#160;</td></tr><tr style="vertical-align: bottom;"><td style="font-size: 10pt;">&#160;</td><td style="font: bold 10pt/normal 'times new roman', times, serif; padding-bottom: 1.5pt; font-stretch: normal;">&#160;</td><td style="font: bold 10pt/normal 'times new roman', times, serif; text-align: center; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid; font-stretch: normal;" colspan="2">March 31,&#160;<br />2016</td><td style="font: bold 10pt/normal 'times new roman', times, serif; padding-bottom: 1.5pt; font-stretch: normal;">&#160;</td><td style="font: 10pt/normal 'times new roman', times, serif; padding-bottom: 1.5pt; font-stretch: normal;">&#160;</td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: center; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid; font-stretch: normal;" colspan="2"><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: center; font-stretch: normal;"><b>December&#160;31,</b></p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: center; font-stretch: normal;"><b>2015</b></p></td><td style="font: 10pt/normal 'times new roman', times, serif; padding-bottom: 1.5pt; font-stretch: normal;">&#160;</td><td style="font: bold 10pt/normal 'times new roman', times, serif; padding-bottom: 1.5pt; font-stretch: normal;">&#160;</td><td style="font: bold 10pt/normal 'times new roman', times, serif; text-align: center; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid; font-stretch: normal;" colspan="2">March 31,&#160;<br />2016</td><td style="font: bold 10pt/normal 'times new roman', times, serif; padding-bottom: 1.5pt; font-stretch: normal;">&#160;</td><td style="font: bold 10pt/normal 'times new roman', times, serif; padding-bottom: 1.5pt; font-stretch: normal;">&#160;</td><td style="font: bold 10pt/normal 'times new roman', times, serif; text-align: center; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid; font-stretch: normal;" colspan="2">December&#160;31,<br />2015</td><td style="font: bold 10pt/normal 'times new roman', times, serif; padding-bottom: 1.5pt; font-stretch: normal;">&#160;</td></tr><tr style="vertical-align: bottom; background-color: #cceeff;"><td style="font: 10pt/normal 'times new roman', times, serif; width: 815px; text-align: left; font-stretch: normal;">Term loan</td><td style="font: 10pt/normal 'times new roman', times, serif; width: 16px; font-stretch: normal;">&#160;</td><td style="font: 10pt/normal 'times new roman', times, serif; width: 16px; text-align: left; font-stretch: normal;">$</td><td style="font: 10pt/normal 'times new roman', times, serif; width: 142px; text-align: right; font-stretch: normal;">436,441</td><td style="font: 10pt/normal 'times new roman', times, serif; width: 16px; text-align: left; font-stretch: normal;">&#160;</td><td style="font: 10pt/normal 'times new roman', times, serif; width: 16px; font-stretch: normal;">&#160;</td><td style="font: 10pt/normal 'times new roman', times, serif; width: 16px; text-align: left; font-stretch: normal;">$</td><td style="font: 10pt/normal 'times new roman', times, serif; width: 142px; text-align: right; font-stretch: normal;">432,601</td><td style="font: 10pt/normal 'times new roman', times, serif; width: 16px; text-align: left; font-stretch: normal;">&#160;</td><td style="font: 10pt/normal 'times new roman', times, serif; width: 15px; font-stretch: normal;">&#160;</td><td style="font: 10pt/normal 'times new roman', times, serif; width: 15px; text-align: left; font-stretch: normal;">$</td><td style="font: 10pt/normal 'times new roman', times, serif; width: 141px; text-align: right; font-stretch: normal;">148,942</td><td style="font: 10pt/normal 'times new roman', times, serif; width: 15px; text-align: left; font-stretch: normal;">&#160;</td><td style="font: 10pt/normal 'times new roman', times, serif; width: 15px; font-stretch: normal;">&#160;</td><td style="font: 10pt/normal 'times new roman', times, serif; width: 15px; text-align: left; font-stretch: normal;">$</td><td style="font: 10pt/normal 'times new roman', times, serif; width: 141px; text-align: right; font-stretch: normal;">259,503</td><td style="font: 10pt/normal 'times new roman', times, serif; width: 15px; text-align: left; font-stretch: normal;">&#160;</td></tr><tr style="vertical-align: bottom; background-color: white;"><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; padding-bottom: 1.5pt; font-stretch: normal;">Capitalized equipment leases</td><td style="font: 10pt/normal 'times new roman', times, serif; padding-bottom: 1.5pt; font-stretch: normal;">&#160;</td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid; font-stretch: normal;">&#160;</td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: right; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid; font-stretch: normal;">17,092</td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; padding-bottom: 1.5pt; font-stretch: normal;">&#160;</td><td style="font: 10pt/normal 'times new roman', times, serif; padding-bottom: 1.5pt; font-stretch: normal;">&#160;</td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid; font-stretch: normal;">&#160;</td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: right; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid; font-stretch: normal;">18,547</td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; padding-bottom: 1.5pt; font-stretch: normal;">&#160;</td><td style="font: 10pt/normal 'times new roman', times, serif; padding-bottom: 1.5pt; font-stretch: normal;">&#160;</td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid; font-stretch: normal;">&#160;</td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: right; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid; font-stretch: normal;">64,625</td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; padding-bottom: 1.5pt; font-stretch: normal;">&#160;</td><td style="font: 10pt/normal 'times new roman', times, serif; padding-bottom: 1.5pt; font-stretch: normal;">&#160;</td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid; font-stretch: normal;">&#160;</td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: right; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid; font-stretch: normal;">69,315</td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; padding-bottom: 1.5pt; font-stretch: normal;">&#160;</td></tr><tr style="vertical-align: bottom; background-color: #cceeff;"><td style="font-size: 10pt;">&#160;</td><td style="font-size: 10pt;">&#160;</td><td style="text-align: left; font-size: 10pt;">&#160;</td><td style="text-align: right; font-size: 10pt;">&#160;</td><td style="text-align: left; font-size: 10pt;">&#160;</td><td style="font-size: 10pt;">&#160;</td><td style="text-align: left; font-size: 10pt;">&#160;</td><td style="text-align: right; font-size: 10pt;">&#160;</td><td style="text-align: left; font-size: 10pt;">&#160;</td><td style="font-size: 10pt;">&#160;</td><td style="text-align: left; font-size: 10pt;">&#160;</td><td style="text-align: right; font-size: 10pt;">&#160;</td><td style="text-align: left; font-size: 10pt;">&#160;</td><td style="font-size: 10pt;">&#160;</td><td style="text-align: left; font-size: 10pt;">&#160;</td><td style="text-align: right; font-size: 10pt;">&#160;</td><td style="text-align: left; font-size: 10pt;">&#160;</td></tr><tr style="vertical-align: bottom; background-color: white;"><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; padding-bottom: 4pt; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;">Total long term debt</td><td style="font: 10pt/normal 'times new roman', times, serif; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; padding-bottom: 4pt; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;">&#160;</td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;">$</td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: right; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;">453,533</td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; padding-bottom: 4pt; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;">&#160;</td><td style="font: 10pt/normal 'times new roman', times, serif; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; padding-bottom: 4pt; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;">&#160;</td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;">$</td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: right; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;">451,148</td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; padding-bottom: 4pt; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;">&#160;</td><td style="font: 10pt/normal 'times new roman', times, serif; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; padding-bottom: 4pt; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;">&#160;</td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;">$</td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: right; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;">213,567</td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; padding-bottom: 4pt; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;">&#160;</td><td style="font: 10pt/normal 'times new roman', times, serif; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; padding-bottom: 4pt; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;">&#160;</td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;">$</td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: right; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;">328,818</td></tr></table></div> <div><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;">&#160;</p><table style="width: 1567px; text-transform: none; text-indent: 0px; letter-spacing: normal; font-family: 'times new roman', times, serif; word-spacing: 0px; border-collapse: collapse; widows: 1; -webkit-text-stroke-width: 0px;" cellspacing="0" cellpadding="0"><tr style="vertical-align: bottom;"><td style="font: bold 10pt/normal 'times new roman', times, serif; text-align: center; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid; font-stretch: normal;">12 month period ending March 31,</td><td style="padding-bottom: 1.5pt; font-size: 10pt;">&#160;</td><td style="font-size: 10pt;" colspan="2">&#160;</td><td style="padding-bottom: 1.5pt; font-size: 10pt;">&#160;</td></tr><tr style="vertical-align: bottom; background-color: #cceeff;"><td style="font: 10pt/normal 'times new roman', times, serif; width: 1379px; text-align: left; font-stretch: normal;">2017</td><td style="font: 10pt/normal 'times new roman', times, serif; width: 16px; font-stretch: normal;">&#160;</td><td style="font: 10pt/normal 'times new roman', times, serif; width: 16px; text-align: left; font-stretch: normal;">$</td><td style="font: 10pt/normal 'times new roman', times, serif; width: 141px; text-align: right; font-stretch: normal;">453,533</td><td style="font: 10pt/normal 'times new roman', times, serif; width: 15px; text-align: left; font-stretch: normal;">&#160;</td></tr><tr style="vertical-align: bottom; background-color: white;"><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; font-stretch: normal;">2018</td><td style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; font-stretch: normal;">&#160;</td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: right; font-stretch: normal;">167,918</td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; font-stretch: normal;">&#160;</td></tr><tr style="vertical-align: bottom; background-color: #cceeff;"><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; font-stretch: normal;">2019</td><td style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; font-stretch: normal;">&#160;</td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: right; font-stretch: normal;">19,326</td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; font-stretch: normal;">&#160;</td></tr><tr style="vertical-align: bottom; background-color: white;"><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; font-stretch: normal;">2020</td><td style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; font-stretch: normal;">&#160;</td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: right; font-stretch: normal;">19,682</td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; font-stretch: normal;">&#160;</td></tr><tr style="vertical-align: bottom; background-color: #cceeff;"><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; padding-bottom: 1.5pt; font-stretch: normal;">2021</td><td style="font: 10pt/normal 'times new roman', times, serif; padding-bottom: 1.5pt; font-stretch: normal;">&#160;</td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid; font-stretch: normal;">&#160;</td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: right; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid; font-stretch: normal;">6,641</td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; padding-bottom: 1.5pt; font-stretch: normal;">&#160;</td></tr><tr style="vertical-align: bottom; background-color: white;"><td style="text-align: left; font-size: 10pt;">&#160;</td><td style="font-size: 10pt;">&#160;</td><td style="text-align: left; font-size: 10pt;">&#160;</td><td style="text-align: right; font-size: 10pt;">&#160;</td><td style="text-align: left; font-size: 10pt;">&#160;</td></tr><tr style="vertical-align: bottom; background-color: #cceeff;"><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; padding-bottom: 4pt; font-stretch: normal;">Total</td><td style="font: 10pt/normal 'times new roman', times, serif; padding-bottom: 4pt; font-stretch: normal;">&#160;</td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double; font-stretch: normal;">$</td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: right; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double; font-stretch: normal;">667,100</td></tr></table></div> <p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-indent: 0px; text-transform: none; white-space: normal; widows: 1; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; margin: 0px; text-align: justify;"></p><table style="font: 10pt/normal 'times new roman', times, serif; width: 1567px; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; border-collapse: collapse; widows: 1; font-size-adjust: none; font-stretch: normal; -webkit-text-stroke-width: 0px;" cellspacing="0" cellpadding="0"><tr style="vertical-align: bottom;"><td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt;">&#160;</td><td style="font-weight: bold; text-align: center; border-bottom-width: 1.5pt; border-bottom-style: solid; border-bottom-color: black;" colspan="6">Three Months Ended&#160;<br />March 31,</td><td style="padding-bottom: 1.5pt; font-weight: bold;">&#160;</td></tr><tr style="vertical-align: bottom;"><td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt;">&#160;</td><td style="font-weight: bold; text-align: center; border-bottom-width: 1.5pt; border-bottom-style: solid; border-bottom-color: black;" colspan="2">2016</td><td style="padding-bottom: 1.5pt; font-weight: bold;">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt;">&#160;</td><td style="font-weight: bold; text-align: center; border-bottom-width: 1.5pt; border-bottom-style: solid; border-bottom-color: black;" colspan="2">2015</td><td style="padding-bottom: 1.5pt; font-weight: bold;">&#160;</td></tr><tr style="vertical-align: bottom;"><td style="font-weight: bold;">Loss per common share &#8211;Basic and Diluted</td><td>&#160;</td><td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td><td colspan="2">&#160;</td><td>&#160;</td></tr><tr style="vertical-align: bottom;"><td>&#160;</td><td>&#160;</td><td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td><td colspan="2">&#160;</td><td>&#160;</td></tr><tr style="vertical-align: bottom; background-color: #cceeff;"><td style="width: 1191px; text-align: left;">Net loss</td><td style="width: 16px;">&#160;</td><td style="width: 16px; text-align: left;">$</td><td style="width: 142px; text-align: right;">(540,802</td><td style="width: 16px; text-align: left;">)</td><td style="width: 15px;">&#160;</td><td style="width: 15px; text-align: left;">$</td><td style="width: 141px; text-align: right;">(15,926</td><td style="width: 15px; text-align: left;">)</td></tr><tr style="vertical-align: bottom; background-color: white;"><td>&#160;</td><td>&#160;</td><td style="text-align: left;">&#160;</td><td style="text-align: right;">&#160;</td><td style="text-align: left;">&#160;</td><td>&#160;</td><td style="text-align: left;">&#160;</td><td style="text-align: right;">&#160;</td><td style="text-align: left;">&#160;</td></tr><tr style="vertical-align: bottom; background-color: #cceeff;"><td>Weighted average number of common shares outstanding</td><td>&#160;</td><td style="text-align: left;">&#160;</td><td style="text-align: right;">8,985,858</td><td style="text-align: left;">&#160;</td><td>&#160;</td><td style="text-align: left;">&#160;</td><td style="text-align: right;">8,920,288</td><td style="text-align: left;">&#160;</td></tr><tr style="vertical-align: bottom; background-color: white;"><td>&#160;</td><td>&#160;</td><td style="text-align: left;">&#160;</td><td style="text-align: right;">&#160;</td><td style="text-align: left;">&#160;</td><td>&#160;</td><td style="text-align: left;">&#160;</td><td style="text-align: right;">&#160;</td><td style="text-align: left;">&#160;</td></tr><tr style="vertical-align: bottom; background-color: #cceeff;"><td style="text-align: left;">Loss per common share &#8211; Basic and Diluted</td><td>&#160;</td><td style="text-align: left;">$</td><td style="text-align: right;">(0.06</td><td style="text-align: left;">)</td><td>&#160;</td><td style="text-align: left;">$</td><td style="text-align: right;">0.00</td><td style="text-align: left;">&#160;</td></tr></table> <p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-indent: 0px; text-transform: none; white-space: normal; widows: 1; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; margin: 0px; text-align: justify;">&#160;</p><table style="width: 1567px; text-transform: none; text-indent: 0px; letter-spacing: normal; font-family: 'times new roman', times, serif; word-spacing: 0px; border-collapse: collapse; widows: 1; -webkit-text-stroke-width: 0px;" cellspacing="0" cellpadding="0"><tr style="vertical-align: bottom;"><td style="font-style: normal; font-variant: normal; font-weight: bold; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; border-bottom-width: 1.5pt; border-bottom-style: solid; border-bottom-color: black; text-align: left;">Plan</td><td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; padding-bottom: 1.5pt;">&#160;</td><td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; text-align: center; border-bottom-width: 1.5pt; border-bottom-style: solid; border-bottom-color: black;"><p style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; margin: 0px; text-align: center;"><b>Date</b></p><p style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; margin: 0px; text-align: center;"><b>Granted</b></p></td><td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; padding-bottom: 1.5pt;">&#160;</td><td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; text-align: center; border-bottom-width: 1.5pt; border-bottom-style: solid; border-bottom-color: black;" colspan="2"><p style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; margin: 0px; text-align: center;"><b>Shares</b></p><p style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; margin: 0px; text-align: center;"><b>Underlying</b></p><p style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; margin: 0px; text-align: center;"><b>Options Outstanding</b></p></td><td style="padding-bottom: 1.5pt; font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif;">&#160;</td><td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; padding-bottom: 1.5pt;">&#160;</td><td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; text-align: center; border-bottom-width: 1.5pt; border-bottom-style: solid; border-bottom-color: black;" colspan="2"><p style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; margin: 0px; text-align: center;"><b>Shares</b></p><p style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; margin: 0px; text-align: center;"><b>Underlying Exercisable</b></p><p style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; margin: 0px; text-align: center;"><b>Options</b></p></td><td style="padding-bottom: 1.5pt; font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif;">&#160;</td><td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; padding-bottom: 1.5pt;">&#160;</td><td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; text-align: center; border-bottom-width: 1.5pt; border-bottom-style: solid; border-bottom-color: black;" colspan="2"><p style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; margin: 0px; text-align: center;"><b>Exercise</b></p><p style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; margin: 0px; text-align: center;"><b>Price</b></p></td><td style="padding-bottom: 1.5pt; font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif;">&#160;</td><td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; padding-bottom: 1.5pt;">&#160;</td><td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; text-align: center; border-bottom-width: 1.5pt; border-bottom-style: solid; border-bottom-color: black;"><p style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; margin: 0px; text-align: center;"><b>Expiration</b></p><p style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; margin: 0px; text-align: center;"><b>Date</b></p></td><td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; padding-bottom: 1.5pt;">&#160;</td><td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; text-align: center; border-bottom-width: 1.5pt; border-bottom-style: solid; border-bottom-color: black;" colspan="2"><p style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; margin: 0px; text-align: center;"><b>Weighted</b></p><p style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; margin: 0px; text-align: center;"><b>Average</b></p><p style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; margin: 0px; text-align: center;"><b>Remaining Term</b></p></td><td style="padding-bottom: 1.5pt; font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif;">&#160;</td></tr><tr style="vertical-align: bottom; background-color: #cceeff;"><td style="width: 220px; font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; text-align: left;">2002NQ</td><td style="width: 16px; font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif;">&#160;</td><td style="width: 220px; font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; text-align: center;">12/17/07</td><td style="width: 16px; font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif;">&#160;</td><td style="width: 16px; font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; text-align: left;">&#160;</td><td style="width: 189px; font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; text-align: right;">40,000</td><td style="width: 16px; font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; text-align: left;">&#160;</td><td style="width: 16px; font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif;">&#160;</td><td style="width: 16px; font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; text-align: left;">&#160;</td><td style="width: 173px; font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; text-align: right;">40,000</td><td style="width: 16px; font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; text-align: left;">&#160;</td><td style="width: 16px; font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif;">&#160;</td><td style="width: 15px; font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; text-align: left;">$</td><td style="width: 172px; font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; text-align: right;">1.32</td><td style="width: 15px; font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; text-align: left;">&#160;</td><td style="width: 15px; font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif;">&#160;</td><td style="width: 203px; font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; text-align: center;">12/16/17</td><td style="width: 15px; font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif;">&#160;</td><td style="width: 15px; font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; text-align: left;">&#160;</td><td style="width: 172px; font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; text-align: right;">1.7</td><td style="width: 15px; font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; text-align: left;">&#160;</td></tr><tr style="vertical-align: bottom; background-color: white;"><td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; text-align: left;">2008NQ</td><td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif;">&#160;</td><td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; text-align: center;">1/11/09</td><td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif;">&#160;</td><td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; text-align: left;">&#160;</td><td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; text-align: right;">40,000</td><td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; text-align: left;">&#160;</td><td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif;">&#160;</td><td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; text-align: left;">&#160;</td><td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; text-align: right;">40,000</td><td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; text-align: left;">&#160;</td><td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif;">&#160;</td><td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; text-align: left;">$</td><td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; text-align: right;">0.69</td><td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; text-align: left;">&#160;</td><td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif;">&#160;</td><td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; text-align: center;">1/10/19</td><td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif;">&#160;</td><td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; text-align: left;">&#160;</td><td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; text-align: right;">2.8</td><td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; text-align: left;">&#160;</td></tr><tr style="vertical-align: bottom; background-color: #cceeff;"><td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; text-align: left;">2008NQ</td><td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif;">&#160;</td><td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; text-align: center;">4/26/10</td><td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif;">&#160;</td><td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; text-align: left;">&#160;</td><td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; text-align: right;">20,000</td><td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; text-align: left;">&#160;</td><td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif;">&#160;</td><td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; text-align: left;">&#160;</td><td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; text-align: right;">20,000</td><td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; text-align: left;">&#160;</td><td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif;">&#160;</td><td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; text-align: left;">$</td><td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; text-align: right;">2.07</td><td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; text-align: left;">&#160;</td><td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif;">&#160;</td><td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; text-align: center;">4/25/20</td><td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif;">&#160;</td><td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; text-align: left;">&#160;</td><td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; text-align: right;">4.1</td><td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; text-align: left;">&#160;</td></tr><tr style="vertical-align: bottom; background-color: white;"><td style="font-size: 10pt; padding-bottom: 1.5pt; text-align: left;">&#160;</td><td style="font-size: 10pt; padding-bottom: 1.5pt;">&#160;</td><td style="font-size: 10pt; text-align: center; padding-bottom: 1.5pt;">&#160;</td><td style="font-size: 10pt; padding-bottom: 1.5pt;">&#160;</td><td style="border-bottom-width: 1.5pt; border-bottom-style: solid; border-bottom-color: black; font-size: 10pt; text-align: left;">&#160;</td><td style="border-bottom-width: 1.5pt; border-bottom-style: solid; border-bottom-color: black; font-size: 10pt; text-align: right;">&#160;</td><td style="padding-bottom: 1.5pt; font-size: 10pt; text-align: left;">&#160;</td><td style="font-size: 10pt; padding-bottom: 1.5pt;">&#160;</td><td style="border-bottom-width: 1.5pt; border-bottom-style: solid; border-bottom-color: black; font-size: 10pt; text-align: left;">&#160;</td><td style="border-bottom-width: 1.5pt; border-bottom-style: solid; border-bottom-color: black; font-size: 10pt; text-align: right;">&#160;</td><td style="padding-bottom: 1.5pt; font-size: 10pt; text-align: left;">&#160;</td><td style="font-size: 10pt; padding-bottom: 1.5pt;">&#160;</td><td style="font-size: 10pt; text-align: left;">&#160;</td><td style="font-size: 10pt; text-align: right;">&#160;</td><td style="padding-bottom: 1.5pt; font-size: 10pt; text-align: left;">&#160;</td><td style="font-size: 10pt; padding-bottom: 1.5pt;">&#160;</td><td style="font-size: 10pt; text-align: center; padding-bottom: 1.5pt;">&#160;</td><td style="font-size: 10pt; padding-bottom: 1.5pt;">&#160;</td><td style="padding-bottom: 1.5pt; font-size: 10pt; text-align: left;">&#160;</td><td style="padding-bottom: 1.5pt; font-size: 10pt; text-align: right;">&#160;</td><td style="padding-bottom: 1.5pt; font-size: 10pt; text-align: left;">&#160;</td></tr><tr style="vertical-align: bottom; background-color: #cceeff;"><td style="font-size: 10pt; padding-bottom: 4pt; text-align: left;">&#160;</td><td style="font-size: 10pt; padding-bottom: 4pt;">&#160;</td><td style="font-size: 10pt; text-align: center; padding-bottom: 4pt;">&#160;</td><td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; padding-bottom: 4pt;">&#160;</td><td style="border-bottom-width: 4pt; border-bottom-style: double; border-bottom-color: black; font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; text-align: left;">&#160;</td><td style="border-bottom-width: 4pt; border-bottom-style: double; border-bottom-color: black; font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; text-align: right;">100,000</td><td style="padding-bottom: 4pt; font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; text-align: left;">&#160;</td><td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; padding-bottom: 4pt;">&#160;</td><td style="border-bottom-width: 4pt; border-bottom-style: double; border-bottom-color: black; font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; text-align: left;">&#160;</td><td style="border-bottom-width: 4pt; border-bottom-style: double; border-bottom-color: black; font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; text-align: right;">100,000</td><td style="padding-bottom: 4pt; font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; text-align: left;">&#160;</td><td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; padding-bottom: 4pt;">&#160;</td><td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; text-align: left;">$</td><td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; text-align: right;">1.22</td><td style="padding-bottom: 4pt; font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; text-align: left;">&#160;</td><td style="font-size: 10pt; padding-bottom: 4pt;">&#160;</td><td style="font-size: 10pt; text-align: center; padding-bottom: 4pt;">&#160;</td><td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; padding-bottom: 4pt;">&#160;</td><td style="padding-bottom: 4pt; font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; text-align: left;">&#160;</td><td style="padding-bottom: 4pt; font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; text-align: right;">2.6</td><td style="padding-bottom: 4pt; font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; text-align: left;">&#160;</td></tr></table><div>&#160;</div> 3749702 3853721 4445130 5495717 8194832 9349438 279882 283602 543000 469000 278325 278325 4652669 4652669 9072162 9153057 1293609 1268545 215155 197545 544146 544146 42283 42283 16098349 16136570 10741961 10932959 P30Y P6Y P20Y P3Y P5Y P10Y P15Y P3Y The Company may borrow up to the lesser of (i) $6 million or (ii) a borrowing base equal to 80% of eligible accounts receivable (as defined in the Business Loan Agreement) plus 50% of eligible inventory (as defined in the Business Loan Agreement). 6000000 0.80 0.50 30 day LIBOR rate plus 1.65% per annum 2.0 to 1 30 day LIBOR rate plus 2.65% per annum 2016-07-06 A minimum debt service coverage ratio of 1.75 to 1.00, calculated on a trailing twelve month basis, and a maximum debt to capitalization ratio (generally, funded debt divided by the sum of total net worth and funded debt) of 0.75 to 1, tested quarterly. 1.75 to 1.00 The Company was not in compliance with the financial covenant relating to its minimum debt service coverage ratio, as its debt service coverage ratio was 1.67. 0.75 to 1 The line of credit is subject to several events of default, including a decline in the majority shareholder's ownership below 50% of all outstanding shares. 432601 436441 259503 148942 18547 17092 69315 64625 453533 167918 19326 19682 6641 667100 2430000 585000 0.0354 2017-07-06 88000 82000 Mature on July 1, 2020 0.02 1 2.0 Term loan with a fixed interest rate of 3.54%, subject to an increase to 4.55% in the event the Company's debt service coverage ratio (net profit plus taxes, interest, depreciation, amortization and rent expense divided by debt service plus interest and lease/rent expense, calculated on a trailing four-quarter basis) falls to or below 2.0 to 1. 725000 546000 107000 123000 1051000 1068000 10500 10500 216000 60000 2023-12-31 94800 0.02 P3Y 24000 24000 8920288 8985858 0.00 -0.06 99689 57509 2007-12-17 2009-01-11 2010-04-26 100000 40000 40000 20000 100000 40000 40000 20000 1.22 1.32 0.69 2.07 2017-12-16 2019-01-10 2020-04-25 P2Y7M6D P1Y8M12D P2Y9M18D P4Y1M6D 30000 21600 4519 25481 0 0 0 0 0 9008855 EX-101.SCH 7 obci-20160331.xsd XBRL SCHEMA FILE 001 - Document - Document and Entity Information link:presentationLink link:definitionLink link:calculationLink 002 - Statement - Consolidated Balance Sheets link:presentationLink link:definitionLink link:calculationLink 003 - Statement - Condensed Consolidated Balance Sheets (Parenthetical) link:presentationLink link:definitionLink link:calculationLink 004 - Statement - Condensed Consolidated Statements of Operations (Unaudited) link:presentationLink link:definitionLink link:calculationLink 005 - Statement - Condensed Consolidated Statements of Comprehensive Income (Unaudited) link:presentationLink link:definitionLink link:calculationLink 006 - Statement - Condensed Consolidated Statements of Cash Flows (Unaudited) link:presentationLink link:definitionLink link:calculationLink 007 - Disclosure - Summary of Accounting Policies link:presentationLink link:definitionLink link:calculationLink 008 - Disclosure - Recent Accounting Pronouncements link:presentationLink link:definitionLink link:calculationLink 009 - Disclosure - Inventories link:presentationLink link:definitionLink link:calculationLink 010 - Disclosure - Property, Plant & Equipment link:presentationLink link:definitionLink link:calculationLink 011 - Disclosure - Revolving Line of Credit link:presentationLink link:definitionLink link:calculationLink 012 - Disclosure - Long Term Debt link:presentationLink link:definitionLink link:calculationLink 013 - Disclosure - Related Party Transactions link:presentationLink link:definitionLink link:calculationLink 014 - Disclosure - Commitments and Contingencies link:presentationLink link:definitionLink link:calculationLink 015 - Disclosure - Loss Per Share link:presentationLink link:definitionLink link:calculationLink 016 - Disclosure - Securities Authorized for Issuance under Equity Compensation Plans link:presentationLink link:definitionLink link:calculationLink 017 - Disclosure - Special Cash Dividend link:presentationLink link:definitionLink link:calculationLink 018 - Disclosure - Summary of Accounting Policies (Policies) link:presentationLink link:definitionLink link:calculationLink 019 - Disclosure - Inventories (Tables) link:presentationLink link:definitionLink link:calculationLink 020 - Disclosure - Property, Plant & Equipment (Tables) link:presentationLink link:definitionLink link:calculationLink 021 - Disclosure - Long Term Debt (Tables) link:presentationLink link:definitionLink link:calculationLink 022 - Disclosure - Loss Per Share (Tables) link:presentationLink link:definitionLink link:calculationLink 023 - Disclosure - Securities Authorized for Issuance under Equity Compensation Plans (Tables) link:presentationLink link:definitionLink link:calculationLink 024 - Disclosure - Inventories (Details) link:presentationLink link:definitionLink link:calculationLink 025 - Disclosure - Inventories (Details Textual) link:presentationLink link:definitionLink link:calculationLink 026 - Disclosure - Property, Plant & Equipment (Details) link:presentationLink link:definitionLink link:calculationLink 027 - Disclosure - Revolving Line of Credit (Details) link:presentationLink link:definitionLink link:calculationLink 028 - Disclosure - Long Term Debt (Details) link:presentationLink link:definitionLink link:calculationLink 029 - Disclosure - Long Term Debt (Details 1) link:presentationLink link:definitionLink link:calculationLink 030 - Disclosure - Long Term Debt (Details Textual) link:presentationLink link:definitionLink link:calculationLink 031 - Disclosure - Related Party Transactions (Details Textual) link:presentationLink link:definitionLink link:calculationLink 032 - Disclosure - Commitments and Contingencies (Details Textual) link:presentationLink link:definitionLink link:calculationLink 033 - Disclosure - Loss Per Share (Details) link:presentationLink link:definitionLink link:calculationLink 034 - Disclosure - Loss Per Share (Details Textual) link:presentationLink link:definitionLink link:calculationLink 035 - Disclosure - Securities Authorized for Issuance under Equity Compensation Plans (Details) link:presentationLink link:definitionLink link:calculationLink 036 - Disclosure - Securities Authorized for Issuance under Equity Compensation Plans (Details Textual) link:presentationLink link:definitionLink link:calculationLink 037 - Disclosure - Special Cash Dividend (Details) link:presentationLink link:definitionLink link:calculationLink EX-101.CAL 8 obci-20160331_cal.xml XBRL CALCULATION FILE EX-101.DEF 9 obci-20160331_def.xml XBRL DEFINITION FILE EX-101.LAB 10 obci-20160331_lab.xml XBRL LABEL FILE EX-101.PRE 11 obci-20160331_pre.xml XBRL PRESENTATION FILE XML 12 R1.htm IDEA: XBRL DOCUMENT v3.4.0.3
Document and Entity Information - shares
 3 Months Ended
Mar. 31, 2016
May. 12, 2016
Document and Entity Information [Abstract]    
Entity Registrant Name OCEAN BIO CHEM INC  
Entity Central Index Key 0000350737  
Amendment Flag false  
Current Fiscal Year End Date --12-31  
Document Type 10-Q  
Document Period End Date Mar. 31, 2016  
Document Fiscal Year Focus 2016  
Document Fiscal Period Focus Q1  
Entity Filer Category Smaller Reporting Company  
Entity Common Stock, Shares Outstanding   9,008,855
XML 13 R2.htm IDEA: XBRL DOCUMENT v3.4.0.3
Consolidated Balance Sheets - USD ($)
Mar. 31, 2016
Dec. 31, 2015
Current Assets:    
Cash $ 2,436,078 $ 2,468,415
Trade accounts receivable less allowances of approximately $67,000 and $78,000, respectively 4,090,357 5,092,040
Receivables due from affiliated companies 1,068,430 1,051,091
Inventories, net 9,065,836 7,914,950
Prepaid expenses and other current assets 1,155,669 942,820
Deferred tax asset 122,831 125,335
Total Current Assets 17,939,201 17,594,651
Property, plant and equipment, net 5,203,611 5,356,388
Other Assets:    
Intangible assets, net 1,020,398 1,037,968
Total Other Assets 1,020,398 1,037,968
Total Assets 24,163,210 23,989,007
Current Liabilities:    
Accounts payable - trade 2,119,425 1,101,720
Current portion of long-term debt 453,533 451,148
Dividends payable 540,531  
Accrued expenses payable 893,477 1,098,721
Total Current Liabilities 4,006,966 2,651,589
Deferred tax liability 356,488 365,012
Long-term debt, less current portion 213,567 328,818
Total Liabilities $ 4,577,021 $ 3,345,419
Commitments and contingencies
Shareholders' Equity:    
Common stock - $.01 par value, 12,000,000 shares authorized; 9,008,855 shares and 8,983,374 shares issued, respectively $ 90,089 $ 89,834
Additional paid in capital 9,308,658 9,287,313
Foreign currency translation adjustment (282,108) (284,442)
Retained earnings 10,469,550 11,550,883
Total Shareholders' Equity 19,586,189 20,643,588
Total Liabilities and Shareholders' Equity $ 24,163,210 $ 23,989,007
XML 14 R3.htm IDEA: XBRL DOCUMENT v3.4.0.3
Condensed Consolidated Balance Sheets (Parenthetical) - USD ($)
Mar. 31, 2016
Dec. 31, 2015
CONSOLIDATED BALANCE SHEETS    
Trade accounts receivable, allowance for doubtful accounts $ 67,000 $ 78,000
Common stock, par value $ 0.01 $ 0.01
Common stock, shares authorized 12,000,000 12,000,000
Common stock, shares issued 9,008,855 8,983,374
XML 15 R4.htm IDEA: XBRL DOCUMENT v3.4.0.3
Condensed Consolidated Statements of Operations (Unaudited) - USD ($)
 3 Months Ended
Mar. 31, 2016
Mar. 31, 2015
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS    
Gross sales $ 7,072,535 $ 6,328,343
Less: discounts, returns, and allowances 322,455 325,914
Net sales 6,750,080 6,002,429
Cost of goods sold 4,368,137 3,965,780
Gross profit 2,381,943 2,036,649
Operating Expenses:    
Advertising and promotion 715,872 615,872
Selling and administrative 2,485,863 1,421,546
Total operating expenses 3,201,735 2,037,418
Operating loss (819,792) (769)
Other (expense)    
Interest, net (expense) $ (5,884) (10,075)
Other (expense) (12,522)
Loss before income taxes $ (825,676) (23,366)
Income tax benefit 284,874 7,440
Net loss $ (540,802) $ (15,926)
Loss per common share - basic and diluted $ (0.06)
Dividends declared per common share $ 0.06  
XML 16 R5.htm IDEA: XBRL DOCUMENT v3.4.0.3
Condensed Consolidated Statements of Comprehensive Income (Unaudited) - USD ($)
 3 Months Ended
Mar. 31, 2016
Mar. 31, 2015
CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME    
Net loss $ (540,802) $ (15,926)
Foreign currency translation adjustment 2,334 (8,115)
Comprehensive loss $ (538,468) $ (24,041)
XML 17 R6.htm IDEA: XBRL DOCUMENT v3.4.0.3
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
 3 Months Ended
Mar. 31, 2016
Mar. 31, 2015
Cash flows from operating activities:    
Net loss $ (540,802) $ (15,926)
Adjustments to reconcile net loss to net cash provided by (used in) operating activities:    
Depreciation and amortization 246,841 221,559
Deferred income taxes $ (6,020) (9,012)
Loss on sale of property, plant and equipment 12,522
Other operating non-cash items $ (2,366) 23,874
Changes in assets and liabilities:    
Trade accounts receivable 1,012,558 1,374,194
Inventories (1,154,606) (2,001,274)
Prepaid expenses and other current assets (212,849) (219,163)
Receivables due from affiliated companies (17,339) (332,708)
Accounts payable and other accrued expenses 812,461 340,462
Net cash provided by (used in) operating activities 137,878 (605,472)
Cash flows from investing activities:    
Purchases of property, plant and equipment $ (76,494) (370,795)
Sale of property, plant, and equipment 55,000
Net cash used in investing activities $ (76,494) (315,795)
Cash flows from financing activities:    
Payments on long-term debt (112,866) $ (105,343)
Proceeds from exercise of stock options 21,600
Net cash used in financing activities (91,266) $ (105,343)
Effect of exchange rates on cash (2,455) (24,560)
Net decrease in cash (32,337) (1,051,170)
Cash at beginning of period 2,468,415 3,062,729
Cash at end of period 2,436,078 2,011,559
Supplemental disclosure of cash flow information:    
Cash paid for interest during period $ 6,199 10,379
Cash paid for income taxes during period $ 87,000
XML 18 R7.htm IDEA: XBRL DOCUMENT v3.4.0.3
Summary of Accounting Policies
 3 Months Ended
Mar. 31, 2016
Summary of Accounting Policies [Abstract]  
SUMMARY OF ACCOUNTING POLICIES
1.SUMMARY OF ACCOUNTING POLICIES

 

Interim reporting

 

The accompanying unaudited condensed consolidated financial statements include the accounts of Ocean Bio-Chem, Inc. and its wholly-owned subsidiaries. All significant inter-company accounts and transactions have been eliminated in consolidation. Certain prior-period data have been reclassified to conform to the current period presentation.  Unless the context indicates otherwise, the term “Company” refers to Ocean Bio-Chem, Inc. and its subsidiaries.

 

The unaudited condensed consolidated financial statements have been prepared in accordance with United States generally accepted accounting principles (“GAAP”) for interim financial information and with the instructions to Form 10-Q and Article 8 of Regulation S-X.  Accordingly, they do not include all of the information and footnotes required by GAAP for complete financial statements.

 

The financial information furnished herein reflects all adjustments, consisting of normal recurring items that, in the opinion of management, are necessary for a fair presentation of the Company’s financial position, results of operations and cash flows for the interim periods.  The results of operations for the three months ended March 31, 2016 are not necessarily indicative of the results to be expected for the year ending December 31, 2016.

 

The information included in this Form 10-Q should be read in conjunction with the Company’s Annual Report on Form 10-K for the year ended December 31, 2015.

 

Use of estimates

 

The preparation of condensed consolidated financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period.  Actual results could differ from those estimates and assumptions.
XML 19 R8.htm IDEA: XBRL DOCUMENT v3.4.0.3
Recent Accounting Pronouncements
 3 Months Ended
Mar. 31, 2016
Recent Accounting Pronouncements [Abstract]  
RECENT ACCOUNTING PRONOUNCEMENTS
2.RECENT ACCOUNTING PRONOUNCEMENTS

 

There have been no accounting pronouncements or changes in accounting pronouncements during the three months ended March 31, 2016 that are expected to have a material impact on the Company’s financial position, results of operations or cash flows.  Accounting pronouncements that became effective during the three months ended March 31, 2016 did not have a material impact on disclosures or on the Company’s financial position, results of operations or cash flows.
XML 20 R9.htm IDEA: XBRL DOCUMENT v3.4.0.3
Inventories
 3 Months Ended
Mar. 31, 2016
Inventories [Abstract]  
INVENTORIES
3.INVENTORIES

 

The Company’s inventories at March 31, 2016 and December 31, 2015 consisted of the following:

 

  

March 31,

2016

  

December 31,

2015

 
Raw materials $3,853,721  $3,749,702 
Finished goods  5,495,717   4,445,130 
Inventories, gross  9,349,438   8,194,832 
         
Inventory reserves  (283,602)  (279,882)
         
Inventories, net $9,065,836  $7,914,950 

 

The inventory reserves shown in the table above reflect slow moving and obsolete inventory.

 

The Company manages an inventory program for one of its customers to improve the promotion of the Company's products.  The Company manages the inventory levels at the customer’s warehouses and recognizes revenue as the products are sold by the customer.  The inventories managed at the customer’s warehouses amounted to approximately $469,000 and $543,000 at March 31, 2016 and December 31, 2015, respectively, and are included in inventories, net on the condensed consolidated balance sheets.
XML 21 R10.htm IDEA: XBRL DOCUMENT v3.4.0.3
Property, Plant & Equipment
 3 Months Ended
Mar. 31, 2016
Property, Plant & Equipment [Abstract]  
PROPERTY, PLANT & EQUIPMENT
4.PROPERTY, PLANT & EQUIPMENT

 

The Company’s property, plant and equipment at March 31, 2016 and December 31, 2015 consisted of the following:

 

  

Estimate

Useful Life

 

March 31,

2016

  

December 31,

2015

 
Land   $278,325  $278,325 
Building and improvements 30 years  4,652,669   4,652,669 
Manufacturing and warehouse equipment 6-20 years  9,153,057   9,072,162 
Office equipment and furniture 3-5 years  1,268,545   1,293,609 
Construction in process    197,545   215,155 
Leasehold improvements 10-15 years  544,146   544,146 
Vehicles 3 years  42,283   42,283 
Property, plant and equipment, gross    16,136,570   16,098,349 
           
Less accumulated depreciation    (10,932,959)  (10,741,961)
           
Property, plant and equipment, net   $5,203,611  $5,356,388 
XML 22 R11.htm IDEA: XBRL DOCUMENT v3.4.0.3
Revolving Line of Credit
 3 Months Ended
Mar. 31, 2016
Revolving Line of Credit and Long Term Debt [Abstract]  
REVOLVING LINE OF CREDIT
5.REVOLVING LINE OF CREDIT

 

On August 4, 2014, the Company and Regions Bank entered into a Business Loan Agreement (the“Business Loan Agreement”), under which the Company was provided a renewed revolving line of credit. Under the renewed revolving line of credit, the Company may borrow up to the lesser of (i) $6 million or (ii) a borrowing base equal to 80% of eligible accounts receivable (as defined in the Business Loan Agreement) plus 50% of eligible inventory (as defined in the Business Loan Agreement). Interest on amounts borrowed under the revolving line of credit is payable monthly at the 30 day LIBOR rate plus 1.65% per annum, unless the Company’s debt service coverage ratio (generally, net operating profit plus depreciation, amortization and lease/rent expense divided by current maturities of long-term debt plus interest and lease/rent expense, calculated on a trailing twelve month basis) falls to or below 2.0 to 1, in which case interest is payable at the 30 day LIBOR rate plus 2.65% per annum.

 

Outstanding amounts under the revolving line of credit are payable on demand. If no demand is made, the Company may repay and reborrow funds from time to time until expiration of the revolving line of credit on July 6, 2016, at which time all outstanding principal and interest will be due and payable. The Company’s obligations under the revolving line of credit are secured by, among other things, the Company’s accounts receivable, inventory, contract rights and general intangibles and, as a result of cross-collateralization of the Company’s obligations under the term loan described in Note 6 and the revolving line of credit, real property and equipment at the Montgomery, Alabama facility of the Company’s subsidiary, Kinpak, Inc. ("Kinpak"). The Business Loan Agreement includes financial covenants requiring a minimum debt service coverage ratio (generally, net operating profit plus depreciation, amortization and lease/rent expense divided by current maturities of long-term debt plus interest and lease/rent expense) of 1.75 to 1.00, calculated on a trailing twelve month basis, and a maximum debt to capitalization ratio (generally, funded debt divided by the sum of total net worth and funded debt) of 0.75 to 1, tested quarterly. The line of credit is subject to several events of default, including a decline in the majority shareholder’s ownership below 50% of all outstanding shares. At March 31, 2016, the Company was not in compliance with the financial covenant relating to its minimum debt service coverage ratio, as its debt service coverage ratio was 1.67. Although the deficiency in the Company’s debt service coverage ratio results in an event of default under the Business Loan Agreement, the Company had no borrowings under the revolving line of credit at March 31, 2016, and Regions Bank waived the default through May 9, 2017. The deficiency in the debt service coverage ratio also may have resulted in an event of default under the term loan described in Note 6 below due to the cross-default provisions of the term loan. However, any resulting default has been waived through May 9, 2017 by Regions Equipment Financing Corporation (“REFCO”), a subsidiary of Regions Bank and the lender under the term loan.
XML 23 R12.htm IDEA: XBRL DOCUMENT v3.4.0.3
Long Term Debt
 3 Months Ended
Mar. 31, 2016
Revolving Line of Credit and Long Term Debt [Abstract]  
LONG TERM DEBT
6.LONG TERM DEBT

 

On July 6, 2011, REFCO provided to the Company a $2,430,000 term loan with a fixed interest rate of 3.54%, subject to an increase to 4.55% in the event the Company's debt service coverage ratio (net profit plus taxes, interest, depreciation, amortization and rent expense divided by debt service plus interest and lease/rent expense, calculated on a trailing four-quarter basis) falls to or below 2.0 to 1. Principal and interest on the term loan are payable in equal monthly installments through July 6, 2017, the date on which the term loan matures. The proceeds of the term loan were used to pay the Company’s remaining obligations under a lease agreement relating to industrial revenue bonds used to fund the expansion of Kinpak’s facilities and acquisition of related equipment. At March 31, 2016, approximately $585,000 was outstanding under the term loan. The term loan and the revolving line of credit under the Bank Loan Agreement are cross-defaulted (i.e., a default under one instrument is a default under the other). See Note 5 for information regarding REFCO’s waiver of an event of default that may be deemed to have occurred under the cross-default provisions of the term loan as a result of an event of default under the Business Loan Agreement; REFCO has waived the default through May 9, 2017.

 

At March 31, 2016 and December 31, 2015, the Company was obligated under capital lease agreements covering equipment utilized in the Company’s operations.  The capital leases, aggregating approximately $82,000 and $88,000 at March 31, 2016 and December 31, 2015, respectively, mature on July 1, 2020 and carry an interest rate of 2%.

 

The following table provides information regarding the Company’s long term debt at March 31, 2016 and December 31, 2015:

 

  Current Portion  Long Term Portion 
  March 31, 
2016		  

December 31,

2015

  March 31, 
2016		  December 31,
2015		 
Term loan $436,441  $432,601  $148,942  $259,503 
Capitalized equipment leases  17,092   18,547   64,625   69,315 
                 
Total long term debt $453,533  $451,148  $213,567  $328,818 

 

Required principal payments under the Company’s long term obligations are set forth below:

 

12 month period ending March 31,   
2017 $453,533 
2018  167,918 
2019  19,326 
2020  19,682 
2021  6,641 
     
Total $667,100 
 
XML 24 R13.htm IDEA: XBRL DOCUMENT v3.4.0.3
Related Party Transactions
 3 Months Ended
Mar. 31, 2016
Related Party Transactions [Abstract]  
RELATED PARTY TRANSACTIONS
7.RELATED PARTY TRANSACTIONS

 

During the three months ended March 31, 2016 and 2015, the Company sold products to companies affiliated with its Chairman, President and Chief Executive Officer. The affiliated companies distribute the products outside of the United States and Canada. The Company also provides administrative services to these companies. Sales to the affiliated companies aggregated approximately $546,000 and $725,000 during the three months ended March 31, 2016 and 2015, respectively.  Administrative fees aggregated approximately $123,000 and $107,000 during the three months ended March 31, 2016 and 2015, respectively. The Company had accounts receivable from the affiliated companies in connection with the product sales and administrative services aggregating approximately $1,068,000 and $1,051,000 at March 31, 2016 and December 31, 2015, respectively. Transactions with the affiliated companies were made in the ordinary course of business.   While the terms of sale to the affiliated companies differed from the terms applicable to other customers, the affiliated companies bear their own warehousing, distribution, advertising, selling and marketing costs, as well as their own freight charges (the Company pays freight charges in connection with sales to its domestic customers on all but small orders).  Moreover, the Company does not pay sales commissions with respect to products sold to the affiliated companies.  As a result, the Company believes its profit margins with respect to sales of its products to the affiliated companies are similar to the profit margins it realizes with respect to sales of the same products to its larger domestic customers.  Management believes that the sales transactions did not involve more than normal credit risk or present other unfavorable features.

 

A subsidiary of the Company currently uses the services of an entity that is owned by its Chairman, President and Chief Executive Officer to conduct product research and development and to assist in the production of television commercials.  Under this arrangement, the Company paid the entity $10,500 for each of the three month periods ended March 31, 2016 and 2015 for research and development services.

 

The Company leases office and warehouse facilities in Fort Lauderdale, Florida from an entity controlled by its Chairman, President and Chief Executive Officer.  The Company believes that the rental payments are below market rates.  See Note 8 for a description of the lease terms.

 

A director of the Company is Regional Executive Vice President of an entity from which the Company sources most of its insurance needs at an arm’s length competitive basis.  During the three months ended March 31, 2016 and 2015, the Company paid an aggregate of approximately $60,000 and $216,000, respectively in insurance premiums on policies obtained through the entity. The decrease in 2016 is primarily attributable to the Company’s prepayment of the entire annual premium for its general liability policy rather than paying the premium in installments.
XML 25 R14.htm IDEA: XBRL DOCUMENT v3.4.0.3
Commitments and Contingencies
 3 Months Ended
Mar. 31, 2016
Commitments and Contingencies [Abstract]  
COMMITMENTS AND CONTINGENCIES
8. COMMITMENTS AND CONTINGENCIES

 

The Company leases its executive offices and warehouse facilities in Fort Lauderdale, Florida from an entity controlled by its Chairman, President and Chief Executive Officer. The lease, as extended, expires on December 31, 2023. The lease requires an annual minimum base rent of $94,800 and provides for a maximum annual 2% increase in subsequent years, although the entity has not raised the minimum rent since the Company entered into a previous lease agreement in 1998. Additionally, the leasing entity is entitled to reimbursement of all taxes, assessments, and any other expenses that arise from ownership. Each of the parties to the lease has agreed to review the terms of the lease every three years at the request of the other party.  Rent expense under the lease was approximately $24,000 for each of the three months ended March 31, 2016 and 2015. 

 

On August 13, 2014, Star-Brite Distributing, Inc. (“Star-Brite”), a wholly-owned subsidiary of the Company, filed a complaint for injunctive relief and damages against Gold Eagle Co. (“Gold Eagle”) in the United States District Court for the Southern District of Florida. The complaint alleged that Gold Eagle, in violation of Section 43(a) of the Lanham Act, the Florida Deceptive and Unfair Trade Practices Act, and the Florida False Advertising Statute, made false and/or misleading statements in a comparative marketing campaign against Star Tron® Enzyme Fuel Treatment, an enzyme based fuel additive for the marine market, used to treat ethanol gasoline, commonly referred to as E10 fuel. The complaint also constitutes a claim for common law unfair competition.

 

Gold Eagle filed an answer to complaint and counterclaim, generally denying the allegations in Star-Brite’s complaint and asserting affirmative defenses to Star-Brite’s claims. Gold Eagle’s counterclaim alleged, among other things, that in various advertising and marketing materials for Star Tron, which Star-Brite markets for use in various types of engines, Star-Brite makes false and misleading claims that are causing harm to Gold Eagle, which markets competitive products under the STA-BIL brand, thereby violating the same statutory provisions as Gold Eagle was alleged to have violated in Star-Brite’s complaint, and also constituting common law unfair competition. 

 

Star-Brite filed an answer to the counterclaim, generally denying the allegations, and asserting affirmative defenses.

  

A jury trial was conducted during February 2016. On March 1, 2016, the jury unanimously found that (i) Gold Eagle’s advertising was not literally false; (ii) Gold Eagle did not commit false advertising under the Florida False Advertising Statute; (iii) Star-Brite’s advertising was not literally false and (iv) Star-Brite did not commit false advertising under the Florida False Advertising Statute. As a result of the jury’s verdict, the Court determined that (i) Star-Brite would recover nothing from Gold Eagle, and Star-Brite’s action was dismissed on the merits and (ii) Gold Eagle would recover nothing from Star-Brite, and Gold Eagle’s counterclaim was dismissed on the merits. Neither party has filed an appeal.

 

In post-trial proceedings, Star-Brite is seeking attorneys’ fees and costs under the Florida False Advertising Statute, which provides that a prevailing party in a civil action for violation of the statute will be awarded costs, including attorneys’ fees.  Star-Brite is asserting, among other things, that the issues asserted by Gold Eagle in its counterclaim were the significant issues in the case, that Star-Brite obtained a defense judgment in its favor on the counterclaim, and, therefore, Star-Brite is the prevailing party, entitled to costs and attorney’s fees under the statute.  Star-Brite also asserts that it is entitled to attorney’s fees and costs as a prevailing party on the counterclaim under the Florida Deceptive and Unfair Trade Practices Act.  Gold Eagle has asserted, among other things, that because both parties were denied the relief they sought, neither party should be deemed a prevailing party, or, in the event the Court determines that either party is a prevailing party, Gold Eagle, as defendant in the action, should be deemed the prevailing party. The Court has referred the matter to a Magistrate Judge for appropriate disposition or report and recommendation.
XML 26 R15.htm IDEA: XBRL DOCUMENT v3.4.0.3
Loss Per Share
 3 Months Ended
Mar. 31, 2016
Earnings Per Share [Abstract]  
EARNINGS PER SHARE
9.LOSS PER SHARE

 

Basic and diluted loss per share is calculated by dividing net loss by the weighted average number of shares outstanding during the reported period.    The following table sets forth the computation of basic and diluted loss per common share.

 

  Three Months Ended 
March 31,		 
  2016  2015 
Loss per common share –Basic and Diluted      
       
Net loss $(540,802) $(15,926)
         
Weighted average number of common shares outstanding  8,985,858   8,920,288 
         
Loss per common share – Basic and Diluted $(0.06) $0.00 
         

 

For the three months ended March 31, 2016 and 2015, 57,509 and 99,689 shares underlying outstanding stock awards were not included in the computation of loss per common share – diluted because their effect would have been antidilutive.
XML 27 R16.htm IDEA: XBRL DOCUMENT v3.4.0.3
Securities Authorized for Issuance under Equity Compensation Plans
 3 Months Ended
Mar. 31, 2016
Securities Authorized for Issuance Under Equity Compensation Plans [Abstract]  
SECURITIES AUTHORIZED FOR ISSUANCE UNDER EQUITY COMPENSATION PLANS
10. SECURITIES AUTHORIZED FOR ISSUANCE UNDER EQUITY COMPENSATION PLANS

 

During the three months ended March 31, 2016, stock options to purchase an aggregate of 30,000 shares were exercised. The Company received a total of $21,600, withheld 4,519 shares in connection with the net exercise feature of the stock options and delivered an aggregate of 25,481 shares to the option holders who exercised their options.

 

No stock compensation expense was recognized during the three months ended March 31, 2016 and 2015. At March 31, 2016, there was no unrecognized compensation expense related to stock options. 

No stock awards were issued during the three months ended March 31, 2016 and 2015.

 

The following table provides information at March 31, 2016 regarding outstanding stock options under the Company’s stock option plans. As used in the table below, “2002 NQ” refers to the Company’s 2002 Non-Qualified Stock Option Plan and “2008 NQ” refers to the Company’s 2008 Non-Qualified Stock Option Plan.

 

Plan 

Date

Granted

 

Shares

Underlying

Options Outstanding

  

Shares

Underlying Exercisable

Options

  

Exercise

Price

  

Expiration

Date

 

Weighted

Average

Remaining Term

 
2002NQ 12/17/07  40,000   40,000  $1.32  12/16/17  1.7 
2008NQ 1/11/09  40,000   40,000  $0.69  1/10/19  2.8 
2008NQ 4/26/10  20,000   20,000  $2.07  4/25/20  4.1 
                     
     100,000   100,000  $1.22     2.6 
 
XML 28 R17.htm IDEA: XBRL DOCUMENT v3.4.0.3
Special Cash Dividend
 3 Months Ended
Mar. 31, 2016
Special Cash Dividend [Abstract]  
SPECIAL CASH DIVIDEND
11.SPECIAL CASH DIVIDEND

 

On March 25, 2016, the Company’s Board of Directors  declared a special cash dividend of $0.06 per common share payable on April 26, 2016 to all shareholders of record on April 12, 2016.  On April 12, 2016, there were 9,008,855 shares of common stock outstanding; therefore the Company recorded a $540,531 liability for dividends payable, which is reflected on the March 31, 2016 balance sheet.  In accordance with the action of the Board of Directors, the dividend was paid on April 26, 2016.
XML 29 R18.htm IDEA: XBRL DOCUMENT v3.4.0.3
Summary of Accounting Policies (Policies)
 3 Months Ended
Mar. 31, 2016
Summary of Accounting Policies [Abstract]  
Interim reporting

Interim reporting

 

The accompanying unaudited condensed consolidated financial statements include the accounts of Ocean Bio-Chem, Inc. and its wholly-owned subsidiaries. All significant inter-company accounts and transactions have been eliminated in consolidation. Certain prior-period data have been reclassified to conform to the current period presentation.  Unless the context indicates otherwise, the term “Company” refers to Ocean Bio-Chem, Inc. and its subsidiaries.

 

The unaudited condensed consolidated financial statements have been prepared in accordance with United States generally accepted accounting principles (“GAAP”) for interim financial information and with the instructions to Form 10-Q and Article 8 of Regulation S-X.  Accordingly, they do not include all of the information and footnotes required by GAAP for complete financial statements.

 

The financial information furnished herein reflects all adjustments, consisting of normal recurring items that, in the opinion of management, are necessary for a fair presentation of the Company’s financial position, results of operations and cash flows for the interim periods.  The results of operations for the three months ended March 31, 2016 are not necessarily indicative of the results to be expected for the year ending December 31, 2016.

 

The information included in this Form 10-Q should be read in conjunction with the Company’s Annual Report on Form 10-K for the year ended December 31, 2015.
Use of estimates

Use of estimates

 

The preparation of condensed consolidated financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period.  Actual results could differ from those estimates and assumptions.
XML 30 R19.htm IDEA: XBRL DOCUMENT v3.4.0.3
Inventories (Tables)
 3 Months Ended
Mar. 31, 2016
Inventories [Abstract]  
Summary of composition of inventories

 

  

March 31,

2016

  

December 31,

2015

 
Raw materials $3,853,721  $3,749,702 
Finished goods  5,495,717   4,445,130 
Inventories, gross  9,349,438   8,194,832 
         
Inventory reserves  (283,602)  (279,882)
         
Inventories, net $9,065,836  $7,914,950
XML 31 R20.htm IDEA: XBRL DOCUMENT v3.4.0.3
Property, Plant & Equipment (Tables)
 3 Months Ended
Mar. 31, 2016
Property, Plant & Equipment [Abstract]  
Summary of property, plant and equipment

 

  

Estimate

Useful Life

 

March 31,

2016

  

December 31,

2015

 
Land   $278,325  $278,325 
Building and improvements 30 years  4,652,669   4,652,669 
Manufacturing and warehouse equipment 6-20 years  9,153,057   9,072,162 
Office equipment and furniture 3-5 years  1,268,545   1,293,609 
Construction in process    197,545   215,155 
Leasehold improvements 10-15 years  544,146   544,146 
Vehicles 3 years  42,283   42,283 
Property, plant and equipment, gross    16,136,570   16,098,349 
           
Less accumulated depreciation    (10,932,959)  (10,741,961)
           
Property, plant and equipment, net   $5,203,611  $5,356,388
XML 32 R21.htm IDEA: XBRL DOCUMENT v3.4.0.3
Long Term Debt (Tables)
 3 Months Ended
Mar. 31, 2016
Revolving Line of Credit and Long Term Debt [Abstract]  
Summary of company's long term debt

 


  Current Portion  Long Term Portion 
  March 31, 
2016		  

December 31,

2015

  March 31, 
2016		  December 31,
2015		 
Term loan $436,441  $432,601  $148,942  $259,503 
Capitalized equipment leases  17,092   18,547   64,625   69,315 
                 
Total long term debt $453,533  $451,148  $213,567  $328,818
Summary of principal payments under Company's long term obligations

 

12 month period ending March 31,   
2017 $453,533 
2018  167,918 
2019  19,326 
2020  19,682 
2021  6,641 
     
Total $667,100
XML 33 R22.htm IDEA: XBRL DOCUMENT v3.4.0.3
Loss Per Share (Tables)
 3 Months Ended
Mar. 31, 2016
Earnings Per Share [Abstract]  
Summary of computation of basic and diluted earnings per common share

  Three Months Ended 
March 31,		 
  2016  2015 
Loss per common share –Basic and Diluted      
       
Net loss $(540,802) $(15,926)
         
Weighted average number of common shares outstanding  8,985,858   8,920,288 
         
Loss per common share – Basic and Diluted $(0.06) $0.00 
XML 34 R23.htm IDEA: XBRL DOCUMENT v3.4.0.3
Securities Authorized for Issuance under Equity Compensation Plans (Tables)
 3 Months Ended
Mar. 31, 2016
Securities Authorized for Issuance Under Equity Compensation Plans [Abstract]  
Schedule of outstanding stock options under company's stock options plans

 

Plan 

Date

Granted

 

Shares

Underlying

Options Outstanding

  

Shares

Underlying Exercisable

Options

  

Exercise

Price

  

Expiration

Date

 

Weighted

Average

Remaining Term

 
2002NQ 12/17/07  40,000   40,000  $1.32  12/16/17  1.7 
2008NQ 1/11/09  40,000   40,000  $0.69  1/10/19  2.8 
2008NQ 4/26/10  20,000   20,000  $2.07  4/25/20  4.1 
                     
     100,000   100,000  $1.22     2.6 
 
XML 35 R24.htm IDEA: XBRL DOCUMENT v3.4.0.3
Inventories (Details) - USD ($)
Mar. 31, 2016
Dec. 31, 2015
Summary of composition of inventories    
Raw materials $ 3,853,721 $ 3,749,702
Finished goods 5,495,717 4,445,130
Inventories, gross 9,349,438 8,194,832
Inventory reserves (283,602) (279,882)
Inventories, net $ 9,065,836 $ 7,914,950
XML 36 R25.htm IDEA: XBRL DOCUMENT v3.4.0.3
Inventories (Details Textual) - USD ($)
Mar. 31, 2016
Dec. 31, 2015
Inventories (Textual)    
Inventories managed at the customer's warehouses $ 469,000 $ 543,000
XML 37 R26.htm IDEA: XBRL DOCUMENT v3.4.0.3
Property, Plant & Equipment (Details) - USD ($)
 3 Months Ended
Mar. 31, 2016
Dec. 31, 2015
Summary of property, plant and equipment    
Land $ 278,325 $ 278,325
Building and improvements 4,652,669 4,652,669
Manufacturing and warehouse equipment 9,153,057 9,072,162
Office equipment and furniture 1,268,545 1,293,609
Construction in process 197,545 215,155
Leasehold improvements 544,146 544,146
Vehicles 42,283 42,283
Property, plant and equipment, gross 16,136,570 16,098,349
Less accumulated depreciation (10,932,959) (10,741,961)
Property, plant and equipment, net $ 5,203,611 $ 5,356,388
Building and Improvements [Member]    
Summary of property, plant and equipment    
Estimate Useful Life 30 years  
Manufacturing and warehouse equipment [Member] | Minimum [Member]    
Summary of property, plant and equipment    
Estimate Useful Life 6 years  
Manufacturing and warehouse equipment [Member] | Maximum [Member]    
Summary of property, plant and equipment    
Estimate Useful Life 20 years  
Office equipment and furniture [Member] | Minimum [Member]    
Summary of property, plant and equipment    
Estimate Useful Life 3 years  
Office equipment and furniture [Member] | Maximum [Member]    
Summary of property, plant and equipment    
Estimate Useful Life 5 years  
Leasehold improvements [Member] | Minimum [Member]    
Summary of property, plant and equipment    
Estimate Useful Life 10 years  
Leasehold improvements [Member] | Maximum [Member]    
Summary of property, plant and equipment    
Estimate Useful Life 15 years  
Vehicles [Member]    
Summary of property, plant and equipment    
Estimate Useful Life 3 years  
XML 38 R27.htm IDEA: XBRL DOCUMENT v3.4.0.3
Revolving Line of Credit (Details) - USD ($)
$ in Millions
 3 Months Ended
Aug. 04, 2014
Mar. 31, 2016
Revolving line of credit (Textual)    
Term of revolving line of credit The Company may borrow up to the lesser of (i) $6 million or (ii) a borrowing base equal to 80% of eligible accounts receivable (as defined in the Business Loan Agreement) plus 50% of eligible inventory (as defined in the Business Loan Agreement).  
Maximum borrowing capacity of the company $ 6  
Percentage of eligible accounts receivables as part of borrowing base 80.00%  
Percentage of eligible inventory as part of the borrowing base 50.00%  
Description of interest on the revolving line of credit 30 day LIBOR rate plus 1.65% per annum  
Minimum debt service coverage ratio to qualify for LIBOR plus 1.65 % 2.0 to 1  
Alternate interest rate condition if it doesn't satisfy the debt coverage ratio 30 day LIBOR rate plus 2.65% per annum  
Due date of outstanding principal and interest borrowed under revolving line of credit Jul. 06, 2016  
Financial covenants under credit agreement A minimum debt service coverage ratio of 1.75 to 1.00, calculated on a trailing twelve month basis, and a maximum debt to capitalization ratio (generally, funded debt divided by the sum of total net worth and funded debt) of 0.75 to 1, tested quarterly.  
Debt service coverage ratio 1.75 to 1.00 The Company was not in compliance with the financial covenant relating to its minimum debt service coverage ratio, as its debt service coverage ratio was 1.67.
Debt capitalization ratio 0.75 to 1  
Ownership requirement of majority shareholder to prevent default The line of credit is subject to several events of default, including a decline in the majority shareholder's ownership below 50% of all outstanding shares.  
XML 39 R28.htm IDEA: XBRL DOCUMENT v3.4.0.3
Long Term Debt (Details) - USD ($)
Mar. 31, 2016
Dec. 31, 2015
Summary of long term debt    
Total long term debt, Current Portion $ 453,533 $ 451,148
Total long term debt, Long Term Portion 213,567 328,818
Term loan [Member]    
Summary of long term debt    
Term loan, Current Portion 436,441 432,601
Term loan, Long-term Portion 148,942 259,503
Capitalized equipment leases [Member]    
Summary of long term debt    
Capitalized equipment leases, Current Portion 17,092 18,547
Capitalized equipment leases, Long-term Portion $ 64,625 $ 69,315
XML 40 R29.htm IDEA: XBRL DOCUMENT v3.4.0.3
Long Term Debt (Details 1)
Mar. 31, 2016
USD ($)
Summary of principal payments under Company's long term obligations  
2017 $ 453,533
2018 167,918
2019 19,326
2020 19,682
2021 6,641
Total $ 667,100
XML 41 R30.htm IDEA: XBRL DOCUMENT v3.4.0.3
Long Term Debt (Details Textual)
 3 Months Ended
Jul. 06, 2011
USD ($)
Mar. 31, 2016
USD ($)
Dec. 31, 2015
USD ($)
Long Term Debt (Textual)      
Term loan   $ 585,000  
Aggregate capital lease   $ 82,000 $ 88,000
Maturity period for capital lease   Mature on July 1, 2020  
Minimum [Member]      
Long Term Debt (Textual)      
Debt service coverage ratio   1  
Maximum [Member]      
Long Term Debt (Textual)      
Debt service coverage ratio   2.0  
REFCO [Member]      
Long Term Debt (Textual)      
Term loan $ 2,430,000    
Interest rate 3.54%    
Term loan maturity date Jul. 06, 2017    
Percentage of interest rates 2.00%    
Term loan description Term loan with a fixed interest rate of 3.54%, subject to an increase to 4.55% in the event the Company's debt service coverage ratio (net profit plus taxes, interest, depreciation, amortization and rent expense divided by debt service plus interest and lease/rent expense, calculated on a trailing four-quarter basis) falls to or below 2.0 to 1.    
XML 42 R31.htm IDEA: XBRL DOCUMENT v3.4.0.3
Related Party Transactions (Details Textual) - USD ($)
 3 Months Ended
Mar. 31, 2016
Mar. 31, 2015
Dec. 31, 2015
Related Party Transactions (Textual)      
Sales to the affiliated companies $ 546,000 $ 725,000  
Administrative fees 123,000 107,000  
Receivables due from affiliated companies 1,068,000   $ 1,051,000
Amount paid to entity for research and development services 10,500 10,500  
Insurance premiums paid $ 60,000 $ 216,000  
XML 43 R32.htm IDEA: XBRL DOCUMENT v3.4.0.3
Commitments and Contingencies (Details Textual) - Fort Lauderdale Florida Facility [Member] - USD ($)
 3 Months Ended
Mar. 31, 2016
Mar. 31, 2015
Commitments (Textual)    
Extended expiration date of lease Dec. 31, 2023  
Minimum base rent $ 94,800  
Maximum annual percentage increase in base rent 2.00%  
Period to review term of lease 3 years  
Rent expense under the lease $ 24,000 $ 24,000
XML 44 R33.htm IDEA: XBRL DOCUMENT v3.4.0.3
Loss Per Share (Details) - USD ($)
 3 Months Ended
Mar. 31, 2016
Mar. 31, 2015
Earnings per common share - Basic    
Net loss $ (540,802) $ (15,926)
Weighted average number of common shares outstanding 8,985,858 8,920,288
Loss per common share - Basic and Diluted $ (0.06) $ 0.00
XML 45 R34.htm IDEA: XBRL DOCUMENT v3.4.0.3
Loss Per Share (Details Textual) - shares
 3 Months Ended
Mar. 31, 2016
Mar. 31, 2015
Earnings Per Share (Textual)    
Anti-dilutive stock options outstanding 57,509 99,689
XML 46 R35.htm IDEA: XBRL DOCUMENT v3.4.0.3
Securities Authorized for Issuance under Equity Compensation Plans (Details)
 3 Months Ended
Mar. 31, 2016
$ / shares
shares
Summary of outstanding options, exercisable options, exercise price, expiration date, weighted average remaining life under company stock option plans  
Shares Underlying Options Outstanding 100,000
Shares Underlying Exercisable Options 100,000
Exercise Price | $ / shares $ 1.22
Weighted Average Remaining Term 2 years 7 months 6 days
2002NQ One [Member]  
Summary of outstanding options, exercisable options, exercise price, expiration date, weighted average remaining life under company stock option plans  
Date Granted Dec. 17, 2007
Shares Underlying Options Outstanding 40,000
Shares Underlying Exercisable Options 40,000
Exercise Price | $ / shares $ 1.32
Expiration Date Dec. 16, 2017
Weighted Average Remaining Term 1 year 8 months 12 days
2008NQ One [Member]  
Summary of outstanding options, exercisable options, exercise price, expiration date, weighted average remaining life under company stock option plans  
Date Granted Jan. 11, 2009
Shares Underlying Options Outstanding 40,000
Shares Underlying Exercisable Options 40,000
Exercise Price | $ / shares $ 0.69
Expiration Date Jan. 10, 2019
Weighted Average Remaining Term 2 years 9 months 18 days
2008NQ Two [Member]  
Summary of outstanding options, exercisable options, exercise price, expiration date, weighted average remaining life under company stock option plans  
Date Granted Apr. 26, 2010
Shares Underlying Options Outstanding 20,000
Shares Underlying Exercisable Options 20,000
Exercise Price | $ / shares $ 2.07
Expiration Date Apr. 25, 2020
Weighted Average Remaining Term 4 years 1 month 6 days
XML 47 R36.htm IDEA: XBRL DOCUMENT v3.4.0.3
Securities Authorized for Issuance under Equity Compensation Plans (Details Textual) - USD ($)
 3 Months Ended
Mar. 31, 2016
Mar. 31, 2015
Securities Authorized for Issuance Under Equity Compensation Plans (Textual)    
Stock option exercised 30,000  
Total Number of shares received in connection with net exercise feature of options 21,600  
Number of shares withhold in connection with net exercise feature of options 4,519  
Shares issued to option holders 25,481  
Stock compensation expense $ 0 $ 0
Unrecognized compensation expense related to stock options $ 0  
Stock awards issued 0 0
XML 48 R37.htm IDEA: XBRL DOCUMENT v3.4.0.3
Special Cash Dividend (Details)
 3 Months Ended
Mar. 31, 2016
USD ($)
$ / shares
shares
Special Cash Dividend [Abstract]  
Dividends declared per common share | $ / shares $ 0.06
Common stock, shares outstanding | shares 9,008,855
Dividends payable | $ $ 540,531
EXCEL 49 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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end XML 50 Show.js IDEA: XBRL DOCUMENT /** * Rivet Software Inc. * * @copyright Copyright (c) 2006-2011 Rivet Software, Inc. All rights reserved. * Version 2.4.0.3 * */ var Show = {}; Show.LastAR = null, Show.hideAR = function(){ Show.LastAR.style.display = 'none'; }; Show.showAR = function ( link, id, win ){ if( Show.LastAR ){ Show.hideAR(); } var ref = link; do { ref = ref.nextSibling; } while (ref && ref.nodeName != 'TABLE'); if (!ref || ref.nodeName != 'TABLE') { var tmp = win ? win.document.getElementById(id) : document.getElementById(id); if( tmp ){ ref = tmp.cloneNode(true); ref.id = ''; link.parentNode.appendChild(ref); } } if( ref ){ ref.style.display = 'block'; Show.LastAR = ref; } }; Show.toggleNext = function( link ){ var ref = link; do{ ref = ref.nextSibling; }while( ref.nodeName != 'DIV' ); if( ref.style && ref.style.display && ref.style.display == 'none' ){ ref.style.display = 'block'; if( link.textContent ){ link.textContent = link.textContent.replace( '+', '-' ); }else{ link.innerText = link.innerText.replace( '+', '-' ); } }else{ ref.style.display = 'none'; if( link.textContent ){ link.textContent = link.textContent.replace( '-', '+' ); }else{ link.innerText = link.innerText.replace( '-', '+' ); } } }; XML 51 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 53 FilingSummary.xml IDEA: XBRL DOCUMENT 3.4.0.3 html 33 169 1 false 14 0 false 4 false false R1.htm 001 - Document - Document and Entity Information Sheet http://www.oceanbiochem.com/role/Documentandentityinformation Document and Entity Information Cover 1 false false R2.htm 002 - Statement - Consolidated Balance Sheets Sheet http://www.oceanbiochem.com/role/ConsolidatedBalanceSheets Consolidated Balance Sheets Statements 2 false false R3.htm 003 - Statement - Condensed Consolidated Balance Sheets (Parenthetical) Sheet http://www.oceanbiochem.com/role/CondensedConsolidatedBalanceSheetsParenthetical Condensed Consolidated Balance Sheets (Parenthetical) Statements 3 false false R4.htm 004 - Statement - Condensed Consolidated Statements of Operations (Unaudited) Sheet http://www.oceanbiochem.com/role/CondensedConsolidatedStatementsOfOperationsUnaudited Condensed Consolidated Statements of Operations (Unaudited) Statements 4 false false R5.htm 005 - Statement - Condensed Consolidated Statements of Comprehensive Income (Unaudited) Sheet http://www.oceanbiochem.com/role/CondensedConsolidatedStatementsOfComprehensiveIncomeUnaudited Condensed Consolidated Statements of Comprehensive Income (Unaudited) Statements 5 false false R6.htm 006 - Statement - Condensed Consolidated Statements of Cash Flows (Unaudited) Sheet http://www.oceanbiochem.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited Condensed Consolidated Statements of Cash Flows (Unaudited) Statements 6 false false R7.htm 007 - Disclosure - Summary of Accounting Policies Sheet http://www.oceanbiochem.com/role/SummaryOfAccountingPolicies Summary of Accounting Policies Notes 7 false false R8.htm 008 - Disclosure - Recent Accounting Pronouncements Sheet http://www.oceanbiochem.com/role/RecentAccountingPronouncements Recent Accounting Pronouncements Notes 8 false false R9.htm 009 - Disclosure - Inventories Sheet http://www.oceanbiochem.com/role/Inventories Inventories Notes 9 false false R10.htm 010 - Disclosure - Property, Plant & Equipment Sheet http://www.oceanbiochem.com/role/PropertyPlantEquipment Property, Plant & Equipment Notes 10 false false R11.htm 011 - Disclosure - Revolving Line of Credit Sheet http://www.oceanbiochem.com/role/RevolvingLineOfCredit Revolving Line of Credit Notes 11 false false R12.htm 012 - Disclosure - Long Term Debt Sheet http://www.oceanbiochem.com/role/LongTermDebt Long Term Debt Notes 12 false false R13.htm 013 - Disclosure - Related Party Transactions Sheet http://www.oceanbiochem.com/role/RelatedPartyTransactions Related Party Transactions Notes 13 false false R14.htm 014 - Disclosure - Commitments and Contingencies Sheet http://www.oceanbiochem.com/role/Commitmentsandcontingencies Commitments and Contingencies Notes 14 false false R15.htm 015 - Disclosure - Loss Per Share Sheet http://www.oceanbiochem.com/role/LossPerShare Loss Per Share Notes 15 false false R16.htm 016 - Disclosure - Securities Authorized for Issuance under Equity Compensation Plans Sheet http://www.oceanbiochem.com/role/SecuritiesAuthorizedForIssuanceUnderEquityCompensationPlans Securities Authorized for Issuance under Equity Compensation Plans Notes 16 false false R17.htm 017 - Disclosure - Special Cash Dividend Sheet http://www.oceanbiochem.com/role/SpecialCashDividend Special Cash Dividend Notes 17 false false R18.htm 018 - Disclosure - Summary of Accounting Policies (Policies) Sheet http://www.oceanbiochem.com/role/SummaryOfAccountingPoliciesPolicies Summary of Accounting Policies (Policies) Policies http://www.oceanbiochem.com/role/SummaryOfAccountingPolicies 18 false false R19.htm 019 - Disclosure - Inventories (Tables) Sheet http://www.oceanbiochem.com/role/INVENTORIESTables Inventories (Tables) Tables http://www.oceanbiochem.com/role/Inventories 19 false false R20.htm 020 - Disclosure - Property, Plant & Equipment (Tables) Sheet http://www.oceanbiochem.com/role/PropertyPlantEquipmentTables Property, Plant & Equipment (Tables) Tables http://www.oceanbiochem.com/role/PropertyPlantEquipment 20 false false R21.htm 021 - Disclosure - Long Term Debt (Tables) Sheet http://www.oceanbiochem.com/role/LongTermDebtTables Long Term Debt (Tables) Tables http://www.oceanbiochem.com/role/LongTermDebt 21 false false R22.htm 022 - Disclosure - Loss Per Share (Tables) Sheet http://www.oceanbiochem.com/role/LossPerShareTables Loss Per Share (Tables) Tables http://www.oceanbiochem.com/role/LossPerShare 22 false false R23.htm 023 - Disclosure - Securities Authorized for Issuance under Equity Compensation Plans (Tables) Sheet http://www.oceanbiochem.com/role/SecuritiesAuthorizedForIssuanceunderEquityCompensationPlansTables Securities Authorized for Issuance under Equity Compensation Plans (Tables) Tables http://www.oceanbiochem.com/role/SecuritiesAuthorizedForIssuanceUnderEquityCompensationPlans 23 false false R24.htm 024 - Disclosure - Inventories (Details) Sheet http://www.oceanbiochem.com/role/INVENTORIESDetails Inventories (Details) Details http://www.oceanbiochem.com/role/INVENTORIESTables 24 false false R25.htm 025 - Disclosure - Inventories (Details Textual) Sheet http://www.oceanbiochem.com/role/INVENTORIESDetailsTextual Inventories (Details Textual) Details http://www.oceanbiochem.com/role/INVENTORIESTables 25 false false R26.htm 026 - Disclosure - Property, Plant & Equipment (Details) Sheet http://www.oceanbiochem.com/role/PropertyPlantEquipmentDetails Property, Plant & Equipment (Details) Details http://www.oceanbiochem.com/role/PropertyPlantEquipmentTables 26 false false R27.htm 027 - Disclosure - Revolving Line of Credit (Details) Sheet http://www.oceanbiochem.com/role/RevolvingLineOfCreditDetails Revolving Line of Credit (Details) Details http://www.oceanbiochem.com/role/RevolvingLineOfCredit 27 false false R28.htm 028 - Disclosure - Long Term Debt (Details) Sheet http://www.oceanbiochem.com/role/LongTermDebtDetails Long Term Debt (Details) Details http://www.oceanbiochem.com/role/LongTermDebtTables 28 false false R29.htm 029 - Disclosure - Long Term Debt (Details 1) Sheet http://www.oceanbiochem.com/role/LongTermDebtDetails1 Long Term Debt (Details 1) Details http://www.oceanbiochem.com/role/LongTermDebtTables 29 false false R30.htm 030 - Disclosure - Long Term Debt (Details Textual) Sheet http://www.oceanbiochem.com/role/LongTermDebtDetailsTextual Long Term Debt (Details Textual) Details http://www.oceanbiochem.com/role/LongTermDebtTables 30 false false R31.htm 031 - Disclosure - Related Party Transactions (Details Textual) Sheet http://www.oceanbiochem.com/role/RelatedPartyTransactionsDetailsTextual Related Party Transactions (Details Textual) Details http://www.oceanbiochem.com/role/RelatedPartyTransactions 31 false false R32.htm 032 - Disclosure - Commitments and Contingencies (Details Textual) Sheet http://www.oceanbiochem.com/role/CommitmentsAndContingenciesDetailsTextual Commitments and Contingencies (Details Textual) Details http://www.oceanbiochem.com/role/Commitmentsandcontingencies 32 false false R33.htm 033 - Disclosure - Loss Per Share (Details) Sheet http://www.oceanbiochem.com/role/LossPerShareDetails Loss Per Share (Details) Details http://www.oceanbiochem.com/role/LossPerShareTables 33 false false R34.htm 034 - Disclosure - Loss Per Share (Details Textual) Sheet http://www.oceanbiochem.com/role/LossPerShareDetailsTextual Loss Per Share (Details Textual) Details http://www.oceanbiochem.com/role/LossPerShareTables 34 false false R35.htm 035 - Disclosure - Securities Authorized for Issuance under Equity Compensation Plans (Details) Sheet http://www.oceanbiochem.com/role/SecuritiesAuthorizedForIssuanceunderEquityCompensationPlansDetails Securities Authorized for Issuance under Equity Compensation Plans (Details) Details http://www.oceanbiochem.com/role/SecuritiesAuthorizedForIssuanceunderEquityCompensationPlansTables 35 false false R36.htm 036 - Disclosure - Securities Authorized for Issuance under Equity Compensation Plans (Details Textual) Sheet http://www.oceanbiochem.com/role/SecuritiesAuthorizedForIssuanceUnderEquityCompensationPlansDetailsTextual Securities Authorized for Issuance under Equity Compensation Plans (Details Textual) Details http://www.oceanbiochem.com/role/SecuritiesAuthorizedForIssuanceunderEquityCompensationPlansTables 36 false false R37.htm 037 - Disclosure - Special Cash Dividend (Details) Sheet http://www.oceanbiochem.com/role/SpecialCashDividendDetails Special Cash Dividend (Details) Details http://www.oceanbiochem.com/role/SpecialCashDividend 37 false false All Reports Book All Reports obci-20160331.xml obci-20160331.xsd obci-20160331_cal.xml obci-20160331_def.xml obci-20160331_lab.xml obci-20160331_pre.xml true true ZIP 55 0001213900-16-013366-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001213900-16-013366-xbrl.zip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end